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ABSTRACT 
Background: Hypovitaminosis D is a major health concern in the UK. Reduced sunshine 
exposure and limited dietary sources of vitamin D, coupled with other factors lead to 
increased risk of hypovitaminosis D among the whole population especially amongst 
ethnic minorities (EMGs) due to their eating habits and high skin pigmentation. Vitamin 
D3 supplement is the most common form of vitamin D used today to correct deficiency, 
however, evidence shows that calcifediol may increase vitamin D levels more rapidly. 
Aims: To determine differences in the risk factors for hypovitaminosis D among different 
EMGs in the UK, and to investigate the efficacy of calcifediol supplementation, and its 
effect on improving vitamin D levels in deficient adults from EMGs. 
Methods: A self-reported questionnaire was completed by 253 participants to assess sun 
exposure behaviours and lifestyle factors. Food frequency questionnaire (FFQ) was used 
to estimate vitamin D intake. Overall, seventy-four ethnic minority participants had their 
vitamin D level measured.  42 of these participants had a vitamin D level ≤30 nmol/l and 
were subsequently supplemented with 140 µg/week of calcifediol for 5 weeks. 
Results: Dietary intake of vitamin D and supplement intake were low among all 
participants regardless of ethnicity (P>0.05). Ethnic differences were found in 
socioeconomic status, time spent outdoors and sun index (p<0.001). Other risk factors 
included being overweight or obese (64% Arab and 39% Afro/Caribbean); smoking and 
alcohol intake (13.3% Arab, 45.5% Afro/Caribbean); history of vitamin D deficiency (35% 
Arab and 24% South Asian). Vitamin D level was low across all of the population studied 
(29.9 nmol/l), dietary intake of vitamin D (1.26 µg) and total intake of vitamin D (2.83 
µg). The median level of 25(OH)D (26.6 nmol/l) significantly increased rapidly to more 
than ≥75 nmol/l (151.4) in all groups, it declined over the next 5 weeks after supplement 
termination, while nevertheless remaining above the baseline value (55.9 nmol/l). 
Conclusion: Dietary habits and sun exposure behaviours varied between EMGs, but they 
all were at risk of developing vitamin D deficiency. The calcifediol supplement was found 
to improve vitamin D status in all the groups and resulted in improved levels even after 
the five week termination period. 
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1. INTRODUCTION
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1.1 General introduction 
Since the discovery of skeletal diseases such as rickets many decades ago, there has been 
considerable interest in the role played by vitamin D in human health. Findings show that 
vitamin D deficiency is a significant concern at the population level and that rates of this 
health risk are increasing worldwide. Therefore, significant attention has been directed 
to investigating this issue; not only by dietitians, medical practitioners and researchers, 
but also by organizations and governments. As a result of this interest, the role of the 
active component, calcitriol (1,25(OH)2D3), has been well described. Beside its role in 
controlling calcium homeostasis, where the deficiency causes rickets in children and 
osteomalacia in adults (Holick and Chen, 2008), it also regulates hormone secretion and 
is associated with anti-proliferative and immunomodulatory effects, as well as regulating 
almost 200 genes around the body by binding with vitamin D receptors (VDRs) (Gropper 
and Smith, 2012; Bikle, 2014). Epidemiological studies have demonstrated that vitamin 
D insufficiency is related to various adverse health outcomes associated with major 
diseases such as cancer (Grant, 2016; Jeon and Shin, 2018), immune dysfunction (Cutolo 
and Otsa, 2008), cardiovascular diseases (Pludowski et al., 2013a), type 1 diabetes 
(Palermo and Holick, 2017) and hypertension (Vimaleswaran et al., 2014). However, 
casual relationships between vitamin D and non-skeletal disorders have not been clearly 
established (Autier et al. 2014). 
Globally, hypovitaminosis D in humans is defined as a low concentration of serum 25-
hydroxyvitamin D [25(OH)D], meaning a level of ≤25 nmol/L (SACN, 2007; Cancer 
Research UK, 2010), whereas a level of at least 75 nmol/L is considered optimal (Dawson-
Hughes et al., 2005; Holick et al., 2011; Sinha et al., 2013), although the optimal level is 
still the subject of debate. Symptoms of vitamin D deficiency can be severe, affecting 
general health and causing fatigue and muscle pain (Pearce and Cheetham, 2010; Holick 
et al., 2011). However, outward symptoms may not necessarily be apparent to an 
individual, therefore, vitamin D screening of the whole population should ideally be 
undertaken periodically. 
The principal and richest source of vitamin D in the UK is its cutaneous synthesis by 
exposing the skin to ultraviolet B (UVB) radiation from sunlight. However, UVB is 
accessible in sufficient quantities for only part of the year (typically April to September), 
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due to the relatively high latitude of the UK (Lanham‐New et al., 2016; Webb et al., 2018). 
Vitamin D is also present in some foods, such as egg yolk, oily fish and wild mushrooms, 
but as foods containing vitamin D are limited, it can be difficult to maintain sufficient 
dietary intake over the winter months. Individuals can benefit from vitamin D reserves 
built up during the summertime to sustain a sufficient vitamin D level during the 
wintertime (Cannell and Hollis, 2008). However, it is now clear that this is not achievable 
for the entire population, as many individuals have hypovitaminosis D all year round. The 
National Diet and Nutrition Survey (NDNS) reports that vitamin D deficiency (<25 nmol/L) 
affects 24% of men and 22% of women year round, while between January and March 
levels rise to 39% in both sexes (Bates et al., 2014). 
According to previous studies of the prevalence of vitamin D deficiency among the British 
regions, Scotland and the northwest of England have been highlighted as at particular 
risk (Pal et al., 2003; Hyppönen and Power, 2007;  Macdonald et al., 2008; Hirani et al., 
2009; Mavroeidi et al., 2010; Zgaga et al., 2011). Vitamin D deficiency/insufficiency is 
prevalent not only in the UK but worldwide (Hilger et al., 2014; Van Schoor and Lips, 
2017). According to Spiro and Buttriss, (2014) vitamin D deficiency has been found in 2-
30 % of European adults. In the UK, there is also a high proportion of the ethnic minority 
population considered at risk of vitamin D deficiency due to environmental and lifestyle 
factors, as reported in South Asian (Darling et al., 2013), Middle Eastern (Ahmed et al., 
2013) and Black African populations (Maxwell et al., 2006). 
The Scientific Advisory Committee on Nutrition (SACN) has set a recent recommendation 
for adults aged ≥18 years to take a dose of 10 micrograms per day (µg/d) (SACN, 2015); 
this dose can be sufficient to sustain a vitamin D levels of >25 nmol/L, but may not be 
beneficial in relation to non-skeletal outcomes. Considering the absence of sufficient 
UVB skin irradiation in wintertime and limited dietary sources rich in vitamin D, it remains 
problematic to achieve a sufficiently high intake of vitamin D. Nonetheless, vitamin D 
supplementation is considered an effective way to maintain and correct vitamin D 
deficiency. Vitamins D3 and D2 are common subtypes of vitamin D, which are usually 
prescribed by clinicians and practitioners in cases of deficient levels of serum 25(OH)D. 
Several trials have examined which different sources of vitamin D most effectively 
correct vitamin D deficiency and make it possible to reach sufficient 25(OH)D 
concentration. Interventions can include oral intake of vitamin D (supplement and food) 
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(Vieth et al., 2001; Heaney et al., 2003a; Armas et al., 2004; Aloia et al., 2008; Cashman 
et al., 2008; Gupta et al., 2010; Hashemipour et al., 2012; Gallagher et al., 2014) and 
exposure to ultraviolet light, whether natural or artificial (Rhodes et al., 2010; Wicherts 
et al., 2011; Farrar et al., 2013; Lagunova et al., 2013).    
1.2  Study rationale  
From the literature, it is clear that the rate of vitamin D deficiency/insufficiency is high 
among the population worldwide. In the UK, and particularly in Manchester, a high 
percentage of vitamin D deficiency would be expected. As the richest source of vitamin 
D is cutaneous synthesis, the limited sunlight, when coupled with high skin pigmentation 
among certain ethnic groups, reduces the ability of individuals to produce vitamin D, 
particularly placing darker-skinned people at risk of vitamin D deficiency. 
This is important from a population-based perspective, as a large number of immigrants 
from Asia and Africa have settled in Manchester, comprising 33.3% of the total 
population, and the number is increasing constantly (Manchester City Council, 2015). 
Coupled with the potential health consequences of vitamin D deficiency and the 
potential costs associated with these adverse outcomes, a higher priority should be given 
to prevention. 
Owing to the limited number of studies in this field and the lack of ethnic/cultural 
minorities in the sampled populations, a thorough investigation into the variables known 
to influence vitamin D status is lacking. In order to inform potentially beneficial 
interventions to address this problem, there is a need for an in-depth study involving 
adults at risk of hypovitaminosis D among the main ethnic minority groups (EMGs) living 
in the UK: Arabs, South Asians, Afro/Caribbeans and East Asians. The research reported 
in this thesis makes a valuable contribution to exploring differences among ethnic 
minorities living in Manchester (53°N) who are known to be susceptible to the risk of 
hypovitaminosis D, by describing differences in vitamin D intake and lifestyle factors. In 
addition, further research is needed to make sensible recommendations regarding which 
actions should be adopted or avoided to successfully attain the optimal level of vitamin 
D for different ethnic groups. 
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The effect of vitamin D supplementation with cholecalciferol (D3) or ergocalciferol (D2) 
has been assessed in numerous studies, with the aim of improving vitamin D levels in 
adults (Vieth et al., 2001; Heaney et al., 2003a; Barnes et al., 2006). Recent studies 
relating to the efficacy of calcifediol have been relatively scant, carried out 
predominantly on older Caucasians (Cavalli et al., 2009; Bischoff-Ferrari et al., 2012; 
Cashman et al., 2012; Jetter et al., 2014), with very few studies involving young adults 
(Barger-Lux et al., 1998; Russo et al., 2011; Shieh et al., 2017). To the best of the author’s 
knowledge, there are no published studies focusing on multi-ethnic minority adults in 
the UK. Additionally, calcifediol is not currently commercially available in the UK as a 
nutritional supplement or as a therapeutic drug. Thus, this study will provide an insight 
into the effect of this supplement for treating hypovitaminosis D, before it becomes 
commercially available in the UK. 
The PhD thesis attempts to: 
1. Produce a clear comparison data in diet and lifestyle factors between ethnic 
minority groups living in the UK, who could be susceptible to the risk of 
hypovitaminosis D. 
2. Emphasis the recommendations regarding lifestyle factors that could improve the 
vitamin D status for different ethnic minority groups. 
3. Provide a new knowledge in vitamin D research regarding the effect of calcifediol 
supplementation on improving vitamin D level among EMGs in the UK. 
1.3 Research aims and objectives 
Study 1: Risk factors influencing the vitamin D status of ethnic minority adults living in 
Manchester. 
Aim 
 Investigate differences in the risk factors for vitamin D deficiency between ethnic 
minority groups. 
Objectives 
 Estimate vitamin D intake for the main ethnic minority groups living in 
Manchester from dietary sources, supplement use and sun exposure using a 
questionnaire. 
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 Evaluate lifestyle factors and sun exposure behaviours that could affect 
estimated total intake of vitamin D. 
Study 2: Association of vitamin D intake and other risk factors with 25(OH)D 
concentrations  in ethnic minority adults living in Manchester. 
Aim 
 Examine the association between dietary intake, lifestyle factors and 25(OH)D 
concentrations among ethnic minority adults. 
Objectives 
 Estimate vitamin D intake for Arab, South Asian and Black African from dietary 
sources, supplement use and sun exposure using a questionnaire. 
 Measure serum 25(OH)D concentrations for ethnic minority participants. 
 Determine the diet and lifestyle factors that affect vitamin D status among ethnic 
minority adults. 
Study 3: The efficacy of calcifediol supplementation in increasing 25(OH)D 
concentration. 
Aim 
 Investigate the efficacy of calcifediol supplementation, and its effects on 
improving vitamin D levels in deficient adults from ethnic minority groups. 
Objectives 
 Investigate the effect of 140 µg/week calcifediol supplementation on vitamin D 
levels among deficient ethnic minority participants. 
 Measure serum 25(OH)D concentrations for ethnic minority participants after 
five weeks of supplementation. 
 Examine the persistence effects of calcifediol after five weeks of termination of 
supplementation. 
 Analysis of serum 25(OH)D concentrations at baseline (pre-intervention), mid-
intervention and post-intervention. 
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1.4 Thesis structure 
The remainder of the thesis is structured as follows: Chapter 2 reviews the 
relevant literature, Chapters 3, 4 and 5 report the conduct and results of studies 
1, 2 and 3 respectively, then the work concludes with a general discussion in 
Chapter 6. 
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2. LITERATURE REVIEW
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2.1 Vitamin D 
2.1.1 Vitamin D forms and sources 
Vitamin D metabolites are a group of fat-soluble secosteroids consisting of two 
bioequivalent forms, cholecalciferol (vitamin D3) and ergocalciferol (Vitamin D2) (Norman, 
2012). The structure of vitamin D is shown in Figure 2.1.  Vitamin D3 can be obtained from 
sunlight exposure, diet and supplementation, while vitamin D2 is obtained only from diet 
or supplementation.  
 
Figure 2.1: The chemical structure of vitamin D2 and D3 (Source: Holick, 2007) 
2.1.1.1 Cutaneous synthesis 
Vitamin D3 is a hormone that can be produced naturally in the body through exposure of 
the skin to UVB from either sunlight or artificial light at wavelengths between 290 and 315 
nanometres (nm) (Nair and Maseeh, 2012). The effects of ultraviolet radiation differ 
according to its wavelength: long wavelength UVA can penetrate the dermis (below the 
surface of the skin), causing tanning and ultimately skin ageing and wrinkling, while 
medium wavelength UVB can penetrate only the epidermis but burns the surface of the 
skin and is considered a key factor in skin cancer development (Narayanan et al., 2010). 
Cutaneous synthesis is the most effective mode of vitamin D production, far exceeding that 
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which can be obtained from dietary sources (Spiro and Buttriss, 2014). It has been reported 
that the best time to produce sufficient levels of vitamin D by exposing the body to sunlight 
is between 10 am and 3 pm in all seasons except winter (Holick et al., 2011). Exposing the 
whole body to sunlight for one minimal erythemal dose, which is broadly defined as 
developing a pinkness of skin, produces the equivalent of 250 µg (Macdonald, 2013) to 400 
µg of vitamin D3 (Tsiaras and Weinstock, 2011). The difference in these values may be 
explained by differential cutaneous synthesis of vitamin D dependent upon extraneous 
factors, including age and body weight (Tsiaras and Weinstock, 2011). Alternatively, Webb 
et al. (2018) state that exposure of a quarter of the body (face, arms and hands) to the UK 
summer sun could produce at least 25 µg of vitamin D3. 
2.1.1.2 Diet and vitamin D fortified food 
Vitamin D is also obtained from natural dietary sources in animal-related foods such as egg 
yolk, oily fish (salmon, mackerel, herring and sardines), liver and cod liver oil (Schmid and 
Walther, 2013), or from non-animal sources such as wild mushrooms, which are rich in 
vitamin D2 ( Gropper and Smith, 2012). Because natural foodstuffs containing vitamin D are 
limited, many countries fortify certain food products with vitamin D2/D3 (Calvo and 
Whiting, 2013). However, fortification practices vary from country to country and may be 
either optional or mandatory. In the UK, food fortification is governed by strict legislation, 
limiting its application (Sinha et al., 2013). Only certain foods such as margarine and infant 
milk are mandatorily fortified with vitamin D (SACN, 2007), with voluntary fortification of 
products such as soya and breakfast cereals (NHS, 2011). In addition, Jakobsen and 
Knuthsen (2014) report that vitamin D content may be affected by cooking, depending on 
the particular foodstuff and the cooking temperature. 
2.1.1.3 Supplementation  
Vitamin D is available in a range of licensed medicines and food supplements as vitamin D3 
or D2 and can be administrated either orally or by intramuscular injection. In the UK, most 
supplemental vitamin D is the D3 form, provided in doses of 5 to 25 μg without a 
prescription, and it may be included as an ingredient in multivitamin and calcium 
supplements (Sinha et al., 2013). Vitamin D deficiency can be also corrected by vitamin D 
metabolites such as calcifediol (25(OH)D3), which is available in some European countries 
but not in the UK. The quantity of vitamin D in either foods or supplements is expressed in 
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micrograms (μg), or in International Units (IU); 1 µg= 40 IU (Ross et al., 2011). Calcifediol is 
expressed only in μg when used as a supplement (Brandi and Minisola, 2013; Cianferotti et 
al., 2015). Vitamin D supplementation will be discussed later in this chapter (Section 2.6).    
2.1.2 Vitamin D metabolism 
Whilst dietary vitamin D3/D2 is initially processed via different metabolic pathways as 
compared to cutaneously produced vitamin D3, they both undergo the same pathway at 
the biological activation phase (Figure 2.2). 
Digested vitamin D2 and D3 are absorbed by passive diffusion in the small intestine into 
enterocytes, then incorporated into chylomicrons and carried by the lymphatic system into 
the blood circulation. From there, the vitamin D is transported by vitamin D binding protein 
(VDBP) or lipoproteins (chylomicrons) to the liver (DeLuca, 2004). As vitamin D is fat-
soluble, excess amounts can be stored in adipose tissue for up to eight weeks and used 
when required (Tsiaras and Weinstock, 2011). 
The process of cutaneous vitamin D synthesis starts in the skin, where UVB radiation is 
absorbed and converts 7-dehydrocholesterol (7-DHC) into pre-vitamin D3, which isomerizes 
under the body’s temperature conditions to form vitamin D3 (Holick, 2008; Tsiaras and 
Weinstock, 2011). This is diffused into the capillary system by VDBP and then into the liver 
(Holick, 2008).  
The biological activation of vitamin D, irrespective of its source, occurs in the liver. Vitamin 
D is metabolized to 25-hydroxyvitamin D (25(OH)D) (inactive vitamin D) via the vitamin D-
25-hydroxylase enzymes (CYP2R1 and CYP27B1) produced from cytochrome P450 (Gropper 
and Smith, 2012). 25(OH)D in the bloodstream binds to VDBP and is then transported to 
the kidneys, where further hydroxylation occurs. It is converted to 24,25-dihydroxyvitamin 
D (24,25(OH)2D) via the enzyme 24-hydroxylase or to the biologically active form, 1,25-
dihydroxyvitamin D [1,25(OH)2D] (calcitriol) by the enzyme 25(OH)D-1α-hydroxylase, such 
as CYP27A1 (Christakos et al., 2015). In the kidneys, the production of 1,25(OH)2D increases 
when serum 25(OH)D is low and vice versa (Norman, 2012). 
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Figure 2.2: Vitamin D metabolism (Source: Tsiaras and Weinstock, 2011) 
 
Previously, it was believed that the second hydroxylation occurs only in the kidneys, but 
current evidence has shown that 1,25(OH)2D is produced in other tissues such as the 
prostate and colon (Anderson et al., 2003), as shown in Figure 2.3. 
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Figure 2.3: Tissues capable of synthesis 1,25(OH)2D (Source: Hollis and Wagner, 2006) 
2.1.3 Mechanism of vitamin D action 
Vitamin D (1,25(OH)2D) is released into the bloodstream and binds to intracellular vitamin 
D receptors (VDRs), then acts as transcription factors to modulate gene expression (Holick, 
2010; Christakos et al., 2013), eventually triggering a biological reaction. This can either be 
the stimulation of intestinal absorption of calcium or providing the appropriate balance of 
elements crucial for bone function and growth (Holick, 2010). The primary role of 
1,25(HO)2D is to act with parathyroid hormone (PTH), which is essential for regulating and 
maintaining blood levels of both calcium and phosphate for bone mineralisation, 
contraction of muscles and prevention of hypercalcaemia by optimising intestinal calcium 
absorption (DeLuca, 2004) (Figure 2.3). During hypovitaminosis D, PTH secretion increases, 
resulting in an increase in the production of 1,25(OH)2D, thus promoting absorption of 
calcium from bone and potential skeletal disorders (Visser et al., 2003). 
2.1.4 Assessment of vitamin D status  
2.1.4.1 Biochemical assessment 
There is a consensus of opinion that circulating level of serum 25(OH)D is the best indicator 
of vitamin D status, reflecting the incoming contributions of vitamin D from either diet 
and/or cutaneous synthesis (DeLuca, 2004; Seamans and Cashman, 2009). The half-life of 
25(OH)D, at approximately three weeks (Prentice et al., 2008), is relatively long when 
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compared to that of 1,25(OH)2D, which is only 4-6 hours (Lips, 2007). Circulating 25(OH)D 
is measured in nanomoles per litre (nmol/L) or nanograms per millilitre (ng/ml); 1 ng/ml = 
2.5 nmol/L.  
Although serum or plasma samples are routinely used in clinical practice, dried blood spot 
(DBS) sampling has more recently been successfully used for the analysis of a range of 
circulating biological compounds, with valid, reliable and accurate results as compared to 
serum or plasma (Spooner et al., 2009; Lehmann et al., 2013; Heath et al., 2014). In relation 
to vitamin D, a number of comparative studies have shown that DBS results were highly 
correlated with plasma measurements and there were no statistical differences in 
25(OH)D3 concentration ( Newman et al., 2009; Heath et al., 2014; Shea and Berg, 2017).  
Many methods have been used to measure serum 25(OH)D concentrations, including 
immunoassay and chromatography (Hollis, 2008). Examples of the former are competitive 
protein binding assays (Preece et al., 1974) and enzyme immunoassay (Hollis, 2008), 
whereas for the latter, high-performance liquid chromatography (HPLC) has been coupled 
with a mass spectrometry (MS) methodology (Carter, 2009). Liquid Chromatography-
Tandem Mass Spectrometry (LC-MS/MS), which is applied in the current study, has been 
recently proven as superior to other techniques; it can differentiate between 25(OH)D3 and 
25(OH)D2 (Hedman et al., 2014), whereas all immunoassays are unable to do so. According 
to Binkley et al. (2004), measurement of serum 25(OH)D levels often varies from study to 
study because of the different laboratories and assay methodologies used. Historically, the 
measurement of serum 25(OH)D faced a major challenge related to the absence of 
international standards or a common calibrator, leading to difficulties in comparing results 
from different laboratories and assays (Carter, 2009). More recently, most commercial 
manufacturers have started to adopt a standard reference, produced by the National 
Institute of Standards and Technology for use with LC-MS/MS or HPLC methods (Binkley et 
al., 2014).  
2.1.4.2 Nutritional assessment 
Dietary assessment is employed to assess the food consumption and nutrient intake of 
different groups (Coulston et al., 2017). There are several types of assessment to measure 
nutrient intake, including recalls and records, such as 24-hour dietary recall, dietary history 
and Food Frequency Questionnaires (FFQs). These have been used in national surveys, as 
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well as in household and individual analyses (Gibson, 2005). The selection of an appropriate 
method for any study depends on the type of study and the level of information required 
(Gibson, 2005; Coulston et al., 2017). 
FFQs are the preferred method of assessing dietary intakes in epidemiologic studies 
(Thompson et al., 1994). They are designed to assess participants’ eating patterns and 
which specific foods they usually consume by asking them to state the frequency of 
consumption of each food item listed over a specified period (Gibson, 2005). The many 
advantages of using an FFQ to assess nutritional status include low cost, self-administration 
and the ability to collect data from a large population sample. These have made this the 
most commonly used technique among researchers (Barrett-Connor, 1991; Metcalf et al., 
2003; Liu et al., 2013). A number of different types of FFQ have been used in 
epidemiological studies of diet and health, particularly related to disease (Rockett et al., 
1995; Kalantar-Zadeh et al., 2002). FFQs have also been used in several studies specifically 
relating to vitamin D. For example, they were used to explore the relationship between the 
vitamin D intake and chronic disease by Merlino et al. (2004) and Pittas et al. (2006). 
Additionally, Maxwell et al. (2006) used an FFQ to study the relationship between dietary 
vitamin D intake and hypovitaminosis D. 
2.1.4.3 Sun exposure assessment 
As mentioned above, the richest source of vitamin D is via sunlight exposure. Therefore, 
when assessing vitamin D intake, it is necessary to estimate how much vitamin D is made 
from sunlight exposure, alongside the intake of vitamin D from food and supplements. Sun 
exposure can be estimated by methods such as an electronic UV dosimeter (Thieden et al., 
2004), changes of skin colour (Macdonald et al., 2011) and self-report questionnaire 
(Barger-Lux and Heaney, 2002; Armas et al., 2007; Macdonald et al., 2011; Gould et al., 
2015). 
Self-report questionnaires have been employed when examining other areas of health, 
such as ophthalmological and skin cancer studies (Astner and Anderson, 2004; McCarty, 
2008; Daniel et al., 2009). However, simply considering a country’s latitude does not 
provide an accurate estimate of UV exposure, nor does it assess an individual's sun 
exposure behaviour (Millen and Bodnar, 2008). Sunlight exposure questionnaires have 
tended to be developed ad hoc for individual studies, and as there are no standardised 
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versions, researchers have typically designed new questionnaires or modified existing ones 
(McCarty, 2008). Time outdoors, the areas exposed to sunlight, use of sunscreen and 
sunbathing behaviour are the main factors that should be included in a sun exposure 
questionnaire (McCarty, 2008; Macdonald et al., 2011; Gould et al., 2015). In light of the 
various limitations noted above, McCarty (2008) is justified in stating that using 
questionnaires to assess behaviour or to estimate vitamin D production is not a fully 
reliable method to measure 25(OH)D levels without additional verification methods.  
2.1.5 Classification of vitamin D status 
2.1.5.1 Optimal serum 25(OH)D concentrations 
Internationally, there remains a considerable debate over the optimal 25(OH)D 
concentration cut-offs (from deficiency to optimal levels) (Van Schoor and Lips, 2011; 
Bischoff‐Ferrari et al., 2012; Bouillon et al., 2013). Vitamin D deficiency is defined as having 
a serum 25(OH)D concentration below 25 nmol/L (SACN, 2007; SACN, 2015), relevant to 
protecting against rickets in children and osteomalacia in adults. Heaney (2004) reports 
that the range of 25(OH)D insufficiency lies between 30 and 50 nmol/L, which may lead to 
an increase in adverse health outcomes. However, the Institute of Medicine (IOM) 
considers the deficient level of 25(OH)D to be <30 nmol/L and it defines a sufficient level 
as a 25(OH)D concentration of >50 nmol/L (Ross et al., 2011). IOM cut-offs have also been 
agreed by the National Osteoporosis Society for adoption by UK health practitioners 
(Francis et al., 2013). 
Alternatively, Dawson-Hughes and colleagues (2005) have suggested that the optimal level 
of vitamin D could be defined as a concentration related to maximum suppression of 
parathyroid hormone (PTH), to maximal calcium absorption and to elevated bone mineral 
density (BMD) as well as decreased bone loss. It has been indicated that higher PTH levels 
(>10-65 pg/mL) are evident when 25(OH)D concentrations decrease to 37.5-50 nmol/L (Lips 
et al., 1988; Lips et al., 2014) or to 110 nmol/L (Dawson-Hughes et al., 2005). Potential 
reasons for this wide range of threshold levels are differences in ethnicity, age, calcium 
intake and the assays of serum 25(OH)D used (Bates et al., 2003; Aloia et al., 2006; Prentice 
et al., 2008; Gutierrez et al., 2011). 
Other functional methods suggested to evaluate the optimal level of vitamin D are calcium 
absorption and elevated BMD, with numerous studies suggesting that the threshold for 
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maximal calcium absorption is when serum vitamin D concentrations are at 75 nmol/L 
(Barger-Lux and Heaney, 2002; Heaney et al., 2003b). However, other studies have found 
that BMD correlated positively with a serum 25(OH)D concentration above 100 nmol/L 
(Bischoff-Ferrari et al., 2004). From the preliminary evidence above, it has been suggested 
by the Endocrine Society Task Force that the desirable level of vitamin D concentration is 
at least 75 nmol/L (Bischoff-Ferrari et al., 2006; Cashman et al., 2016) when considering 
other health issues. 
2.1.5.2 Toxicity of vitamin D 
Hypervitaminosis D is the result of the excessive consumption of vitamin D supplements 
(Vieth, 2006) or fortified food (Brown et al. 2013), not of excessive exposure to sunlight (De 
Paula and Rosen, 2012). According to De Paula and Rosen (2012), when pre-vitamin D3 is 
produced after excessive exposure to sunlight, the metabolism of vitamin D in the skin will 
regulate itself and convert the excess to other photoproducts. Vitamin D intoxication 
symptoms are attributable to hypercalcemia (defined as an excess of calcium level in excess 
of 10.6 mg/L in the blood). Symptoms include nausea, increased thirst, depression and 
lethargy (Vieth, 2007). According to Ross et al. (2011), excessive vitamin D levels may be 
correlated to a range of detrimental outcomes, including cardiovascular disease, fractures 
and some types of cancers. The toxic level of vitamin D is still widely disputed (Jones, 2008). 
According to Ross et al. (2011) and Heaney (2005), the safe level of 25(OH)D for children 
and adults is up to 250 nmol/L, whereas a study in animals showed that hypercalcemia 
begins to appear when serum 25(OH)D concentration reaches 375-500 nmol/L (Jones, 
2008). 
2.2 Vitamin D recommendations  
Differing recommendations for vitamin D intake have been set in different countries for 
various life-stage groups. However, Dawson-Hughes et al. (2005) suggested daily doses 
ranging from 10-40 µg to achieve an optimal vitamin D level. 
2.2.1 UK recommendations  
The UK Department of Health has suggested Reference Nutrient Intake (RNI) values of 
vitamin D for infants, adults over 65 years, pregnant women and during lactation (SACN, 
2007), but no RNI had been provided for people aged between 4 and 64 years (Cashman et 
al., 2008; Ashwell et al., 2010) until 2015, when Public Health England’s Scientific Advisory 
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Committee on Nutrition set recommended that they should take a supplement of 10 µg/d 
(SACN, 2015). Regarding sun exposure, British government policy has focused on reducing 
the incidence of skin cancer primarily by recommending sunscreen use, with additional 
advice about covering the body and avoiding outdoor skin exposure around midday (Gillie, 
2010). However, to maintain adequate vitamin D production whilst avoiding sunburn, 
people need a little sun exposure frequently (Sinha et al., 2013). 
2.3 Prevalence of vitamin D deficiency among adults  
2.3.1 Worldwide prevalence of vitamin D deficiency  
Vitamin D deficiency is a major issue worldwide, affecting all age groups in developed and 
developing countries (Van Schoor and Lips, 2011). Cashman et al. (2016) and Płudowski et 
al. (2013b) have documented the occurrence of vitamin D deficiency/insufficiency among 
adults in various countries in Europe. In Denmark, the prevalence of vitamin D deficiency 
(<25nmol/L) was found to be 13.8% among adults (n= 6784), while 52.2% had an 
insufficient level <50 nmol/L (Thuesen et al., 2012). A study of 4030 German adults (18 to 
79 years old) found that over half of the participants had 25(OH)D concentrations of <50 
nmol/L (Hintzpeter et al., 2008). In Finland, there is also a high rate of hypovitaminosis D, 
affecting 54.8% of Finnish adults (n=328) (Lamberg-Allardt et al., 2001). 
The prevalence of vitamin D deficiency and insufficiency is particularly high among ethnic 
minority groups. A study of pre-menopausal female immigrants in Finland (n= 134; age 20–
48 years) reported a mean 25(OH)D of <50 nmol/L amongst in 89.6% of the total sample 
(Islam et al., 2012). Andersson et al. (2013) conducted a study of immigrant and native 
Swedish women(n= 61) and found that the mean 25(OH)D level of all participants was <50 
nmol/L, with 61% of immigrants having a serum 25(OH)D level below 25 nmol/L. Studies 
conducted among multi-ethnic adults in Norway reported that serum 25(OH)D levels of 
<25nmol/L were common (Holvik et al., 2005; Madar et al., 2008; Knutsen et al., 2014). In 
Denmark, the prevalence of vitamin D deficiency was high amongst Pakistani adults 
(Andersen et al., 2008). Solar radiation levels are high in many countries in the Middle East, 
Asia and Africa, yet the highest rates of hypovitaminosis D have been observed among 
these populations, across different age groups (Bassil et al., 2013; Al-Daghri, 2016). Possible 
factors explaining these discrepancies are discussed later in this chapter (Section 2.5). 
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2.3.2 Prevalence of vitamin D deficiency in the UK  
As to vitamin D deficiency in the UK, it appears that the prevalence of 25(OH)D 
concentrations less than 25 nmol/L differs markedly between individuals of different ages, 
as Figure 2.4 shows (O’Connor and Benelam, 2011).  
 
Figure 2.4: Prevalence of vitamin D deficiency [25(OH)D concentration <25 nmol/L] in 
individuals in the UK (Source: O’Connor and Benelam, 2011) 
 
An NDNS report for the period 2011-12 states that 24% of men and 22% of women aged 
19 years and over had serum 25(OH)D concentrations below 25 nmol/L (Bates et al., 2014), 
while the SACN found that the incidence of rickets was high in specific UK populations 
(SACN, 2007). Moreover, Blair (2012) notes that approximately half of the UK’s Caucasian 
(Cauc) population and a substantial proportion (90%) of its ethnic minority groups (EMG) 
are likely to be affected by hypovitaminosis D. In light of these findings, there is concern 
among nutritionists and medical practitioners, who have suggested a need for regular 
screenings to detect hypovitaminosis D (Lanham-New et al., 2011; Lanham-New and 
Wilson, 2016; Pearce and Cheetham, 2010). This concern is also driving researchers to 
investigate the risk factors and find possible ways to address the issue of vitamin D 
deficiency (Holick 2004a; Hyppönen and Power 2007; Hirani et al., 2009; Pearce and 
Cheetham, 2010; Lanham-New et al., 2011; Zgaga et al., 2011; Lanham-New and Wilson 
2016). Considering lifestyle as a factor, it has been demonstrated in Britain that working 
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indoors during daylight hours, coupled with a low dietary intake of vitamin D, obesity and 
alcohol intake, increases the prevalence of hypovitaminosis D (Hyppönen and Power 2007; 
Gillie 2010; Zgaga et al., 2011; Rhein, 2014). Table 2.1 summarises the studies showing the 
prevalence of vitamin D deficiency among the UK population.  
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Table 2.1: Summary of studies shows prevalence of vitamin D deficiency among adults in the UK 
Reference Study sample Region Assay 
used 
Mean Age 25(OH)D nmol/L 
Mean 
Ethnic 
groups 
Results 
Zgaga et al. 
(2011) 
2235 females Scotland LC-
MS/MS 
21–82 y 22.5% had ≥50 nmol/L 
14% had ≥40 nmol/L 
34.5% had <25 nmol/L 
Caucasian A high prevalence of hypovitaminosis D in the sample; 
high level of vitamin D in some participants who was due 
to supplement intake. 
Pal et al. 
(2003) 
60 males 
60 females 
Birmingha
m 
 
RIA 50 years winter94%,summer 85% 
had <33 nmol/L 
Asian & 
Non-
Asian 
The prevalence of hypovitaminosis D was greater in 
Asians than non-Asians in both summer and winter. 
Bunn et al. 
(2004) 
292 Somalis Liverpool 
 
- >20 years  Black 
African 
11% and 20% of adults suffering from osteoporosis and 
osteopaenia respectively. The whole sample had low 
vitamin D level. 
Maxwell et a. 
(2006) 
 
15 males 
45 females 
Somali 
Liverpool 
 
- 42 years 47.8±21.8 Black 
African 
Somalis living in the UK are at higher risk of 
hypovitaminosis D because of dark skin, limited sun 
exposure and above all, low vitamin D intake. 
Roy et al. 
(2006) 
78 females Mancheste
r  
 
HPLC& 29.2 years 94% had ≤ 37.4 nmol/L 
 
South 
Asian 
Hypovitaminosis is spread among South Asian people 
and having <37 nmol/L of vitamin D may cause reduced 
bone mass in this sample. 
Ford et al.  
(2006) 
317 white, 125 
Afro-C and 251 
Asian 
Birmingha
m 
 
NAC and 
RIA 
53 y Caucasian 23nmol/L 
Asian 14.2 nmol/L 
Afro-Caribbean 16 
nmol/L 
Asian, 
African 
and 
Caucasian 
24% of total sample had a deficiency at <25 nmol/l. 
Ethnic minority groups had a higher deficiency than 
Caucasian did. 43% of Asian females were deficient, 
more than Asian males, perhaps due to dress style. 
Hypponen & 
Power (2007) 
3725 males 
3712 females 
Great 
Britain  
ELISA 45 years 
old 
46% and 89% had 
<40, <75 nmol/L 
British 
(White) 
A high prevalence of vitamin D deficiency in the general 
adult population. 
Macdonald et 
al. 
(2008) 
3113 females Aberdeen  
 
EIA 54.8 years 59.2 nmol/L in autumn, 
49.2 nmol/L in spring 
 
Caucasian The impact of seasonal variation was slight among 
sample. The vitamin D intake of Scottish females may 
prevent hypovitaminosis D. 
Smith. (2010) 56 white, 56 SA 
male and 53 white, 
35 SA female 
Peterborou
gh 
 
HPLC 43 years ≥70 % from total sample 
has vitamin D deficiency 
Caucasian 
& South 
Asian 
There was a significant difference between groups in 
winter and summer. Serum vitamin D decreased from 
summer to winter. D decreased from summer to winter  
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Reference Study sample Region Assay 
used 
Mean Age 25(OH)D nmol/L 
Mean 
Ethnic 
groups 
Results 
Mavroeidi et 
al. 
(2010) 
338 female 
Caucasian, & 
138 Caucasian, 
and 35 Asian 
female 
Aberdeen 
and Surry   
 
EIA 61.7 y 
61.4 y 
59.9 y 
In winter, Aberdeen had 
53.3 nmol/L  Caucasian 
had 60.4 nmol/L and 
Asian had 25.8 nmol/L. 
while in winter/spring A 
had 40.4,43 and 23 
nmol/L respectively 
Caucasian 
&Asian 
Seasonal variation in 25(OH)D was observed with 
significantly higher concentration among both groups 
but it was higher among ethnic group. 
Farrar et al. 
(2011) 
12 men 
3 women 
Mancheste
r 
 
HPLC 26 y 27% had <12 nmol/L 
The rest of them had < 
50 nmol/L 
 
South 
Asians 
The current recommendation for sun exposure in the UK 
is not effective to have at least sufficient vitamin Level 
Patel et al. 
(2013) 
1105SA, males,748 
BA 
Birmingha
m 
 
LC-MS^ SA 57.6y 
BA 61y 
75% SA had 
29 nmol/L, 48% 
BA had 29 nmol/L 
South 
Asian and 
Black 
African 
Vitamin D deficiency was high in total sample but  it was 
higher in SA compered to AC, perhaps due to cultural 
factors 
Darling et al. 
(2013) 
105 Caucasians 
35 Asians 
Surry   EIA 33.87 y 
37.91 y 
81 % SA had 
<25 nmol/L, C had ≤ 50 
nmol/L 
South 
Asian and 
Caucasian 
Vitamin D deficiency was high among ethnic groups in 
Scotland. Caucasians had a sufficient level of vitamin D. 
LC-MS/MS: Liquid chromatography–mass spectrometry. ELISA: The enzyme-linked immunosorbent assay. RIA: Radioimmunoassay. EIA: enzyme immunoassay 
NAC: Nichols Advantage chemiluminescence. HPLC: High-performance liquid chromatography 
CHAPTER 2 
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Zgaga et al. (2011) assessed the vitamin D status of Cauc females (n=2235, age 21–82 
years) living in Scotland. Results showed the prevalence of low vitamin D was high, with 
63% of participants having 25(OH)D levels ≤40 nmol/L, while 22.5% had levels of ≥50 
nmol/L. The study found that vitamin D supplementation contributed the most to total 
vitamin D intake and that it was positively correlated with vitamin D status. 
Mavroeidi et al. (2010) studied Cauc (n=481) and Asian females (n=35) with a mean age 
of 61.9 years and found that the mean serum 25(OH)D level of Cauc females was ≥40 
nmol/L in summertime and slightly less in wintertime, while more than half of the Asian 
females had serum levels of 25(OH)D at ≤25 nmol/L in both seasons. Similarly, Mavroeidi 
et al. (2010) found that low vitamin D was more prevalent in ethnic minority groups than 
Cauc (p<0.001). Possible explanations are discussed in Section 2.5. 
Another comparative study by Pal et al. (2003) found that over 80% of South Asians (SA) 
(n=60) had vitamin D deficiency, while the mean 25(OH)D level among Cauc participants 
(n=60) was ≥40 nmol/L. Serum 25(OH)D levels differed significantly by sex and ethnicity 
in this study (p<0.05), with lower 25(OH)D levels in SA females compared to the males in 
both groups. A study carried out in Liverpool by Bunn et al. (2004) showed that a Somali 
sample (n=292) had vitamin D deficiency, while 20% had osteopaenia or osteoporosis. 
Similarly, Maxwell et al. (2006) found in a separate study that most of the Somali 
participants (n=60, mean age 42) had vitamin D deficiency in wintertime, primarily due 
to a low dietary intake of vitamin D.   
A comparative study conducted by Ford et al. (2006) on Cauc, Afro Caribbean (AfroC) and 
SA (n= 693, mean age 52 years) participants, found that 24% of the total sample had 
25(OH)D levels of <25 nmol/l. Ethnic differences were detected in 25(OH)D 
concentrations, with SA groups having a higher deficiency than the Cauc group. Overall, 
43% of female SA participants were vitamin D deficient, significantly more than the males 
in the same group, an observation that may be partially explained by clothing style and 
skin coverage. Findings from a study by Smith (2010) on Cauc and SA adults (n=200, mean 
age 42 years) showed that 70% of SA had vitamin D deficiency. The study found 
significant seasonal fluctuations in 25(OH)D concentrations, with serum 25(OH)D levels 
decreasing from summer to winter. 
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Patel et al. (2013) recently assessed the prevalence of vitamin D deficiency in a multi-
ethnic sample, SA (n=1105, mean age 57 years) and Black Afro-Caribbean (n=748, mean 
age 61 years), finding that 42% of SA had severe vitamin D deficiency, while 48% of AfroC 
had vitamin D deficiency and only 12% had a severe deficiency. Darling et al. (2013) 
studied Cauc (n=105, mean age 33.8 years) and SA (n=35, mean age 37.9 years) adults 
and found that in the winter, a higher percentage of SA (81%) had <25 nmol/L 25(OH)D 
compared to Cauc women (10%), while in the summertime 60% of Cauc women had ≤ 
50 nmol/L 25(OH)D. In a more recent comparative study conducted among Asians, Black 
and white British living in London (n=222, mean age 72 years), the mean plasma 25(OH)D 
level of half of the total participants was <25 nmol/L (Jolliffe et al., 2016). 
When reviewing these studies, it should be noted that the serum 25(OH)D 
concentrations were influenced by a range of factors including age, ethnicity, threshold 
variability considered as a deficient level, season and the method of analysis. Notably, 
the recommendations of these studies include actions targeting the wider population, 
rather than narrower at-risk groups such as children and pregnant women (Cashman et 
al., 2016, Hyppönen and Power, 2007; Gillie, 2010). As to the amount of research into 
differences in risk factors for vitamin D deficiency between ethnic minority groups, these 
differences are not as considerable as those observed between Caucs and specific EMGs. 
Therefore, this research offers an insight into the major factors that could place different 
EMGs at risk of vitamin D deficiency and provides recommendations on how to avoid 
these risk factors. 
2.3.3 Ethnic minority groups living in Manchester 
The definition of an ethnic minority group is ‘a group of people smaller in number than 
the majority categories and who by their customs, language, race, values, and group 
interests differ from the majority population’ (Carlson et al., 1984:203). The current 
ethnic minority population of Manchester is approximately 33.3% of the total population 
(Manchester City Council, 2015). The largest EMGs in Manchester are of Pakistani and 
African ethnicity, totalling 9% and 5% of the whole population respectively. Other smaller 
groups are Chinese (3%), Indian (2%) and Arab (2%) (Jivraj and Simpson, 2015). The 
African region is geographically defined as comprising Nigeria, Somalia, Zimbabwe, 
Kenya, Ghana, Uganda and South Africa, while the Arab region comprises Bahrain, Egypt, 
Iraq, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Syria, the United Arab 
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Emirates, Yemen and Palestine. Asia is subdivided into South Asia (Pakistan, Bangladesh 
and India), East Asia (China, Japan and Korea) and South-East Asia (Malaysia, Indonesia, 
Philippine and Thailand). While all of these groups live in Manchester, each has a clearly 
distinct lifestyle, culture, religious practices and dietary habits. 
2.3.3.1 Food habits of the diverse ethnic minorities populations 
Obeidat (2002:18) states that food habits ‘are an aspect of culture in which personal, 
social and situational factors interplay’. Thus, acculturation and adoption of a Western 
lifestyle, beside factors such as economic status and the accessibility of the food of the 
new country, may cause immigrants to change their traditional diets (Gilbert and Khokar, 
2008; Wandel et al., 2008). Dietary behaviours vary from one EMG to another, with each 
of them favouring certain types of traditional food (Leung and Stanner, 2011) that may 
lack significant levels of vitamin D. Nakamura et al. (2002) analysed the dietary intake of 
the Japanese population and found that fish was a popular food in Japan. A cross-
sectional study by Vyas et al. (2003) which found that meat was the preferred protein 
source among SA and AfroC groups, with semi-skimmed milk also being favoured by 
AfroCs (Vyas et al., 2003). Nolan (2007) found that lamb and chicken were widely 
consumed in the Middle East, as were fermented dairy products such as yoghurt and 
cheese, while milk-containing desserts were consumed more than milk alone. Margarine 
and butter were consumed by most Sri Lankans (Wandel et al., 2008). Consumer type 
can also influence dietary habits; thus, vegans and vegetarians refrain from eating meat 
and fish, which are considered rich sources of essential vitamins and minerals (Hill et al., 
2004).  
Specific religious groups including Muslims, Christians, Jews, Hindus, Sikhs and Buddhists 
often have particular dietary restrictions. For example, Muslims are prohibited from 
consuming alcohol and pork, while beef is generally forbidden for Hindus (Fam et al., 
2004). Alcohol intake is allowed in religious groups such as Sikhs, Buddhists and 
Christians (Cochrane and Bal, 1990; Michalak et al., 2007), while for Jews, there is no 
proscription of drinking alcohol, but pork consumption is forbidden (Fam et al., 2004). 
2.3.3.2 Prevalence of vitamin D deficiency among ethnic minorities in Manchester 
A few studies have provided robust evidence of the prevalence of vitamin D deficiency 
among different EMG populations, especially SA (Macfarlane et al., 2005; Darling et al., 
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2013; Webb et al., 2016). The average Cauc needs approximately 15 minutes’ exposure 
of 35% of the skin to summer sunlight to achieve a sufficient level of 25(OH)D (Rhodes 
et al., 2014), while ethnic minorities with skin colours V and VI need at least 30 to 40 
minutes (Farrar et al. 2013). Roy et al. (2006) studied Pakistani females (n=78, mean age 
29 years) and found that 96% of them had 25(OH)D levels of ≤37.4 nmol/L, which was 
related to the reduction of bone mass at wrist and hip in this sample. 
In order to determine whether the UK recommendation of sun exposure is sufficient for 
Cauc people to attain an adequate 25(OH)D level of ≥50 nmol/L, Rhodes et al. (2010) 
studied 109 mixed-gender participants (mean age 35 years), finding that their vitamin D 
level was 37.5 nmol/L at baseline and that after exposing 35% of their skin to the summer 
sunlight for 13 minutes, it increased to ≥50 nmol/L. Farrar et al. (2011) conducted a 
similar study but on South Asians (n=15, mean age 26 years), to examine the efficacy of 
current sun exposure recommendation in achieving sufficient 25(OH)D levels for darker 
skinned individuals. They found that most participants had 25(OH)D levels of <50 nmol/L 
and that four had <12.5 nmol/L. Farrar et al. (2011) conclude that current UK sun 
exposure recommendations are not sufficient for EMGs, especially those having higher 
levels of skin pigmentation.  
A comparative study of 53 patients with a photosensitivity disorder by Rhodes et al. 
(2014) and a study by Webb et al. (2010) of 109 healthy participants (mean age 44 years) 
found no significant difference in terms of dietary or supplement intake, while significant 
seasonal variations in serum 25(OH)D concentrations were observed in both groups 
(p=0.01). Both groups of study participants had a low 25(OH)D levels during the winter 
months (medians of 31.8 and 45.2 nmol/L respectively), but higher levels at the end of 
summer (medians of 50 and 67 nmol/L respectively). However, the difference in vitamin 
D levels in the summer was due to the patient group’s higher use of sunscreen at this 
time of year (Rhodes et al., 2014). 
More recently, Hayden et al. (2015) conducted a study using laboratory databases from 
general medical practitioners in primary care in Manchester (n=11,291 cases) and report 
that >70% had serum 25(OH)D levels which could potentially increase the risk of skeletal 
disease. They also found a correlation between vitamin D deficiency and higher levels of 
social deprivation (p<0.0001). Webb et al. (2016) investigated qualitatively the 
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knowledge and attitudes of people towards sun exposure and vitamin D (n=20 SA and 
n=6 Cauc). The authors found that the SAs were more knowledgeable about vitamin D 
than the Cauc group, possibly reflecting that the SAs had experienced vitamin D 
deficiency. 
2.4 Evaluating the health impact of vitamin D deficiency and 
insufficiency  
Vitamin D plays a significant role in maintaining the normal functioning of the human 
body (Holick, 2004b; Holick, 2011). Serum 25(OH)D level ≤25 nmol/L has metabolic 
consequences for the skeleton, as it inhibits the accumulation of optimal levels of 
calcium (Holick, 2010). This results in an increased bone turnover and potentially 
osteoporosis or osteomalacia in adults (Gillie, 2010), due to a mineralization defect of 
the collagen matrix, with osteomalacia often characterized by chronic bone pain (SACN, 
2007; Messer and Powell, 2009). Several studies have also shown a high incidence of 
skeletal diseases such as osteomalacia among a number of EMGs (Solanki et al., 1995; 
Hamson et al., 2003; Roy et al., 2007). 
A review of several empirical studies has established a plethora of evidence that the 
active form of vitamin D 1,25(OH)2D is associated with anti-proliferative as well as 
immunomodulatory effects. These effects of vitamin D are suggested to improve several 
serious conditions such as cancer (Jeon and Shin, 2018; Feldman et al., 2014) the risk of 
breast and prostate cancers is reduced by 30% to 50% when serum 25(OH)D 
concentrations are at 50 least nmol/L (Ahonen et al., 2000; Holick, 2004; Garland et al., 
2007), while the risk of colon cancer decreased by 50% when the 25(OH)D level was 
above 80 nmol/L (Gorham et al., 2005). Vitamin D insufficiency is also associated with 
the incidence of cardiovascular disease (Wang et al., 2008; Pludowski et al., 2013a); it 
has been shown that the risk of CVD among EMGs was approximately 40% higher than 
that of the white population (Patel et al., 2013), in addition to a higher incidence of 
hypertension among Black African (BA), as reported by Lane et al. (2001). A systematic 
review and meta-analysis of 128 studies conducted among multi-ethnic groups showed 
that the risk of having cardiometabolic disorders decreases by 45% when 25(OH)D level 
is high (Parker et al., 2010). The influence of vitamin D has also been shown in other 
diseases including type 1 diabetes, hypertension and rheumatoid arthritis (Vimaleswaran 
et al., 2014; Palermo and Holick, 2017; Ishikawa et al., 2017). 
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2.5 Factors which may affect vitamin D status 
2.5.1 Low vitamin D intake 
The NDNS found that the mean daily dietary intake of vitamin D was 3.9 µg for men and 
3.4 µg for women (Bates et al., 2014), i.e., below the current recommendation. Public 
Health England (2014) published a recent survey about food consumption, showing that 
most of the UK population has either vitamin D insufficiency or deficiency. Indeed, the 
dietary intake of vitamin D is much lower in the UK than in other Western nations 
including the USA and Canada (Calvo and Whiting, 2013). The disparity between the UK 
and North America has been attributed to the differing extents to which mandatory 
fortification of foodstuffs occurs in these countries (outlined in Section 2). Clinical 
nutritional assessments of natural food items suggest that, with the exception of fish and 
cod liver oil, most natural foodstuffs contain minimal amounts of vitamin D, including 
meat, eggs and dairy products (Brough et al., 2010; Sinha et al., 2013). 
The NDNS showed that only 23% of vitamin D intake was provided by oily fish and 23-
35% by consumption of meat products, whereas fat and cereal products contributed 19% 
and 13-20%, respectively (Bates et al., 2014). Two other national surveys Irish 
Universities Nutrition Alliance (IUNA) and Irish National Food Consumption have 
reported that 30%, 12% and 9% respectively of mean dietary intake of vitamin D was 
obtained from meat, fish and egg product (IUNA, 2011; Hill et al., 2004). Irrespective of 
these different assessments, Schmid and Walther (2013) state that it is difficult for 
people to meet their recommended intake of vitamin D through consumption of 
foodstuffs alone. Therefore, solutions must be found to increase vitamin D intake among 
the whole population. Vitamin D supplements could be an alternative and effective way 
to enhance vitamin D status, especially among people who cannot obtain a sufficient 
level of vitamin D due to a lack of sunlight and natural food sources (Sinha et al., 2013). 
According to Hyppönen and Power (2007) and Zgaga et al. (2011), higher 25(OH)D levels 
were positively correlated with supplement intake.  
2.5.2 Factors influencing cutaneous synthesis of vitamin D  
2.5.2.1 Season and latitude 
As the majority of vitamin D is produced in the skin, where UVB is required to initiate the 
process, seasonal variation in sun strength can have a pronounced effect on vitamin D 
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status (Bolland et al., 2007), particularly when daylight is limited during the winter as 
compared to the summer months. In winter, increased cloud cover also affects vitamin 
D synthesis by reducing the amount of UVB that reaches the earth’s surface by around 
45% (Sullivan et al., 2003). 
Furthermore, latitude has a significant impact on vitamin D levels (Webb, 2006). In 
countries located below latitude 35°N, the body can produce sufficient vitamin D all year 
round (Tsiaras and Weinstock, 2011), while at latitudes above 35°N (i.e. much of Europe, 
including Germany, Italy and the Netherland), skin synthesis of vitamin D tends to be 
sufficient only in summer time (Lanham-New et al., 2016). Consequently, European 
citizens are at a higher risk of vitamin D deficiency compared to citizens of countries 
located nearer the equator (Grimes, 2011). 
Seasonal variations are observed in the UK at 55°N (Hyppönen and Power, 2007; Darling 
et al., 2013), with concentrations of 25(OH)D lower in spring and winter as a result of 
diminishing UVB photons reaching the earth’s surface caused by the increasing solar 
zenith angle (Levis et al., 2005; Webb, 2006). Figure 2.5 shows a summary of the results 
obtained. 
 
Figure 2.5: Seasonal and geographical variation in the prevalence of 25(OH)D 
insufficiency (<40 nmol/L) in Great Britain (Source: Hyppönen and Power, 2007) 
 
A study by Pal et al. (2003) found that seasonal timing was statistically correlated to 
serum 25(OH)D levels, where 94% of the participants (n=120, mean age 50 years) had a 
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low serum 25(OH)D level (<33 nmol/L) in the wintertime, while 85% had a low serum 
25(OH)D level during summer. 
A nationwide cohort study of middle-aged British adults (n= 7,437) demonstrated that 
hypovitaminosis D was more prevalent during the winter and spring months, with 16% 
of the sample having serum 25(OH)D levels below 24.9 nmol/L, while 46.6% had 
sufficient levels (>39.9 nmol/L) (Hyppönen and Power, 2007). Similarly, a study carried 
out by Mavroeidi et al. (2010) on 173 postmenopausal women living in two locations in 
Surrey found that 17.1% of Asian (n=35) women were deficient in vitamin D in the 
summertime, rising to 58.1% during the winter. In comparison, none of the Caucs had a 
25(OH)D level of less than 19.9 nmol/L. In Aberdeen, the highest rates of hypovitaminosis 
D were recorded among 25% of Caucs (n=338) during winter and spring, decreasing to 
4.2% in the summer. The authors conclude that seasonal variation significantly affects 
vitamin D status (Mavroeidi et al., 2010). 
Conversely, research carried out in Aberdeen by Macdonald et al. (2008) indicated that 
seasonal changes in vitamin D status were minor among 3,113 Cauc females with a mean 
age of 54.8 years. In autumn, the serum 25(OH)D concentration was 59.1 nmol/L, while 
in spring it was 49.1 nmol/L. This stability was attributed to the fact that the participants 
consumed a diet rich in vitamin D and supplement (Macdonald et al., 2008). This poses 
a challenge to the vitamin D status of people residing in such areas, particularly if they 
fail to implement dietary changes to compensate for any deficiency. 
2.5.2.2 Skin type and ethnicity 
According to Fitzpatrick (1988), human skin colour ranges from the lightest to darkest as 
presented in . 
Table 2.2, dependent on the amount of melanin (Bowyer et al., 2009). It has been found 
that melanin has an impact on vitamin D synthesis by absorbing UVB, thus reducing the 
cutaneous synthesis of vitamin D3 (Kift et al., 2013; Webb et al., 2018). Therefore, 
whenever the melanin content of the skin is high, exposure time must be increased in 
order to allow sufficient cutaneous synthesis of previtamin D3 (Holick, 2004a). Data from 
the National Health and Nutrition Examination Survey (NHANES) showed that the rate of 
hypovitaminosis D was higher in Black participants (82.1%) compared to White 
participants (30%) (Looker et al., 2011). 
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A meta-analysis conducted by Martin et al. (2016) showed that the rate of 
hypovitaminosis D was highest among people with darker skin pigmentation. In another 
study, Chen et al. (2007) measured serum 25(OH)D concentrations in adults with 
different types of skin as classified by Fitzpatrick (. 
Table 2.2), after exposure to a controlled dose of UVB from one type of sunbed over a 
period of three months. By the end of the study, serum 25(OH)D concentrations had 
increased dramatically in all skin types. Respective mean increases in 25(OH)D recorded 
for skin types II, III, IV and V were 210%, 187%, 125% and 40%. The authors conclude that 
the production of previtamin D3 in type II skin is five to ten times higher than type V 
(highly pigmented) skin. In the UK, low vitamin D levels have been seen among EMGs, 
particularly in those of SA (Shaw and Pal, 2003) and BA origins (Maxwell et al., 2006; Patel 
et al., 2013). For instance, almost 94% of Pakistani women (n=78), with a mean age of 
29.2 years, had serum 25(OH)D levels below 37.1 nmol/L (Roy et al., 2007). Possible 
explanations for this low level of vitamin D include skin pigmentation and dress style 
(Brough et al., 2010; De Roos et al., 2012). 
A cross-sectional study conducted in 125 SA volunteers with skin type V living in the UK 
found that in the summer, the participants reached a mean serum 25(OH)D level of 22.4 
nmol/L, whilst during wintertime, 40% of them were found to be deficient, with levels as 
low as 15 nmol/l (Kift et al., 2013). By analysing measured 25(OH)D levels and 
demographic factors, UV exposure and vitamin D intake for all participants collected by 
questionnaire, the researchers found that hypovitaminosis D was not due to a single 
factor, but instead a combination of low dietary vitamin D intake, low sunlight exposure 
and high skin pigmentation (Kift et al., 2013). Another cross-sectional study, conducted 
by Maxwell et al. (2006), involving 60 Somali immigrants living in Liverpool, revealed that 
36% of the participants were suffering from osteomalacia, with the remaining 
participants deemed to be at a greater risk of vitamin D deficiency caused by a low 
vitamin D intake and limited exposure to sunlight. Several comparative studies have 
shown that the serum 25(OH)D level of BAs was lower than in Caucs, again due to high 
skin pigmentation (Hall et al., 2010; looker et al., 2002). Consequently, vitamin D 
intervention may be necessary for certain ethnic minorities in the UK, to assist them in 
attaining optimal levels of vitamin D. 
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Table 2.2: Skin type, colour and reaction to sun exposure 
Skin 
type 
Skin colour Skin reaction 
I Pale white; blond or red hair; blue eyes; 
freckles 
Always burns, never tans 
II White; fair; blond or red hair; blue or green 
eyes 
Burns easily 
III Cream white; fair with any hair or eye colour Mild burn, tans average 
IV Moderate brown; typical Mediterranean skin Rarely burns, tans easily 
V Dark brown skin types Very rarely burns 
VI Dark-skinned black No burn 
Source: Bowyer et al. (2009) 
 
The SunSmart campaign promoted by the UK Department of Health has put forward 
recommendations for the population regarding sunlight exposure (Cancer Research UK, 
2010), but may not be appropriate for dark-skinned people, because they will fail to 
achieve sufficient 25(OH)D levels (Farrar et al., 2011). Furthermore, while the UK 
National Institute for Health and Care Excellence (NICE) has published health guidance 
for sun exposure for different population groups (NICE, 2016), it offers no specific advice 
regarding sun exposure for people with skin type V. Farrar et al. (2011) and Webb et al. 
(2018) state that people with skin types V or VI need additional exposure to sunlight in 
the UK (ca. 25 to 40 minutes more) to get the same amount of vitamin D3 as do people 
with skin types II or III (Farrar et al., 2011; Webb et al., 2018).  
2.5.2.3 Sunscreen  
Sunscreen is a physical barrier to both UVA and UVB radiation and therefore affects 
vitamin D synthesis (Macdonald et al., 2011; Tsiaras and Weinstock, 2011). According to 
Holick (2004b), sunscreen usage reduces the number of UVB photons that reach 7-DHC 
in the skin by absorbing or scattering UVB radiation, thus decreasing vitamin D 
production. Most sunscreens have a stated sun protection factor (SPF), which is for 
‘measuring the efficacy of sunscreen products in shielding the sun’s ultraviolet radiation 
(UVR) and thereby protecting the skin against sunburn’ (Reinau et al., 2015:1). Using SPF 
8 to 15 was found to decrease vitamin D production in the skin, but these findings remain 
contentious. Some studies have found it to be a strong inhibitor, reducing vitamin D 
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production by more than 95% (Holick, 2004b; Faurschou et al., 2012; Libon et al., 2017), 
while others have found no significant effect (Kimlin et al., 2007; Linos et al., 2012). 
Possible explanations for these divergent results are the amount of sunscreen applied 
(Wolpowitz and Gilchrest, 2006), its thickness (Faurschou et al., 2012) and the level of 
SPF used (Libon et al., 2017). 
Furthermore, individuals using sunscreen may be encouraged to expose themselves to 
sunlight for longer and more frequently (Linos et al., 2012). In the UK, a campaign 
established by Cancer Research UK calls for the population to avoid sun exposure and 
use sunscreen frequently to protect against skin cancer, which in turn can lead to 
reductions in vitamin D synthesis (Cancer Research UK, 2010). Therefore, studies have 
attempted to find an appropriate approach to optimize sunscreen use without overly 
affecting cutaneous vitamin D production (Kockott et al., 2016). 
2.5.2.4 Clothing 
It has been reported that the production of pre-vitamin D3 is reduced by clothing (Salih, 
2004) and that the specific fabric quality could restrict or block effective skin irradiation 
of pre-vitamin D (Aguilera et al., 2014). Blocking out sunlight with clothing for religious 
or cultural reasons is particularly associated with hypovitaminosis D, as reported 
previously. For example, a cross-sectional study conducted by Glerup et al. (2000) found 
mean serum 25(OH)D concentrations of 7.1 nmol/L among 60 immigrant women (veiled 
and ethnic Muslim women), which was found to be significantly lower than in Danish 
women (n=44, 47.1 nmol/L). Similar results have been shown in a Turkish study (Alagöl 
et al., 2000), where the mean 25(OH)D concentrations of women who dressed in the 
traditional Islamic style (covering their whole bodies excluding their hands and faces) 
were significantly lower (9 nmol/L) as compared to women wearing Western‐style 
clothing (56 nmol/L). A study among immigrants in Sweden (Granlund et al., 2016) 
showed that wearing long sleeves was associated with a higher likelihood of low vitamin 
D levels (adjusted odds ratio = 3.15 (95% CI, 11.09–9.12). Individuals living in a cloudy 
city and choosing a specific dress style for cultural or religious reason could be at a 
particularly high risk of vitamin D deficiency. 
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2.5.3 Other factors that influence vitamin D status 
2.5.3.1 Obesity 
An additional factor that can affect vitamin D levels is obesity (Pourshahidi, 2015), 
typically defined as a body mass index (BMI) of 30 kg/m2 and above. It has been shown 
to be inversely correlated with serum vitamin D concentrations and positively correlated 
with PTH levels (Wortsman et al., 2000; Macdonald et al., 2008; Rajakumar et al., 2011). 
Some studies have reported that the association between obesity and vitamin D status 
is in the opposite direction: It has been posited that cutaneous vitamin D synthesis is 
greater in obese than in non-obese people due to exposure of a larger skin area to UVB 
(Verbraecken et al., 2006; Looker et al., 2007). However, the findings of a clinical study 
by Wortsman et al. (2000) contradict this claim, as there were no differences between 
26 non-obese and obese people (mean age 34 years) in terms of vitamin D production 
after exposure to UVB (38 and 17 nmol/L respectively) or after receiving oral D2 
supplements (5.3 and 3.5 nmol/L respectively). Wortsman et al. (2000) suggest that 
obesity does not influence vitamin D production directly, but rather the release of 
vitamin D3 from the skin into the circulation. A recent study by Turer et al. (2013) 
supports this hypothesis by showing that the deposition of vitamin D in body fat 
compartments results in decreased bioavailability of vitamin D3 from cutaneous and 
dietary sources. Alternatively, low vitamin D levels among obese people could be linked 
to behavioural factors, as they may tend to cover themselves more fully, providing a 
barrier to sunlight and thus reducing the production of vitamin D cutaneously (Pereira‐
Santos et al., 2015). Kull et al. (2009) found that obese participants who had a BMI over 
30 kg/m2 tended to avoid sunbathing and outdoors activity compared to participants 
with a BMI below 30 kg/m2 (p<0.01).  
Furthermore, BMI and body fat could have a significant impact on identifying the 
recommended dosage of a vitamin D supplement, as supported by Lee et al. (2009). 
Obese people may need a higher dose of the supplement than the non-obese to increase 
vitamin D levels, because of the excessive sequestering and storage of vitamin D in fatty 
tissue. In fact, those who are obese and living in high-risk regions, such as North-West 
England, are deemed to be at twice the risk of those living in lower-risk regions of Great 
Britain (Hyppönen and Power, 2007). 
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2.5.3.2 Socioeconomic status 
Low vitamin D intake may be associated with low economic status (Dealberto, 2006). 
Numerous studies cite issues such as poor nutrition, poor lifestyle and the inability to 
afford supplements to treat vitamin D deficiency. According to Brough et al. (2010) and 
Grimes (2011), a socially deprived population may not be able to afford some basic 
nutrients or supplements such as vitamin D, which are essential for normal metabolic 
function. Hirani et al. (2009) conducted a study of vitamin D levels among adults, aged 
≥19 years in two British surveys: 1297 people from the NDNS and 792 from the Low 
Income Diet and Nutrition Survey (LIDNS). They found that the LIDNS sample had a mean 
25(OH)D lower than that observed in the NDNS (p<0.001). More recently, Hayden et al. 
(2015) showed that higher social deprivation contributed to an increased proportion of 
insufficient/deficient people who had 25(OH)D ≤50 nmol/L, while Webster (2013) found 
in a study that low economic status was only related to severe hypovitaminosis D 
(25(OH)D <15 nmol/L). However, the latter study focused on EMGs, with a high 
percentage of these groups living in deprived areas, whereas the former study was 
sampled the whole population. A more recent study by Léger‐Guist'hau et al. (2017) 
indicated that the risk of severe vitamin D deficiency increased with low socio-economic 
status.  
A report released by the Greater Manchester Poverty Commission (GMPC) in 2002 
identified Manchester as one of the most poverty-affected regions in Britain, with 
approximately 25% of its population living in abject poverty (GMPC, 2012). A few decades 
ago, there was a five-year campaign aiming to address vitamin D deficiency by giving 
ethnic Asian schoolchildren a daily dose of vitamin D (2.5 µg), which led to a decrease in 
the occurrence of rickets (Dunnigan et al., 1985). This effort led to significant 
improvement in the targeted cities in the north of England. But it is reported that the 
improvements made almost forty years ago are no longer visible (Roy et al., 2007), which 
may be due in part to most people not knowing about the Healthy Start programme, 
which provides a free supplement to pregnant women and children from low-income 
families to avoid vitamin D deficiency (Blair, 2012). However, low-income EMGs also 
need such action to avoid hypovitaminosis D. 
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2.5.3.3 Smoking and alcohol intake   
Many studies have shown that alcohol intake is positively correlated with serum vitamin 
D concentration (Lamberg-Allardt et al., 2001; Ilich et al., 2002; McCullough et al., 2010; 
Gorter et al., 2016). According to Lee (2012), the effect of alcohol lies in its ability to 
impede vitamin D metabolism and hinder the conversion of 25(OH)D to 1,25(OH)D. 
However, the association between vitamin D and alcohol intake is still controversial 
(Tardelli et al., 2017), as a number of alternative studies show that there is no significant 
association (Cheng et al., 2014: Rapuri et al., 2000; Egan et al., 2008). 
Regarding smoking status, some studies have reported no relationship between smoking 
and vitamin D level (Arunabh et al., 2003; Cheng et al., 2014), whereas a number of 
others show a negative association between smoking and serum 25(OH)D concentration 
among mixed gender adults (Lamberg-Allardt et al., 2001; Jorde et al., 2005; Laaksi et al., 
2007; Kassi et al., 2015). However, the exact mechanisms by which the constituents of 
tobacco smoke affect vitamin D metabolism are still not clear (Shinkov et al., 2015). 
Additional research is needed to understand the effects of alcohol intake and smoking 
on serum 25(OH)D levels. 
2.6 Supplementation Studies 
Many intervention studies have considered the viability of vitamin D supplementation, 
taking into account factors such as the different forms of the vitamin (D2 or D3) used, the 
dosage levels applied, body fat and the time needed to reach the desired vitamin D level 
(Zittermann et al., 2014). Supplementation regimes could either maintain a sufficient or 
optimal level of vitamin D or treat vitamin D deficiency and vitamin D-related diseases 
(Holick et al., 2011). 
2.6.1 Previous supplementation studies using vitamin D3/D2 
Vitamin D supplementation is an effective strategy to maximize a serum 25(OH)D levels 
in the absence of sun exposure and limited dietary sources. It has been suggested that 
people could achieve the optimal level of serum 25(OH)D (75 nmol/L) when they are 
supplemented with 20-25 μg of vitamin D daily (Dawson-Hughes et al., 2005), although 
a rival opinion suggests that adults need at least 55 μg/d to reach a desired level of ≥75 
nmol/L (Heaney, 2005) and a dose of 100 μg/d may be required for people with baseline 
levels of 25(OH)D at <45 nmol/L (Talwar et al., 2007). The latter suggestion may be 
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particularly relevant to dark-skinned people. However, the tolerable upper intake level 
for oral vitamin D is suggested as 100 µg/d (Ross et al., 2011). A summary of the literature 
regarding supplementation studies to improve vitamin D status among healthy adults is 
presented in Table 2.3.  
A supplementation study was conducted by Barnes et al. (2006) on 27 healthy mixed-sex 
adults, with a mean age of 21.6 years, who were divided into a vitamin D3 group (15 μg/d 
and 1500 calcium) and a control group (1500 calcium). In the vitamin D treatment group, 
serum 25(OH)D levels rose from 47.4 to 87.3 nmol/L after eight weeks compared to the 
control group, which decreased by 7.5 nmol/L. The authors concluded that a 15 μg/d 
vitamin D3 supplement increased serum 25(OH)D concentrations by 2.09 nmol/L per 
microgram of vitamin D3 taken. A study was conducted on 110 adults (mean age 28 years 
and baseline 25(OH)D levels of 75 nmol/L), found that a daily supplement of 15 μg of 
vitamin D3 reached a mean 25(OH)D levels of 68.9 nmol/L after 22 weeks (Forsythe et 
al., 2012).  
In another intervention study carried out by Talwar et al. (2007) on 208 BA women with 
a mean baseline 25(OH)D of 46 nmol/L, 104 were given an oral intake of 20 μg/d and 104 
women were given matched placebo for two years. The mean serum 25(OH)D reached a 
level of 71 nmol/L after three months and 65.9 nmol/L after two years, while there was 
no change in the placebo group. The study continued for an additional year with an 
increased dose of 50 μg/d and the level of 25(OH)D reached a level of 87 nmol/L, showing 
that this dose is required for BAs to increase their 25(OH)D to the optimal level >75 
nmol/L. 
In another study, conducted by Nelson et al. (2009) on 86 women with a mean age of 
22.2 years and baseline 25(OH)D level of 62 nmol/L, the participants were given either a 
dose of 20 μg/d or a matched placebo for a year starting in March. The authors reported 
that 80% of participants reached the optimal level ≥75 nmol/L by the end of the study, 
with a mean increase of 35 nmol/L. They conclude that 20 μg/d was sufficient to maintain 
an optimal level of vitamin D during the winter. 
Harris and Dawson-Hughes (2002) examined the effect of age on the response to a 
supplement in 50 participants (18-35 years and 62-79 years), finding that participants 
who were supplemented with 20 μg/d for 8 weeks reached mean serum 25(OH)D levels 
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of 83 nmol/L, while the others remained below the sufficient level. However, there was 
no evidence of an effect of age on the response to the supplement and serum 25(OH) D 
was approximately identical in both age groups at the end of the study, having increased 
by 4.3 and 6.2 nmol/L respectively.  
In contrast, the study by Wicherts et al. (2011) found that 20 µg D3 daily did not reliably 
increase mean serum 25(OH)D concentrations to 75 nmol/L, as 52% of multi-ethnic 
participants (n=71) remained below this cut-off at three months, while only 40% of 
participants reached the cut-off of 50–75 nmol/L at six months. This could be due to 
inadequate compliance in the sample (Wicherts et al.,2011) or to the influence of high 
BMI (33% had a BMI ≥30 kg/m2) on the response to the supplement. 
Holick et al. (2008) conducted a study on 68 adults (mean age of 40 years and baseline 
25(OH)D level of 49/42 nmol/L), divided into two groups and supplemented with 25 µg 
of D3/D2 for 11 weeks. They found that mean serum 25(OH)D level increased from 49.3 
to 72.3 nmol/L for the D3 group and from a mean of 42 to 67 nmol/L for D2 group. The 
authors state that this dose was not effective in correcting the deficiency of vitamin D, 
although it would be sufficient to sustain an optimal level of vitamin D (≥75 nmol/L). In 
another intervention, Vieth et al. (2001) found that the serum 25(OH)D levels of healthy 
adults (n=61, mean age 41 years) who received 25 µg D3 increased from 43.1 nmol/L to 
69.8 nmol/L after 12 weeks, with a 1.02 nmol/L increase per microgram of vitamin D3 
taken. By contrast, in the group administered 100 µg vitamin D3, serum 25(OH)D levels 
rose from 37.4 nmol/L to 97.3 nmol/L, with an increase of 0.57 nmol/L per microgram of 
vitamin D3 (Vieth et al., 2001). Heaney et al. (2003a) agree with the finding of Vieth et al. 
that either 100 or 125 µg/d of D3 can increase serum 25(OH)D levels without any adverse 
effect. The authors conducted a study on 67 healthy adults, with a mean age of 38.7 
years who were supplemented with either placebo, 25, 125, or 250 μg/day of vitamin D3 
for five months (Heaney et al., 2003a). They found that serum 25(OH)D levels increased 
by 12, 92 and  195 nmol/L respectively, while in the placebo group it decreased by 11 
nmol/L.  
However, another study (Aloia et al., 2008) found that participants whether Caucasian 
or Black, required at least 100 µg if they had insufficient vitamin D levels (< 50 nmol/L). 
A recent study conducted among Somali women found that a daily dose of 20 µg of 
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vitamin D3 was not sufficient to increase 25(OH)D levels, while a dose of 40 µg increased 
mean serum 25(OH)D levels from 19 nmol/L to at least 60 nmol/L (Osmancevic et al., 
2016).  
The above review indicates that numerous studies have been conducted on the 
effectiveness of a daily dose of vitamin D3 to increase vitamin D levels to a desirable level. 
Section 2.6.2, which follows, considers additional factors including safety, efficiency and 
rapidity in studies of supplementation with another form of vitamin D.  
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Table 2.3: Supplementation studies to improve vitamin D status amongst healthy adults 
Reference Study 
participants 
Mean 
age 
Vitamin D 
dose 
duration 
& study 
design 
Assay Baseline 
25(OH)D 
nmol/L mean  
Outcomes  
Vieth et al. 
(2001) 
61 male and 
female 
41 years Oral D3 25 μg/d  
100 μg/d 
3 months 
(RCT) 
RIA 40.7 ± 15.4 
37.9 ± 13.4 
 
The mean 25(OH)D concentration 
reached 68.7 nmol/L, 96.4 nmol/L for 
group of 25 and 100 respectively. 
Supplementation with 100 µg vitamin 
D3 is safe and gave a beneficial increase 
in 25(OH)D levels 
Harris and 
Dawson-
Hughes (2002) 
25 young 
adults, 25 
older adults 
(healthy 
men) in USA 
18-35 
years and 
62-79 
years 
20 μg/d oral D3 
 
8 weeks 
(RCT) 
Competitiv
e protein 
binding. 
60 nmol/L This dose was effective for some 
participants to reach 83 nmol/L. 
Heaney et al. 
(2003a) 
Healthy men 
67 in Omaha 
41°N 
38.7 years 0, 25, 125 and 
250 μg/d Oral 
vitamin D3 
20 weeks 
(RCT) 
RIA 70.3 ± 19.9 for all 
groups 
The mean 25(OH)D concentration of 
some participants reached 84 nmol/L at 
the end of trial with the 25-μg/d dose, 
while others remained below 
75nmol/L. At least 100 μg/day 
recommended to achieve desirable 
level. 
Barnes et al. 
(2006) 
27 samples 
in Northern 
Ireland 55°N 
21.6 years 15 μg/d D3 and 
1500 mg 
1500 calcium 
8 weeks  
(RDBPC) 
ELISA 47.9 ± 16 
55.5 ± 18.9 
 
Daily 15 μg increased vitamin D level to 
mean of 86.5 nmol/L 
Talwar et al. 
(2007) 
208 Black 
women 
USA 41°N 
59 years 20 and 50 μg/d 
oral D3 
First stage for 
2 years, in 
third years 
started taking 
50 μg/day  
RIA 46.9 ± 20.6 The level of vitamin D could be 
increased to desired level by consuming  
50 μg/d among Black women 
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Reference Study 
participants 
Mean 
age 
Vitamin D 
dose 
duration 
& study 
design 
Assay Baseline 
25(OH)D 
nmol/L mean  
Outcomes  
Holick et al., 
(2008) 
68 healthy 
adults in 
Boston 42 °N 
40 years 
 
25 µg D3 and D2, 
placebo 
11 weeks 
(RDBPC) 
LC-MS D2 group= 42.3 ± 
26.3; 
 D3 group= 49.0 ± 
27.8; 
Placebo group=  
46.5 ± 22.3  
Daily 25 µg of D3/D2 is effective in 
sustaining a sufficient level of vitamin D   
Nelson et al 
(2009) 
86 women in 
Main 45°N 
22 years 20 µg/d D3 
placebo 
12 month 
(RCT) 
RIA 62.1 ± 24.0 
61.9 ± 22.6 
The mean serum 25(OH)D level of 80% 
of participants  reached  ≥75 nmol/L at 
the end of the study.  
Forsythe et 
al.(2012) 
110 sample 
in Northern 
Ireland 55°N 
28 years 15 μg/d D3 22 weeks 
(RDBPC) 
ELISA 75.8 (median) 
65.7 (median) 
placebo 
 
Daily 15 μg for 22 weeks was effective 
for participants to achieve at least  
>50 nmol/L (mean 68.9) 
Osmancevic et 
al (2016) 
114 Somali 
women in 
Sweden 55°N 
34 years 20, 40 µg/d D3 12 weeks 
(RDBPC) 
Automated 
immunoass
ay 
23 (median) 
19 (median) 
Daily dose of 20 µg increased mean 
serum 25(OH)D by 15 nmol/L at week 6 
and reached 38 nmol/L at week 12. 
Daily  dose of 40 µg increased it to 60.5 
nmol/L at week 12   
RCT: Randomized control trial, RDBPC: Randomized double blind placebo control 
LC-MS/MS: Liquid chromatography–mass spectrometry 
ELISA: Enzyme-linked immunosorbent assay 
RIA: Radioimmunoassay 
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2.6.2 Oral vitamin D metabolite (calcifediol) 
Although, the two common forms of vitamin D (D2 and D3) are mostly employed to treat 
vitamin D deficiency or insufficiency, other synthetic metabolites such as calcifediol, also 
referred to calcidiol, can be used as a drug in clinical practice to raise 25(OH)D levels 
(Cianferotti et al., 2015; Haddad and Stamp, 1974; Haddad and Rojanasathit, 1976). 
Calcifediol can be taken as a pharmaceutical compound, supplement or ingredient in 
normal food (Ovesen et al., 2003; Purchas et al., 2007). It has a higher polarity and 
biological activity than vitamin D itself, which makes it more soluble in the blood, and 
has a short half-life of 10–13 days (Jean et al., 2008; Bischoff‐Ferrari et al., 2012; 
Cianferotti et al., 2015). As a consequence, it raises 25(OH)D levels more rapidly than 
vitamin D3, so that 1 μg of calcifediol administered orally will raise 25(OH)D 
concentrations by 3–4 nmol/L, compared with a 1 nmol/L increase from vitamin D3 
(Bischoff‐Ferrari et al., 2012; Cashman et al., 2012). Recently, concern has been raised 
over the consequences of taking high doses of vitamin D, including increased risk of falls 
and fractures (Sanders et al., 2010; Dawson-Hughes and Harris, 2010; Rossini et al., 
2012). There is thus a perceived need to avoid high doses of vitamin D (Brandi and 
Minisola, 2013). A satisfactory solution may be to use calcifediol, as a small dose can 
treat vitamin D deficiency over a short period.   
Section 2.6.2.1, reviews previous studies of the use of calcifediol to treat vitamin D 
deficiency among healthy people and studies of its use to address deficiency caused by 
specific medical conditions. A summary of these studies and their key findings is also 
presented in Table 2.4.  
2.6.2.1 Use of calcifediol to treat hypovitaminosis D  
Several studies have investigated the effect of calcifediol and have shown its ability to 
increase serum 25(OH)D level rapidly (Barger-Lux et al., 1998; Shieh et al., 2017; Jetter 
et al., 2014). Shieh et al. (2017) recently conducted a comparative study on 35 multi-
ethnic adults (mean baseline 25(OH)D levels of 40 nmol/L), who were supplemented with 
either 60 D3 µg/d (n=16) or 20 µg/d calcifediol (n=19) for 16 weeks. They found that in 
the calcifediol group, 25(OH)D levels reached 86.1 nmol/L at week 4 and were further 
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elevated beyond week 16, while in the vitamin D3 group, 25(OH)D levels remained below 
75 nmol/L. 
An earlier study by Barger-Lux et al. (1998) assessed the effect of graded oral dosing of 
calcifediol (10, 20 or 50 µg/d) for 4 weeks and vitamin D3 (25, 250 or 1250 µg/d) for 8 
weeks in 116 healthy men (mean age of 28 years and baseline 25(OH)D levels of 67 
nmol/L). The authors report that at week 4 the changes in mean serum 25(OH)D level in 
the calcifediol group were approximately 40 nmol/L, 75 nmol/L and 204 nmol/L for 10, 
20 and 50 µg/d of 25(OH)D3 respectively, while in the vitamin D3 group, the respective 
changes at week 8 were 28.7, 146 and 634 nmol/L for 25, 250 and 1250 µg. The half-life 
of calcifediol was 19 days (Barger-Lux et al., 1998). 
A recent long-term study was conducted by Jetter et al. (2014) to assess the 
pharmacokinetics of vitamin D3 vs calcifediol on plasma 25(OH)D levels of 35 
postmenopausal women.  The participants were divided into seven groups, which were 
given either a daily oral dose of 20 µg vitamin D3 or calcifediol, a weekly dose of 140 µg 
D3 or calcifediol (both for 15 weeks), or a single dose of 140 µg vitamin D3 or calcifediol. 
The plasma 25(OH)D levels of the calcifediol group increased to more than 75 nmol/L at 
week 4 and levels did not differ significantly between daily and weekly application. In the 
vitamin D3 groups, 70% of women who were given the same doses reached 25(OH)D 
levels of 75 nmol/L at week 15. Finally, it was found that calcifediol was associated with 
a 2.5-fold increase in plasma 25(OH)D levels compared to vitamin D3 (Jetter et al., 2014). 
Similarly, Cashman et al. (2012) studied 58 adults with a mean age of 57.2 years, to 
compare the effects of calcifediol and vitamin D3 in enhancing 25(OH)D levels. These 
participants were divided into four groups and given a daily dose of either 20 µg vitamin 
D3 or calcifediol, 7 µg calcifediol or placebo, for 10 weeks. It was found that mean serum 
25(OH)D levels increased from 38.2 nmol/L to 134 nmol/L in the 20 µg calcifediol group 
and from 42 nmol/L to 70 nmol/L in 7 µg calcifediol group, while in the vitamin D3 group 
the increase was from 49 nmol/L to only 69 nmol/L and no change was registered in the 
placebo group (Cashman et al., 2012). The authors conclude that calcifediol 
supplementation was about 4.2 to 5 times more efficacious in enhancing serum 25(OH)D 
levels compared to vitamin D3 (Cashman et al., 2012). The difference between the Jetter 
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and Cashman studies in the extent of the superior therapeutic effectiveness of calcifediol 
over D3 in raising 25(OH)D levels may due to the assay methods used or to errors in 
sampling and processing.  
2.6.2.2 Use of calcifediol to treat hypovitaminosis D caused by diminished hepatic or 
renal hydroxylation 
Several supplementation trials have been conducted to investigate the efficacy of 
calcifediol in treating some diseases. A recent study by Bischoff-Ferrari et al. (2012) 
investigated the effect on postmenopausal women (mean age of 61.5 years and a mean 
baseline 25(OH)D levels of 34 nmol/L) of a daily dose of 20 µg calcifediol or vitamin D3 
over 4 months. The mean serum 25(OH)D level of the calcifediol group was found to 
increase to 173.7 nmol/L, compared with 77.5 nmol/L in the vitamin D3 group. The 
authors supported the benefit of using calcifediol on systolic blood pressure and as a 
marker of innate immunity in postmenopausal women, thus implying how the use of 
calcifediol is likely to boost vitamin D levels. 
 An intervention study conducted by Jean et al. (2008) found the use of either 10 or 30 
µg calcifediol in haemodialysis patients with a mean age of 67 years was effective and 
safe. Mean baseline serum 25(OH)D levels were 30 nmol/L, increasing to 126 nmol/l after 
six months of treatment. 
In another study, females aged between 24 and 72 years were supplemented with a 
monthly dose of 500 µg calcifediol for 4 months (Russo et al., 2011). The authors report 
that with respect to baseline values, there was a highly significant difference in 25(OH)D 
levels after the first dose, reached a peak at day 3 and stabilised over the rest of the 
month. Repeated measurements of blood levels at a variety of times were used in this 
study to assess the pharmacokinetics of the first dosage and showed that subsequent 
values continued to be significantly higher than baseline (p<0.001). At the end of the 
study, the authors found that all participants had reached serum levels above 75 nmol/L 
(Russo et al., 2011).  
Participants in most studies of the effects of calcifediol in increasing 25(OH)D 
concentrations have been adults aged from 50 to 70 years, while there are few 
references in the literature to investigations of the effects of this supplement in younger 
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adults and there are none on ethnic minority groups in the UK. This was the motivation 
behind the present study. In the aforementioned literature, no adverse effects were 
reported in participants who received calcifediol supplements, whether daily, weekly or 
monthly, in the range of 10 µg/d to 500 µg/month. 
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Table 2.4: Supplementation studies (calcifediol) to improve vitamin D status among healthy adults 
Reference 
Study 
participan
ts 
Mean 
age 
Vitamin D 
dose 
Duration 
& Study 
design 
Assay 
Baseline 
25(OH)D 
Nmol/L 
mean  
Outcome 
Barger-Lux et 
al. (1998) 
116 
healthy 
men 
28 
years 
10, 20 and 50 μg/d 
of calcifediol 
25, 250 and 1250 
μg/d 
4 weeks for 
calcifediol 
group and 8 
weeks for 
vitamin D 
HPLC 67 for 
calcifediol 
8 for 
vitamin D 
Mean serum 25(OH)D level of calcifediol 
increased rapidly in  different doses and 
reached 40,76.1 and 206.4 nmol/L 
Mean serum 25(OH)D level of vitamin D level 
increased to 28, 146 and 643 nmol/L. 
Cavalli et al. 
(2009) 
90 
Caucasian 
females 
65-75 
years 
125 μg/week  
250 μg/month 
500 μg /month with 
a combination 500 
mg calcium 
12 week 
(RCT)  
RIA  50.1  
51.4  
52.0  
 
Mean serum 25(OH)D level of calcifediol 
increased to 76, 70 and 77 nmol/L respectively. 
Jean et al. 
(2008) 
149 
haemodial
ysis 
patient 
(mixed 
gender) 
67 
years 
10 μg/d serum 
between (50-75 
nmol/), 20 serum 
between 25-
50nmol/L)and30 
serum ≤ 25nmol/L 
6 months HPLC/MS/M
S 
30 
 
Daily 10-30 μg effective to achieve ≥75 nmol/L, 
without any cases of hypercalcemia  
calcifediol effective to correct vitamin D 
deficiency in haemodialysis patients 
 
Russo et a. 
(2011) 
18 females 24-72 
years 
500 μg/month 4 months RIA 45 Monthly dose of 500 μg calcifediol increased 
serum 25(OH)D significantly. 
Serum 25(OH)D declined after peak but 
remained over 75nmol/L until the next dose 
Bischoff-
Ferrari et al. 
(2012) 
 
20 healthy 
postmeno
pausal 
women 
61.5 
years 
Daily 20, weekly 
140 μg vitamin D3 
and daily 20, weekly 
140 μg calcifediol 
12 weeks 
(RCT) 
HPLC/MS/M
S 
33 1- Mean 25(OH)D levels increased to 77.5 
nmol/L with a slow increase in the vitamin 
D3 group. Women on had a 2.8-fold 
improvement compared with vitamin D3  
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Reference 
Study 
participan
ts 
Mean 
age 
Vitamin D 
dose 
Duration 
& Study 
design 
Assay 
Baseline 
25(OH)D 
Nmol/L 
mean  
Outcome 
2- There were no cases of hypercalcemia at any 
time point. 
3- Significant benefit on lower extremity 
function, systolic blood pressure, and innate 
immune response. 
Cashman et al. 
(2012) 
56 heathy 
males/fem
ales  
57.2 
years 
Daily 20 μg vitamin 
D3 
daily7, 20μg 
calcifediol and 
placebo 
 
 
10 weeks 
(RDBPC) 
ELISA 49.7 D3 
group 
42.5 for 7 
calcifediol 
38.2 for 20 
calcifediol  
Mean 25(OH)D levels increased rapidly in both 
groups of calcifediol more than in vitamin D3 
 
Jetter et al. 
(2014) 
35 healthy 
females 
60 
years 
Daily 20, weekly 
140 μg vitamin D3 
and daily 20, weekly 
140 μg calcifediol 
15 weeks 
(RCT) 
HPLC/MS/M
S 
20 D3= 30 
20 
calcifediol= 
32 
140 D3=40 
140 
calcifediol=
28 
Calcifediol is about 2–3 times more potent in 
increasing plasma 25(OH)D3 level than vitamin 
D3. Plasma 25(OH)D3 concentrations of ≥75 
nmol/l were reached at week 5 while only a few 
participants reached this cut off at week 15 
Shieh et al. 
(2017) 
35 multi-
ethnic 
adults 
≥18 
years 
60 μg/d D3 
20 μg/d Calcifediol 
16 weeks  
(RCT) 
CI 40 
 
25(OH)D level of all participants supplemented 
by calcifediol was increased to ≥ 75nmol/L at 
week 4 while it was reached 75 nmol/L at the 
end of study 
RCT: Randomized control trial, RDBPC: Randomized double blind placebo control 
CI: Chemiluminescence Immunoassay, ELISA: The enzyme-linked immunosorbent assay 
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RIA: Radioimmunoassay, HPLC: High Performance Liquid Chromatography, HPLC/MS/MS: Liquid chromatography–mass spectrometry
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2.7 Summary  
This chapter has reviewed the relevant literature on hypovitaminosis D, beginning with 
the stages of vitamin D metabolism in the human body, from its production through to 
its biological actions. A great proportion of the review evaluated the prevalence of 
vitamin D deficiency in the UK, factors exacerbating the problems of vitamin D deficiency, 
the health outcomes of deficiency and recommended levels. The review also explored 
supplementation studies conducted on adults using different types of vitamin D for 
different durations. 
Despite the growing literature in the area of vitamin D deficiency, there is still sparse 
information in the context of EMGs living in Manchester. A few studies suggest that this 
population needs a stronger focus on addressing the risk factors for vitamin D deficiency 
and establishing beneficial vitamin D sources to enhance public health outcomes. It is 
apparent that various studies have established the need for multiple interventions, 
ranging from dietary to medical, to tackle an apparently growing issue of vitamin D 
deficiency. In order to increase the efficacy of these interventions, there is a significant 
need for education among the population on the importance of adopting a healthy diet 
and lifestyle (De Roos et al., 2012; Farrar et al., 2011). 
The next chapter considers EMGs in the UK and the risk factors influencing their vitamin 
D status. 
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3. RISK FACTORS INFLUENCING 
VITAMIN D STATUS OF ETHNIC 
MINORITY ADULTS LIVING IN 
NORTHERN ENGLAND 
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3.1 Introduction 
Over the years, a great number of immigrants from Asia and Africa have settled in the 
UK (Patel et al., 2013). According to the 2011 census, the ethnic minority population of 
Britain has experienced an increase since 1991; in Manchester, the site of this study, 
ethnic minorities now make up 33% of the population, as mentioned in Section 2.7.3 
(Jivraj and Simpson, 2015). Recently, there has been increasing interest in the vitamin D 
status of the UK population, especially among ethnic minority groups. Various studies 
have shown that hypovitaminosis D is a serious issue among these communities 
throughout the UK due to several factors, including low sun exposure and skin 
pigmentation, which would affect the vitamin D status of those living in Manchester 
(Shaw and Pal, 2002; Ford et al., 2006; Farrar et al., 2011). These studies have 
concentrated on sun exposure behaviour and vitamin D intake in specific ethnic groups. 
Therefore, this chapter considers risk factors applicable to the different EMGs living in 
Manchester which may affect their vitamin D status.  
3.1.1 Aim 
 Investigate differences in the risk factors for vitamin D deficiency between 
ethnic minority groups. 
3.1.2 Objectives 
 Estimate vitamin D intake for the main ethnic minority groups living in 
Manchester from dietary sources, supplement use and sun exposure using a 
questionnaire. 
 Evaluate lifestyle factors and sun exposure behaviours that could affect 
estimated total intake of vitamin D. 
3.1.3 Research hypothesis 
Lifestyle factors and vitamin D intake differ among ethnic minority adults living in the UK.
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3.2 Methodology 
3.2.1 Ethical considerations 
Ethical approval was obtained through the Manchester Metropolitan University 
Research process for all phases of the study. Participants were provided with a 
participation information sheet (Appendix 1) and signed informed consent was obtained 
(Appendix 2). Each participant could withdraw at any time from this research, as 
participation was voluntary. Participants’ contact numbers and email addresses were 
kept in anticipation of their willingness to take part in the next stage of the study in 
accordance with the Data Protection Act, 1998. 
3.2.2 Sample size consideration 
Although it has been claimed that a larger sample size gives a narrower confidence 
interval (Cottrell and McKenzie, 2010), Guthrie (2010) states that a sample size of 384 is 
sufficient for a research survey in a given population of one million or greater. The 
current study targets the ethnic minority population of Manchester, which is stated to 
be 33% of the total population (530,000) of the city (Manchester City Council, 2015). 
3.2.3 Study population and recruitment 
Study recruitment took place in Manchester, located in the North West of England (53°N) 
and was performed between September and November 2015. The electronic version of 
the questionnaire was created using the website Google Docs (docs.google.com). It was 
then distributed via different forms of social media, including targeting relevant 
communities on Facebook, Twitter and Instagram. In addition, a paper version was 
distributed at specific places typically frequented by ethnic minority groups, e.g. towns, 
neighbourhoods, markets and religious centres. 
The eligibility criteria were: 
 Resident in Manchester; 
 Aged 18 to 50-years; 
 From an ethnic minority background (Arab, South Asian, Black African/Caribbean 
(AfroC) and East Asian). 
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3.2.4  Study protocol  
   The design of the observational study is presented in Figure 3.1 as a flowchart: 
 
Figure 3.1: Flowchart of observational study 
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3.2.4.1 Questionnaire design 
The questionnaire gathered the following information: age, sex, ethnicity, place of birth, 
and length of residence in the UK, along with data relating to socioeconomic factors such 
as income, religion, education level and occupation (Appendix 4). Religion was classified 
as Muslim, Christian, Sikh, Hindu, Jewish and other. Occupational status was classified as 
employed, unemployed and student. Generally, the questionnaire was designed to 
determine vitamin D status by estimating dietary vitamin D intake and to assess other 
lifestyle and demographic factors hypothesised to affect vitamin D status among ethnic 
minority groups. The questions were predominantly closed-ended to simplify coding and 
analysis (Obeidat, 2002). They were piloted among 13 postgraduate students and staff 
members at Manchester Metropolitan University and the University of Manchester to 
determine whether the questions were clear and understandable, and whether the 
response options were appropriate. The questionnaire consisted of three sections: sun 
exposure assessment, health factors and vitamin D intake.  
3.2.4.1.1 Sun exposure assessment 
A sun exposure assessment is a self-reported questionnaire used for determining sun 
exposure behaviour by collecting data about the participants’ usual daily routines that 
lead to sun exposure (Appendix 4). The questions regarding usual sun exposure were 
based on those from previous studies (Gandini et al., 2005; Hanwell et al., 2010; Cargill 
et al., 2013). Participants were asked about the time spent outdoors on a typical weekday 
and on weekends, between 7 am and 5 pm, to estimate the amount of sun exposure. 
Participants indicated exposure using these frequency options: ‘<15 mins’, ‘15 mins’ ‘15–
30 mins’, ‘30–45 mins’ and ‘45–60 mins’. Subsequent questions were concerned with 
skin colour and sun-protection behaviour. The description of skin colour was based on 
the Fitzpatrick Scale, as described in (Section 2.9.2.2) (light, white–fair, medium cream 
white, olive, brown skin and black skin). It has been noted that the Fitzpatrick Scale has 
a high correlation with self-reported skin colour (r = –0.63, p< 0.001), which in turn was 
found to be highly correlated with the skin-reflection spectrophotometer (r=–0.70, 
p<0.001) (Daniel et al., 2009). Sun-protective behaviour, including the areas of the body 
exposed to the sun (face, hands, full arms, half arms, full legs and half legs), the use of 
sunscreen with a specific SPF (Cargill et al., 2013) and the use of a sunbed were also 
documented (Humayun et al., 2012; Gandini et al., 2005).   
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3.2.4.1.2 Health factors 
In this section, the participants answered questions about their health, including current 
health conditions that can bring about hypovitaminosis D, a history of hypovitaminosis 
D, smoking status and alcohol intake. Female participants were also asked to report if 
they were pregnant or breastfeeding. 
3.2.4.1.3 Dietary intake of vitamin D  
FFQ is used to assess individuals’ habitual diets, detailing which specific foods they 
usually consume over a specific period (Dehghan et al., 2013; Coulston et al., 2017). This 
study used modified version of an existing validated FFQ designed to assess vitamin D 
intake (Taylor et al., 2009). It was composed of questions about consumption of 22 high-
vitamin-D-containing food items, including oily fish, dairy and meat, and how often they 
were consumed over a period of three months on a scale of six levels from never to twice 
a day. Participants were asked to complete the FFQ themselves by indicating the 
frequency of food consumption of each food item listed. An open-ended question 
regarding consumption of particular breakfast cereals was included to capture the 
vitamin D contribution from what are often fortified products that differ markedly 
despite being categorised as the same product. The participants were asked to report 
their brands in order to obtain the exact amount of vitamin D consumed. Additional 
information was obtained to distinguish consumer type (vegetarian or vegan) and the 
volume of milk consumed. They were also asked about supplement intake and the 
brands and dosages of any supplements taken. 
3.2.4.1.4 Anthropometric data 
Participants were asked to state their body weight in kilograms (kg) and height in 
centimetres (cm) to facilitate the calculation of BMI. According to the World Health 
Organisation (2010), BMI is calculated by dividing body weight in kilogrammes by height 
in metres squared (kg/m2). The categories of BMI are: <18.5 kg/m2 (underweight), 18.5–
24.9 kg/m2 (normal weight), 25 –29.9 kg/m2 (overweight) and ≥30 kg/m2 (obese). 
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3.2.5 Data analysis 
3.2.5.1 Sun exposure calculation  
To calculate time outdoors, data were converted into time values by calculating the 
average figure for each of the four categories (<15 min, 15–30 min, 30–45 min and 45–
60min), yielding respective values of 7.5, 22.5, 37.5 and 52.5 minutes. Hence, the total 
time spent outdoors for each participant in minutes per day can be estimated by adding 
up the daily time of sun exposure during weekdays and weekends (Glanz et al., 2010). As 
Farrar et al. (2011) note, UV radiation levels vary from hour to hour in a single day and 
the highest UV level for vitamin D production occurs at midday. Thus, the exposure time 
to sunlight in a single day was divided into two periods: off-peak time represented the 
times of when vitamin D production is low, whereas peak time was when vitamin D 
production is at its highest. To calculate these figures, each time group was created by 
adding up the time of exposure to sunlight reported by participants: 
Equation 1:  
𝐏𝐞𝐚𝐤 𝐭𝐢𝐦𝐞 =  𝐫𝐞𝐩𝐨𝐫𝐭𝐞𝐝 𝐭𝐢𝐦𝐞 𝐨𝐟 (𝟏𝟎 𝐚𝐦– 𝟏𝟏 𝐚𝐦)  + (𝟏𝟏𝐚𝐦– 𝟏𝟐 𝐩𝐦)  
+  (𝟏𝟐 𝐩𝐦– 𝟏 𝐩𝐦) + (𝟏𝐩𝐦– 𝟐 𝐩𝐦) 
Equation 2:  
 𝐎𝐟𝐟 − 𝐩𝐞𝐚𝐤 𝐭𝐢𝐦𝐞 =  𝐫𝐞𝐩𝐨𝐫𝐭𝐞𝐝 𝐭𝐢𝐦𝐞 𝐨𝐟 (𝟕 𝐚𝐦– 𝟖 𝐚𝐦) + (𝟖– 𝟗 𝐚𝐦) + 
 (𝟗𝐚𝐦– 𝟏𝟎𝐚𝐦) +  (𝟐𝐩𝐦– 𝟑𝐩𝐦)  +  (𝟑𝐩𝐦– 𝟒𝐩𝐦)  
 
A method established by Knaysi et al. (1968) called the ‘rule of nine’ was used to estimate 
the Body Surface Area (BSA) (Table 3.1). This formula is frequently used in adults 
suffering burns to estimate the proportion of body burned; the major body segments are 
divided into multiples of 9%, except for the genital area, which is allotted 1%. In this 
study, four categories were adopted to estimate usual skin exposure: head, face, legs 
and hands. Some changes have thus been made to suit the nature of the study (Table 
3.2) 
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Table 3.1: Original ‘Rule of Nine’ 
Body segment (%) 
Arms legs Anterior 
trunk 
Posterior 
trunk 
Head Perineum Total 
0.18 0.36 0.18 0.18 0.09 0.01 1 
Source: Barger-Lux and Heaney (2002). 
Table 3.2: Adapted ‘Rule of Nine’ 
Body segment (%) 
Arms Legs Head Face 
Hands Half arms Full arms Half legs Full legs   
0.04 0.09 0.18 0.18 0.36 0.09 0.05 
Adapted from Barger-Lux and Heaney (2002), with changes have made in the categories to suit the current 
study 
The sun exposure index is an equation generated by Barger-Lux and Heaney (2002) that 
combines exposure time and the total area of skin exposure in that time in one measure, 
which can be used to compare participants. It is calculated as shown in Equation 3. 
Equation 3:  
𝐒𝐮𝐧 𝐢𝐧𝐝𝐞𝐱 =  𝐡𝐨𝐮𝐫𝐬 𝐨𝐟 𝐬𝐮𝐧 𝐞𝐱𝐩𝐨𝐬𝐮𝐫𝐞 𝐩𝐞𝐫 𝐰𝐞𝐞𝐤
×  𝐟𝐫𝐚𝐜𝐭𝐢𝐨𝐧 𝐨𝐟 𝐁𝐒𝐀 𝐞𝐱𝐩𝐨𝐬𝐞𝐝 𝐭𝐨 𝐬𝐮𝐧𝐥𝐢𝐠𝐡𝐭 
3.2.5.2 Vitamin D intake calculation  
The vitamin D contents of various foods was obtained from McCance and Widdowson’s 
The Composition of Foods according to the Food Standards Agency (2014) Table 3.3. The 
proportional weight in grams assigned to each frequency (PWF) was as follows: never = 
0, one to two times a month = 0.067, once a week = 0.15, two to three times a week = 
0.43, once a day = 1 and twice a day = 2 (Ireland et al., 1994; Willett, 2013). 
The average dietary intake of vitamin D was calculated as shown in Equation 4:  
Equation 4:  
𝐕𝐢𝐭𝐚𝐦𝐢𝐧 𝐃 𝐢𝐧𝐭𝐚𝐤𝐞 =  𝐏𝐖𝐅 ×  𝐧𝐮𝐭𝐫𝐢𝐞𝐧𝐭 𝐜𝐨𝐧𝐭𝐞𝐧𝐭 
The total vitamin D content of all foods was added together to obtain each participant’s 
total vitamin D intake (Food Standards Agency, 2014; Willett, 2013).  
The dietary recommendation for vitamin D is 5 μg/day (WHO and FAO, 2004). Therefore, 
vitamin D intake was classified by three cut-off points: less than 5 μg represented low 
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intake, 5–10 μg a medium intake, and over 10 μg a high intake (Zagag et al., 2011). To 
calculate the proportion of vitamin D contributed by each food group, the 22 foods were 
categorised into five groups according to the similarity of their nutrient composition 
(Cotton et al., 2004; Margetts and Nelson, 1997) then the percentage contribution was 
calculated according to equation 5. 
 Equation 5:  
Contribution of vitamin D proportion =  ∑ vitamin D contributed by each food group/
total vitamin D from all food groups  
Table 3.3: Vitamin D content of food items 
Food  gram Vitamin D (µg) 
Fresh mackerel (cooked)  80 8.0 
Fresh tuna (cooked) 85 4.2 
Fresh sardines (cooked) 85 10.5 
Fresh salmon (cooked) 122 11 
Canned tuna  45 1.6 
Canned sardine  109 10 
Canned salmon  109 9 
Herring  85 13 
Beef   85 0.1 
Pork and Ham  85 0.8 
Beef liver  85 0.3 
Pork liver 85 0.3 
Egg  60 1.8 
Cream cheese  28 0.2 
Hard cheese  28 0.2 
Milk  207 2.2 
Semi-skim Milk   207 0.15 
Margarine  12  1.2 
Butter  12  0.1 
Sun dried mushroom  28  0.7 
Cod liver oil 12  25.0 
Breakfast cereal 60 2.2 
Source: Food Standards Agency (2014) 
3.2.6 Statistical analysis 
Data analysis was performed using SPSS software, version 21 (SPSS Inc., Chicago, IL, USA). 
The data were transferred from the questionnaires to an Excel spreadsheet, then from 
Excel to SPSS for analysis. Prior to commencement of statistical analysis, the data were 
checked for inputting errors and histograms and box plots were used to identify outliers. 
Wherever an outlier was detected, the value was excluded from the analysis. By using 
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descriptive statistics, the results of categorical variables were given as percentages and 
frequencies. As for the continuous variables, normally distributed data were reported as 
mean values accompanied by the standard deviation (SD), with a median value given for 
skewed data (Kirkwood and Sterne, 2010). Normality of data was checked statistically by 
using frequency histograms, and appropriate transformations such as square root were 
used to normalise the data. A value of p<0.05 was considered statistically significant. 
To explore the difference between ethnicity and other continuous variables, including 
BMI and vitamin D intake, the one-way ANOVA test was used, along with a post hoc test 
when significant differences were detected (Kirkwood and Sterne, 2010). However, the 
data for usual sun exposure was found to be skewed and were therefore analysed using 
the Kruskal–Wallis H test. For nominal data, the associations between each categorical 
variable were explored using the chi-square statistic. Additionally, a multiple linear 
regression model was used after checking its assumptions (Draper and Smith, 2014) to 
explore which factors were considered as predictors for vitamin D intake from the 
following independent variables: ethnic origin, income, sex, age and education. In this 
case, some dummy variables were created from the nominal predictor to fit this test 
(McDonald, 2009). 
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3.3 Results 
3.3.1 Recruitment of participants 
A total of 400 questionnaires were distributed and 268 individuals from different ethnic 
minorities agreed to participate in the study, then completed and returned the 
questionnaire, either via electronic survey or on paper. Of these responses, 15 were 
excluded because nine respondents were aged >50 years and six others resided outside 
Manchester. Participants included Arabs (Iraqi, Egyptian, Lebanese, Jordanian, Syrian, 
Palestinian, Yemeni, Saudi Arabian, Kuwaiti and Omani), Africans (Nigerian, Somali, 
Kenyan, Tanzanian, Zimbabwean and South African), Black Caribbeans (Jamaican), South 
Asians (Indian, Pakistani and Bangladeshi), East Asians (Chinese and Japanese) and 
Southeast Asians (Malaysian, Thai and Indonesian). Figure 3.2 is a flowchart of 
participants. 
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Figure 3.2: Flowchart of study participants 
3.3.2 Participants’ demographic characteristics  
A total of 253 respondents completed either the electronic or the paper questionnaire. 
Slightly more than half of the sample (53.4%) comprised females. The distribution by sex, 
age, ethnicity, income status, education level, occupation status and location is 
presented in Table 3.4. The largest ethnic group was the Arabs. Three-quarters of 
respondents were Muslims and 16% Christians; the remaining participants were 
classified as ‘other’ because there were very few responses in any other religious 
category. Nearly half of the participants had lived in the UK for more than five years and 
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only 14% had done so for less than a year. The ages of respondents ranged from 18 to 
49 years, with nearly half aged under thirty, and almost as many between 30 and 39 
years. A total of 28% of participants reported an income of less than £5,200 annually, 
while a few reported an income of over £26,000. The majority had received a higher 
education, over half were employed and only 11% were unemployed. 
Table 3.4: Demographic characteristics and health factors for study sample (n = 253) 
Variable n (%) or mean ± SD 
Number  
Males 118 (47.6) 
Females 135 (53.4) 
Age  
18–29 112 (44.3) 
30–39 101 (39.9) 
40–49 40 (15.8) 
Anthropometric data  
Weight 71.58 ± 14.95 
Height 165.86 ± 10.09 
BMI 25.89 ± 4.25 
Country of Birth 
Gulf countries$ 71 (28.1) 
The Levant^ 11 (4.3) 
North Africa 23 (9.1) 
Other Afro-countries 61 (24.1) 
South Asia 34 (12.4) 
East Asia 18 (7.1) 
Ethnicity  
Arab 105 (41.5) 
Afro/Caribbean** 66 (26.1) 
South Asian*** 61 (24.1) 
East Asian **** 21 (8.3) 
Religion 
Muslim 189 (74.7) 
Christian 41 (16.2) 
Other^^  23 (9.0) 
Length of resident  
<1 year 37 (14.3) 
1–5 years 95 (36.7) 
>5 years 127 (49.0) 
Education level  
College/diploma  37 (14.6) 
Bachelors 118 (46.6) 
Postgraduates 98 (38.7) 
Occupation  
Employed 131 (51.8) 
Unemployed 28 (11.1) 
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Variable n (%) or mean ± SD 
Student 94 (37.2) 
Occupation description  
Mainly indoors 158 (62.5) 
Half indoor/outdoors 75 (29.6) 
Mainly outdoors 20 (7.9) 
Income (£) 
>5,200 73 (28.9) 
5,200 to 10,399 46 (18.2) 
10,400 to 25,999 71 (28.1) 
≥26,000  63 (24.9) 
Smoking status 
No 236 (93.3) 
Current 17 (6.7) 
Every day 13 (5.1) 
Occasionally 4 (1.6) 
Alcohol intake 
No 203 (80.2) 
Yes 50 (19.8) 
3 days and below 40 (80.0) 
More than 3 days 10 (20.0) 
Reported health conditions£ 29 (11.5) 
History of vitamin D 
deficiency 
68 (26.9) 
Supplement intake^ 58 (22.9) 
Type of consumer (vegetarians) 
Yes 14 (5.5) 
No 239 (94.5) 
Consumed fortified food 
Yes 61 (24.1) 
No 50 (19.8) 
Sometimes 92 (36.4) 
Don’t know 50 (19.8) 
 
^From Lebanon, Jordan, Syria and Palestine. **Nigerian, Somalian, Kenyan, Tanzanian, Zimbabwean, 
South African and Jamaican. 
***From India, Pakistan and Bangladesh. ****Chinese, Malaysian, Thai and Japanese. $From Saudi Arabia, 
Kuwait, Qatar, Oman and the United Arab Emirates. ^^Sikh, Buddhist and no religion. 
 £Chronic diseases (diabetes mellitus, heart disease, asthma, dermatomyositis and kidney disease) or 
skeletal diseases (osteoporosis and ankylosing spondylitis). 
^Multivitamins. 
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Figure 3.3 shows that fewer than half of participants fell into the range of healthy weight, 
while a third were overweight and 21% were obese (BMI>30 kg/m2). 
 
 
 
Figure 3.3: Percentage of participants by BMI (n = 253) 
Table 3.4 shows that very few participants were smokers and that most were non-alcohol 
drinkers; fewer than 20% reported alcohol intake, with one in five of these drinking on 
more than three per week. Only a few participants reported suffering from health 
conditions, but over a quarter of the sample had experienced vitamin D deficiency. 
Supplements were taken by a little less than a quarter of participants and a similar 
proportion reported regular consumption of fortified food. Only 14 of the total sample 
reported themselves as vegetarians. 
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3.3.3 The association of variables with sex 
3.3.3.1 Socioeconomic and health factors  
Table 3.5 illustrates how education level, occupation, income, and age groups 
significantly differed by sex (p<0.05). Over half of females held a bachelor degree, while 
45% of males held a postgraduate degree. Table 3.5 demonstrates that there was a 
significant association (p=0.04) between smoking status and sex, with more males than 
females being smoker, but no significant difference between the sexes on intake of either 
alcohol or supplements. There were also significant differences (p<0.001) between the 
sexes in reported health conditions and in the incidence of vitamin D deficiency, with 
more females being affected by hypovitaminosis D and reporting health conditions. 
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Table 3.5: Socioeconomic and health factors according to sex 
Variable 
Male n = 118 Female n = 135 
p value^ 
n (%) 
Age    
18–29 38 (32.2) 74 (54.8)  
30–39 52 (44.1) 49 (36.3) <0.001 
40–49 28 (23.7) 12 (8.9)  
Education level    
College/diploma 19 (16.1) 18 (13.6)  
Bachelor  45 (38.1) 73 (54.1) 0.03 
Postgraduate 53 (45.8) 44 (36.6)  
Income status (£)     
<5,200 24 (20.3) 48 (35.6)  
5,200–10,399 28 (23.7) 21 (15.6) 0.02 
10,400–25,999 32 (27.1) 39 (28.9)  
≥26,000 34 (28.8) 27 (20.0)  
Occupation    
Employed 74 (62.7) 56 (41.5)  
Student  36 (30.5) 20 (14.8) <0.001 
Unemployed  8 (6.8) 59 (43.7)  
Smoking status    
Current  12 (10.2)  5 (3.7)  0.04 
Every day 11 (91.7) 2 (40.0)  
Occasionally 1 (8.3) 3 (60.0)  
Alcohol intake    
Yes  26 (22.0) 24 (17.8) 0.43 
3 days and below 23 (88.5) 17 (70.8)  
More than 3 days 3 (11.5) 7 (29.2)  
Health conditions£ 6 (5.1)  23 (17.0)  <0.001 
History of vitamin D 
deficiency  
23 (19.5)  45 (33.3)  0.01 
Supplement intake^ 22 (18.6) 36 (26.7) 0.13 
^Chi-square test. £Chronic diseases (diabetes, heart disease, asthma, dermatomyositis and kidney disease) or 
skeletal diseases (osteoporosis and ankylosing spondylitis). ^Multivitamins. 
 
BMI was found to significantly differ by sex (p<0.001), with male participants having a 
higher BMI than females. As shown in Figure 3.4, the BMI of approximately half the 
females was in the healthy category, whilst many males were obese than females, 
although the proportion of those classified as overweight differed very little between the 
sexes. 
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Figure 3.4: Distribution of participants by body mass index (BMI) and sex (n=253) 
3.3.4 The association of variables with age 
3.3.4.1 Health and lifestyle factors 
Table 3.6 demonstrates that only alcohol intake, supplement intake and BMI were 
significantly (p<0.001) influenced by age. The highest percentage of alcohol drinkers was 
among participants aged 40–49 years, while those aged 30–39 years were the greatest 
users of supplements. Kruskal-Wallis H test showed that there was a significant 
difference in BMI status between the different age groups (p<0.001), with a mean rank 
BMI of 103.30 for those aged 18–29 years, 138.50 for the 30–39 group and 164.34 for 
the 40–49 age group. 
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Table 3.6: Health and lifestyle factors according to age 
Variable 
18–29 years  
n = 112 
30–39 years  
n = 101 
40–49 years  
n = 40 p value$ 
n (%) 
Smoking status 6 (5.4) 9 (8.9) 2 (5.0) 0.46 
Alcohol intake  17 (15.2) 18 (17.2) 15 (37.5) <0.001 
Health conditions* 8 (7.1) 16 (15.8) 5 (12.5) 0.16 
History of vitamin 
D deficiency 
28 (25.0) 33 (32.7) 7 (17.5) 0.16 
Supplement intake^ 15 (13.4) 29 (28.7) 14 (35.0) <0.001 
BMI (kg/m2)** 23.3 (5.5) 26.4 (5.0) 29.4 (7.8) 
<0.001**
* 
*Chronic diseases (diabetes, heart disease, asthma, dermatomyositis and kidney disease) or skeletal diseases 
(osteoporosis and ankylosing spondylitis). 
^Multivitamins.  
$Chi-square test 
*** Kruskal-Wallis H test 
**Median (interquartile range). 
3.3.5 Distribution of characteristics by ethnicity 
3.3.5.1 Demographic characteristics  
Table 3.7 shows that there were more female than male respondents in each ethnic 
group, except for the Arab grouping. More than half the SA group were in the age range 
18–29 years, while an equal percentage of Arabs fell in the 18–29 and 30–39 age ranges. 
The data also show that approximately half of the Arabs held postgraduate degrees, a 
high proportion compared with other ethnicities. The highest percentage of people who 
had not attended university was among AfroC respondents. Education level, occupation, 
sex and religion differed significantly across ethnic groups (p<0.001), but no statistical 
differences were found between age groups, income status or occupation location across 
ethnicities (p = 0.10, 0.44 and 0.19, respectively).
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Table 3.7: Demographic characteristics of participants according to ethnicity 
Variable 
Arab n = 
105 
South Asian 
n = 61 
Afro/Caribb
ean n = 66 
East Asian 
n = 21  
p 
value$ 
Sex   
Male 61 (58.1) 21(34.4) 31 (47.0) 5 (23.8)  
Female  44 (41.9) 40 (65.6) 35 (53.0) 16 (76.2) <0.001 
Age (year)  
18–29 45 (42.9) 37 (60.7) 21 (31.8) 9 (42.9)  
30–39 45 (42.9) 16 (26.2) 34 (42.9) 6 (42.9) 0.10 
40–49 15 (14.3) 8 (13.1) 11 (42.9) 6 (42.9)  
Religion   
Muslim 105 (100.0) 49 (80.3) 28 (42.4) 7 (33.3)  
Christian 0 (0) 2 (3.3) 37 (56.2) 2 (4.9) <0.001 
Other* 0 (0) 10 (16.4) 1 (1.5) 12 (57.1)  
Education level  
College/diploma 14 (13.3) 4 (6.6) 15 (22.7) 4 (19.0)  
Bachelor  38 (36.2) 40 (65.6) 29 (43.9) 11 (52.4) <0.001 
Postgraduate 53 (50.5) 17 (27.9) 22 (33.3) 6 (28.6)  
Income status 
(£)  
 
<5,200 29 (27.0) 23 (37.7) 12 (18.2) 8 (38.1)  
5,200–10,399 20 (19.0) 7 (11.5) 17 (25.8) 5 (23.8) 0.44 
10,400–25,999 27 (25.7) 17 (27.9) 22 (33.3) 5 (23.8)  
≥26,000 29 (27.6) 14 (23.0) 15 (22.7) 3 (14.3)  
Occupation  
Employed 50 (47.6) 29 (47.5) 44 (67.7) 7 (33.3)  
Unemployed  9 (8.6) 11 (18.0) 3 (4.6) 5 (23.8) <0.001 
Student  46 (43.8) 21 (34.4) 18 (27.7) 9 (42.9)  
Occupation 
location 
 
Mainly indoors 64 (61.0) 41 (67.2) 38 (58.5) 15 (71.4)  
Half 
indoor/outdoor 
36 (34.3) 16 (26.2) 17 (26.2) 6 (28.6) 0.19 
Mainly outdoors 5 (4.8) 4 (6.6) 10 (15.4) 0 (0.0)  
$Chi-square test to examine the association between ethnicity and socioeconomic factors, * ^^Sikh, 
Buddhist and no religion. n (%) 
3.3.5.2 Health and lifestyle factors  
Table 3.8 illustrates how smoking status, alcohol intake and history of vitamin D 
deficiency differed significantly (p<0.001) across the ethnic groups studied. The Arab 
group had the highest percentage of smokers, whilst the highest percentage alcohol 
intake was reported in the AfroC group. By contrast, no significant differences were 
found between ethnic groups in reported health conditions or supplement intakes. 
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Table 3.8: Health and lifestyle factors of respondents according to ethnicity 
Variable 
Arab  
n = 105 
South Asian 
 n = 61  
Afro/Caribbean 
n = 66 
East Asian 
n = 21 p value$ 
n (%) 
BMI (kg/m2)^^ 26.9 (6.62) 23.7 (5.03) 25.7 (5.58) 24.4 (6.09) 0.02
 
Smoking 
status  
14 (13.3) 2 (3.3) 1 (1.5) 0 (0) <0.001 
Alcohol 
intake 
10 (9.5) 2 (3.3) 30 (45.5) 8 (38.1) <0.001 
History of 
vitamin D 
deficiency 
35 (33.3) 24 (39.3) 7 (10.6) 2 (9.5) <0.001 
Health 
conditions***  
6 (11.4) 2 (8.2) 6 (9.1) 6 (28.6) 0.10 
Supplement 
intake^ 
21 (20.0) 14 (23.0) 19 (28.8) 4 (19.0) 0.58 
^^Median (interquartile range) and Kruskal–Wallis H Test was used. 
***Chronic diseases (diabetes, heart disease, asthma, dermatomyositis and kidney disease) or skeletal 
diseases (osteoporosis and ankylosing spondylitis). 
^Multivitamins.  
$Chi-square test. 
 
The Kruskal-Wallis H test showed that there was a statistically significant difference 
between ethnic groups in BMI (p=0.02). Post hoc comparison demonstrated that this 
difference was only between the Arab and SA groups (p<0.001): the median BMI of the 
Arabs, 141.28, was higher than among SA participants, 109.14. 
3.3.6 Sun exposure assessment 
The distribution of skin colour according to ethnicity is shown in Figure 3.5. The majority 
of East Asians had medium skin, while almost the whole AfroC group had black skin (VI). 
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Figure 3.5: Percentage of participants by skin colour and ethnicity (n=253) 
 
Average time spent outdoors ranged from 30 to 420 minutes per day for the month prior 
to completing the questionnaire. The mean (SD) sunlight exposure of the whole sample 
was 159 (82.8) minutes per day. 
Figure 3.6 shows that there was a significant difference (p<0.001) between time spent 
outdoors and different ethnicities. The post hoc statistics indicate that the time spent 
outdoors was lower amongst Arabs than the SA (p=0.03), AfroC (p=0.009) and EA 
(p<0.001) groups. 
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Figure 3.6: Distribution of median time spent outdoors by ethnicity. Error bars 
represent 95% confidant interval 
Figure 3.7, shows that the group with the largest area of skin exposure was EA, followed 
by AfroC, while a high percentage of Arabs exposed only face and hands (p<0.001).  
   CHAPTER 3 
73 
 
 
Figure 3.7: Percentage of participants by body area exposed to sunlight and ethnicity 
(n=253) 
To analyse the usual sun exposure relating to vitamin D production, the time was divided 
into two periods: peak time and off-peak time (See section 3.2.5.1). The various factors 
that generally affect the amount of vitamin D produced from sun exposure include area 
exposed, sunscreen used and time of day (peak/off-peak), all of which were associated 
with differences in vitamin D production among the study sample (Table 3.9). 
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Table 3.9: Comparison of usual sun exposure among ethnicities  
Sun exposure Arab 
n = 105 
South Asian 
n = 61 
Afro/Caribbean 
n = 66 
East Asiana 
n = 21 
Total sample 
n = 253 
p value3 
Median (Interquartile range) 
Sun exposure during peak 
time (hours per day) 
1. 0 (0.75) 1.2 (0.25) 1.4 (1.16) 2.0 (1.31) 1.25 (1.13) <0.001 
Sun exposure during off peak 
time (hours per day) 0.8 (0.75) 1.2 (1.0) 1.2 (0.74) 1.3 (2.4) 1.0 (0.81) 
<0.001 
Fraction of average peak time 
of BSA  
0.10 (0.11) 0.11 (0.16) 0.15 (0.15) 0.24 (0.13) 0.13 (0.14) <0.001 
Fraction of average off peak 
BSA  
0.9 (0.08) 0.14 (0.16) 0.17 (0.16) 0.35 (0.44) 0.12 (0.12) <0.001 
The total sun index 
(hours/week)^ 
0.12 (0.22) 0.19 (0.39) 0.27 (0.56) 0.77 (0.89) 0.20 (0.40) <0.001 
Using sunscreen (%)  
Yes 26 (24.8) 16 (26.2) 12 (18.3) 5 (23.8) 59 (23.3) 0.70** 
No 79 (75.2) 45 (73.8) 54 (81.8) 16 (76.2) 194 (76.7)  
aMalaysian, Chinese, Thai, Japanese, and Indonesian. 
^The total sun index was calculated by multiplying the average of sun exposure per week by a fraction of BSA exposed to sunlight. 
3Kruksal–Wallis H test. **Chi-square test. BSA: body surface area. 
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Ethnic differences were found in sun exposure time (p≤0.001). The post hoc statistics 
indicate that peak time sun exposure was higher among EAs than Arabs, while off-peak 
exposure was higher in the SA than Arab populations. The post hoc tests also 
demonstrate that BSA, both peak and off-peak, was higher in EAs than in Arabs, while 
the total sun index was higher among EAs than the other groups. Table 3.9 also 
demonstrates that sunscreen use did not differ significantly across ethnicities (p=0.70). 
3.3.7 Dietary intake of vitamin D  
The information in Table 3.10 to Table 3.13  and Figure 3.8 to Figure 3.11 and Figure 3.10 
were obtained from the FFQ. These show the differences between ethnicities in the 
frequency of the food items consumed, beginning in Table 3.10  with fresh fish. 
Table 3.10: Frequency of consumption of fresh fish according to ethnicity 
Food 
Arab  
n = 105  
South Asian n 
= 61 
Afro/Caribbean n = 
66 
East Asian 
n = 21 p value* 
n (%) 
Fresh mackerel  
Never 98 (93.3) 46 (75.4) 55 (83.3) 16 (76.2)  
1–3 times a month 6 (5.7) 15 (24.6) 7 (10.6) 3 (14.3) <0.001 
Once or more a 
week$ 
1 (1.0) 0 (0.0) 4 (6.0) 2 (9.5)  
Fresh tuna  
Never 67 (63.8) 35 (57.4) 41 (62.1) 15 (71.4)  
1–3 times a month 27 (25.7) 19 (31.1) 19 (28.8) 2 (29.5) 0.50 
Once or more a 
week$ 
11 (10.5) 7 (11.4) 6 (9.0) 4 (19.1)  
Fresh sardine  
Never 66 (62.9) 41 (67.2) 35 (53.0) 11 (52.4)  
1–3 times a month 31 (29.5) 13 (21.3) 23 (34.8) 10 (47.6) 0.18 
Once or more a 
week$ 
8 (7.7) 7 (11.5) 8 (12.1) 0 (0.0)  
Fresh salmon  
Never 85 (81.0) 46 (75.4) 45 (68.2) 16 (76.2)  
1–3 times a month 19 (18.1) 12 (19.7) 18 (27.3) 4 (19.0) 0.36 
Once or more a 
week$ 
1 (10.0) 3 (4.9) 3 (4.5) 1 (4.8)  
$Several categories were collapsed into ‘once or more a week’ because there were few responses.  
*Chi square test. 
 
 
Table 3.10 shows that fresh mackerel was not a preferred food for most of the 
participants, with the highest percentage being recorded by SAs, who consumed it one 
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to three times monthly (p<0.001). For the consumption of fresh tuna, sardine and 
salmon, there were no significant differences across ethnicities (p>0.05). 
Table 3.11: Frequency of consumption of canned fish according to ethnicity 
Food Arab  
n = 105  
South Asian 
n = 61 
Afro/Caribbean n 
= 66 
East Asian n 
= 21 
p 
value* 
n (%)  
Canned tuna  
Never 32 (30.5) 13 (21.3) 30 (45.5) 8 (38.1)  
1–3 times a month 35 (33.3) 32 (52.5) 16 (24.2) 5 (23.8) <0.001 
2-3 times a week 22 (10.5) 13 (21.3) 10 (15.2) 3 (14.3)  
Once a day 16 (15.3) 3 (4.9) 10 (14.1) 5 (23.8)  
Canned sardine  
Never 69 (65.7) 40 (65.6) 53 (53.0) 15 (71.4)  
1–3 times a month 26 (24.8) 12 (19.7) 8 (12.1) 4 (19.0) 0.36 
Once or more a 
week$ 
10 (20.7) 9 (14.7) 5 (7.6) 2 (9.5)  
Canned salmon  
Never 82 (81.0) 41 (75.4) 60 (90.9) 15 (71.4)  
1–3 times a month 18 (18.1) 13 (21.3) 4 (6.1) 5 (23.8) 0.36 
Once or more a 
week$ 
5 (4.8) 7 (11.5) 2 (3.0) 1 (4.8)  
Herring  
Never 82 (78.1) 51 (83.6) 63 (95.5) 17 (81.0)  
1–3 times a month 21 (20.0) 7 (11.5) 2 (3.0) 2 (9.5) <0.001 
Once or more a 
week$ 
2 (1.9) 3 (4.9) 2 (1.5) 2 (9.5)  
$Several categories were collapsed into ‘once or more a week’ because there were few responses. 
*Chi square test. 
 
Table 3.11 shows the group consuming the highest amount of canned tuna (2–3 times a 
week) was SA, while the Arabs consumed it once or more a month (p<0.001). However, 
most participants from all groups never consumed canned sardine (p=0.36). Most 
participants did not consume canned salmon either, but amongst those who did, SAs 
were the most prevalent and tended to consume it weekly. The consumption of herring 
was significantly (p<0.001) different across ethnicities, with Arabs consuming it once or 
more a month and more often overall than other ethnic groups. 
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Table 3.12: Frequency of consumption of meat according to ethnicity 
Food 
Arab  
n = 105  
South 
Asian n = 
61 
Afro/Caribbea
n n = 66 
East Asian n 
= 21 
p 
value* 
n (%) 
Beef  
Never 22 (21.0) 19 (31.1) 14 (21.2) 8 (38.1)  
1–3 times a month 26 (24.8) 13 (21.3) 16 (24.2) 2 (9.5) <0.001 
Once or more a 
week$ 
57 (54.3) 29 (47.5) 36 (54.5) 11 (52.4)  
Beef liver   
Never 80(76.2) 47 (77.0) 47 (71.2) 20 (95.2)  
1–3 times a month 17(16.2) 9 (14.8) 10 (15.2) 1 (4.8) 0.42 
Once or more a 
week$ 
8 (7.6) 5 (8.2) 9 (13.6) 0 (0.0)  
Pork/ham  
Never 105 (100.0) 50 (82.0) 41 (62.1) 12 (52.4)  
1–3 times a month 0 (0.0) 2 (3.3) 12 (18.2) 1 (4.8) <0.001 
Once or more a 
week$ 
0 (0.0) 9 (14 .8) 13 (19.7) 8 (38.1)  
Pork liver   
Never 105 (100.0) 53 (86.9) 60 (90.9) 20 (95.2)  
1–3 times a month 0 (0.0) 6 (9.8) 4 (6.1) 1 (4.8) <0.001 
Once or more a 
week$ 
0 (0.0) 2 (3.3) 2 (3.0) 0 (0.0)  
$Several categories were collapsed into ‘once or more a week’, as they contained few responses. 
*Chi square test. 
 
 
Table 3.12 shows Arabs and AfroCs having the highest consumption of beef, whilst 38.1% 
of EA never ate it (p < 0.001). The highest recorded consumption of pork/ham was by 
EAs, while Arabs did not consume pork or its derivatives at all (p<0.001).  
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Figure 3.8: Frequency of consumption of whole egg according to ethnicity (n=253) 
Figure 3.8 shows that there was no difference between ethnic groups in terms of whole 
egg consumption. EAs had the highest consumption of egg, one to three times a week, 
while 42.6% of SAs consumed it daily. 
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 Table 3.13: Frequency of consumption of dairy products according to ethnicity 
Food 
Arab  
n = 105  
South Asian 
n = 61 
Afro/Caribbea
n n = 66 
East Asian 
n = 21 
p 
value^ 
n (%) 
Yogurt   
Never 24 (22.9) 6 (9.8) 14 (21.1) 2 (9.5)  
1–3 times a month 20 (19.0) 22 (36.1) 21 (31.1) 3 (14.3) 0.06 
2–3 times a week 43 (40.9) 19 (31.1) 23 (34.9) 12 (57.2)  
Once a day 18 (17.1) 14 (23.1) 8 (12.1) 4 (19.1)  
Cream cheese  
Never 19 (18.1) 13 (21.3) 31 (15.2) 3 (4.8)  
1–3 times a month 20 (19.0) 13 (21.3) 11(16.7) 4 (19.0) <0.001 
2–3 times a week 44 (41.9) 22 (36.0) 14 (21.3) 13 (61.9)  
Once a day 22 (21.0) 13 (21.3) 10 (15.2) 1 (4.8)  
Hard cheese   
Never 35 (33.3) 13 (21.3) 26 (39.4) 10 (47.6)  
1–3 times a month 20 (19.0) 11 (18.6) 17 (25.8) 3 (14.3) 0.24 
2–3 times a week 33 (31.4) 20 (41.0) 14 (21.5) 5 (23.8)  
Once or more a day^ 17 (19.7) 12 (19.7) 9 (13.6) 3 (14.3)  
Whole milk  
Never 39 (37.1) 16 (26.2) 28 (42.4) 10 (47.6)  
1–3 times a month 12 (11.4) 6 (9.8) 7 (10.6) 5 (23.8) 0.12 
2–3 times a week 22 (20.9) 12 (19.6) 8 (13.6) 4 (14.3)  
Once or more a day^ 32 (30.4) 27 (44.3) 23 (34.9) 2 (9.5)  
Semi-skimmed milk  
Never 63 (60.0) 30 (49.2) 28 (42.2) 10 (47.6)  
1–3 times a month 9 (8.6) 5 (8.2) 18 (27.3) 4 (19.0)  
2–3 times a week 8 (7.6) 11 (18.1) 11 (16.6) 1 (4.8) 0.006 
Once or more a day^ 25 (23.8) 15 (24.8) 9 (13.6) 6 (28.6)  
 
^Several categories were collapsed into once or more a day, due to containing few responses.  
*Chi square test. 
 
For the dairy group, there were no ethnic differences in the consumption of yogurt, hard 
cheese or whole milk (p > 0.05). As shown in Table 3.13, there was significant difference 
in the consumption of semi-skimmed milk and creamy cheese across ethnicities (p 
<0.001). The Arab group consumed the most of both items daily. 
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Figure 3.9: Frequency of consumption of fat products according to ethnicity (n=253) 
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Figure 3.9 illustrates that a high percentage of Arabs had never eaten butter, while more 
SAs consumed it two to three times a week than in any other group (p<0.001). Margarine 
was not favoured, as more than half of the participants never ate it (p=0.05). 
 
Figure 3.10: Frequency of consumption of mushroom according to ethnicity (n=253) 
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The consumption of mushrooms was relatively low (Figure 3.10), as less than half of each 
ethnic group reported an intake of two to three times a week (p = 0.56).
 
Figure 3.11: Frequency of consumption of breakfast cereal according to ethnicity 
(n=253) 
Figure 3.11 shows that the highest percentage of participants who eat cereal daily were 
AfroC, followed by SA and EA. There was no significant difference (p=0.06) in the 
consumption of breakfast cereal by the ethnic groups studied. 
3.3.7.1 The estimation of oral intake of vitamin D  
The estimated mean dietary intake of vitamin D for all participants was 2.98 μg/day, 
which is lower than the recommended value of 5 μg/d (WHO and FAO, 2004). The 
classification of total vitamin D intake among the sample is shown in Figure 3.12. Most 
participants had a low intake of vitamin D (<5 µg/d) and only 17% had a medium intake 
(5-10 µg/d). 
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Figure 3.12: Percentage of participants by classification of dietary intake of vitamin D 
(n=253) 
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Table 3.14: Comparison of vitamin D intake by ethnicity 
  
Arab 
 
 
South 
Asian 
 
 
Afro/Caribbe
an 
 
East Asian 
 
 
Total 
sample 
 
p 
value& 
Dietary intake of 
vitamin D (g/day)* 
2.55 (2.4) 3.07 (1.7) 2.62 (3.1) 2.44 (2.1) 2.27 (2.4) 0.28 
Vitamin D 
supplement (%) 
23 (21.9) 8 (13.1) 13 (19.7) 3 (19.4) 49 (19.4) 
0.52 
^^ 
Total vitamin D 
intake (g/day)** 
3.81 (3.3) 3.43 (3.3) 3.93 (4.0) 2.72 (2.8) 3.66 (3.5) 0.51 
*Data expressed as median and interquartile range. 
 ^^Chi-square was used. 
 &Kruskal-Wallis H test was conducted to determine the differences between dietary intake of vitamin D 
and total oral intake of vitamin D among different ethnicities. 
**Diet + supplement. 
 
The Kruskal-Wallis test (p>0.05) carried out on the data shown in Table 3.14, revealed no 
association between ethnicity and vitamin D intake. Additionally, a chi-square test 
indicated that there were no differences in taking vitamin D supplements between 
different ethnicities (p>0.05). The total intake of vitamin D from food and supplements 
for each individual was estimated using Equation 6. 
  Equation 6:  
𝐓𝐨𝐭𝐚𝐥 𝐯𝐢𝐭𝐚𝐦𝐢𝐧 𝐃 𝐢𝐧𝐭𝐚𝐤𝐞 =  ∑ 𝐝𝐢𝐞𝐭𝐚𝐫𝐲 𝐢𝐧𝐭𝐚𝐤𝐞 𝐨𝐟 𝐯𝐢𝐭𝐚𝐦𝐢𝐧 𝐃 +
𝐬𝐮𝐩𝐩𝐥𝐞𝐦𝐞𝐧𝐭 𝐢𝐧𝐭𝐚𝐤𝐞  
The median total of vitamin D for the whole sample was 3.66 µg/d, as presented in Table 
3.14. The Kruskal-Wallis test showed no differences between the total intakes of vitamin 
D across differing ethnicities (p > 0.05). 
Table 3.15: Mean contributions of different food products 
Food (µg /day) % 
Fish group 39 
Egg 35 
Dairy food 21 
Meat 4 
Mushroom 1 
The contribution to vitamin D intake of each food group is shown in Table 3.15. Fish was 
the richest dietary source of vitamin D among the study group. 
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3.3.7.2 The total intake of Vitamin D  
The total vitamin D intake of each individual from the three sources, i.e. dietary, 
supplement and sun, was estimated by summing the results of  Equation 6 and 
Equation 3. The median total intake of vitamin D for the whole sample was 4.30 µg/d. As 
shown in Table 3.16, many important factors that may affect vitamin D intake were 
included in the multiple regression model. Every one year increase in age was associated 
with a 0.17 µg decrease in total vitamin D intake (B = – 0.17, 95% CI: –0.35, 0.00, p=0.05), 
while no other factors significantly affected the total vitamin D intake. 
Table 3.16: Multiple regression model of total vitamin D intake from diet, sun 
exposure and supplements 
Total vitamin D intake Coefficient (B) 95% CI p-value 
Sex   
Male  Reference   
Female  –0.06 –0.22, 0.10 0.46 
Age  
18–29 years Reference   
30–39 years –0.17 –0.35, 0.00 0.05 
40–49 years 0.01 –0.22, 0.25 0.87 
Ethnicity  
Arab Reference   
South Asian 0.14 –0.05, 0.34 0.16 
Afro/Caribbean 0.15 –0.03, 0.34 0.11 
East Asian 0.01 –0.27, 0.31 0.90 
Occupation  
Employed  Reference   
Student  –0.00 –0.18, 0.18 0.97 
Unemployed  0.01 –0.24, 0.27 0.90 
Education level  
College/diploma  Reference    
Bachelor  –0.19 –0.43, 0.03 0.09 
Postgraduate  0.11 –0.13, 0.36 0.35 
Income, £  
<5,200 Reference   
5,200–10,399 –0.02 –0.25, 0.20 0.81 
10,400–25,999 –0.05 –0.27, 0.17 0.63 
≥26,000 –0.10 –0.33, 0.13 0.39 
Occupation location  
Mainly indoors Reference   
Half indoor/outdoor –0.03 –0.19, 0.13 0.70 
Mainly outdoors 0.02  –0.26, 0.31 0.88 
CI: confidence interval.  
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The total vitamin D intake from diet and sun only is shown in Error! Not a valid bookmark 
self-reference.. Educational level showed a significant effect on vitamin D intake. 
Compared with participants who did not attend university, those with a postgraduate 
degree had higher levels of vitamin D intake (B = 0.23, 95% CI: 0.03, 0.43, p = 0.02). 
Ethnicity was another significant predictor of vitamin D intake: SA and AfroC had higher 
vitamin D intake compared with Arabs (B=0.24, 95% CI: 0.07, 0.40, p=0.00), (B=0.15, 95% 
CI: 0.00, 0.31, p=0.05) respectively. 
Table 3.17: Multiple regression model of total vitamin D intake from diet and sun 
exposure 
Total vitamin D intake  Coefficient (B) 95% CI p value 
Sex   
Male  Reference   
Female  –0.07 –0.20, 0.05 0.28 
Age  
18- 29y Reference   
30-39y 0.02 –0.11, 0.17 0.70 
40-49y 0.00 –0.19, 0.27 1.00 
Ethnicity  
Arab Reference   
South Asian 0.24 0.07, 0.40 <0.001 
Afro/Caribbean 0.15 0.00, 0.31 0.05 
East Asian 0.17 –0.05, 0.41 0.13 
Occupation  
Employed  Reference   
Student  0.00 –0.15, 0.14 0.93 
Unemployed  0.07 –0.14, 0.28 0.51 
Education level  
College/diploma  Reference   
Bachelor  0.11 –0.07, 0.30 0.24 
Postgraduate  0.23 0.03, 0.43 0.02 
Income, £  
<5,200 Reference   
5,200–10,399 0.03 –0.15, 0.21 0.74 
10,400–25,999 –0.02 –0.20, 0.15 0.79 
≥26,000 –0.05 –0.24, 0.13 0.55 
Occupation location  
Mainly indoors Reference   
Half indoor/outdoor 0.03 –0.10, 0.16 0.66 
Mainly outdoors –0.09 –0.32, 0.13 0.42 
CI: confidence interval. 
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3.4 Discussion                                                              
The purposes of this research were to examine the factors that influence vitamin D status 
amongst EMGs in the city of Manchester and to investigate the differences in the risk 
factors of hypovitaminosis D across EMGs. A total of 253 adults, consisting of Arabs, 
South Asians, Afro/Caribbeans and East Asians, completed the study. The rate of 
response was low among the target samples, which was also reported in previous studies 
conducted on the same population demographic (Ford et al., 2006; Roy et al., 2007; 
Ahmed et al., 2013). 
3.4.1 Demographic Factors 
It has been found that vitamin D intake is related to demographic factors such as 
education levels, ethnicity, occupation, income and age group (Holvik et al., 2005; Moore 
et al., 2005; Ahmed et al., 2013; Moore et al., 2014). Understanding ethnic differences in 
these factors could play an important role in investigating which EMGs are at higher risk 
of developing hypovitaminosis D. In the current study, ethnic difference in dietary 
vitamin D intake was not statistically significant (p=0.28). While this is consistent with 
previous reports in adults (Hall et al., 2010; Goodman et al., 2016), significant ethnic 
differences have been observed in several other studies (Calvo et al., 2004; Moore et al., 
2005; Rees et al., 2005). Nonetheless, the dietary intake of vitamin D was higher among 
SAs than the other groups, as SAs have the highest consumption of oily fish, which is 
considered to be the richest source of vitamin D (Van Der Meer et al., 2008). This result 
is also in line with those of previous studies (Gozdzik et al., 2008; Hall et al., 2010). A 
variety of lifestyle behaviours, such as sunscreen use and clothing choices, could result 
in the ethnic differences in sun exposure (Hall et al., 2010), while other lifestyle factors 
not analysed in this research, such as physical activity, may contribute to the increased 
cutaneous synthesis of vitamin D (Lee and Im, 2010). In the current study, as in another 
previous study, dietary intake of vitamin D and supplements did not differ between the 
sexes (Holivk et al., 2005). 
Beside ethnicity, educational levels and age had significant correlations with vitamin D 
intake in the current study; the higher the educational level of an individual, the higher 
the mean score for vitamin D intake, as it was in those aged 30–39. These findings, which 
are in line with previous studies (Ahmed et al., 2013; Holvik et al., 2005; Moore et al., 
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2014; Moore et al., 2005), suggest therefore, that lower education levels and age ≥ 40 
increase the risk of hypovitaminosis D (Chowbey and Harrop, 2016). This association may 
be explained by the greater tendency of older adults to maintain a traditional diet (Kumar 
et al., 2004; Gilbert and Khokar, 2008) and by the physiological changes of ageing that 
can impair appetite, hence reducing total food intake (Pilgrim et al., 2015). 
In addition, it has been suggested that income could affect food choices: low income may 
make EMGs more likely to consume poor-quality food (Gilbert and Khokar, 2008). 
Accordingly, there have been reports that income influences dietary intake of vitamin D 
(Hayden et al., 2015); and a more recent study by Léger‐Guist’hau et al. (2017) showed 
that the high cost of vitamin-D-enriched foods, such as fish and dairy or fortified food, as 
well as supplements, could lead to dietary deficiency. In the current study, there was no 
statistically significant association (p>0.05); however, a higher income level did correlate 
with a rise in the total dietary intake. 
3.4.2 Health and lifestyle factors 
Data from a meta-analysis show that obesity is an epidemic issue prevalent in EMGs in 
the UK and Europe and that it has a significant effect on vitamin D levels (Pereira‐Santos 
et al., 2015). Regardless of the biological effect of obesity on vitamin D, as mentioned 
Section 2.9.3.1, it has been hypothesised that avoiding outdoor activities and covering 
the body because of low confidence and body dissatisfaction will tend to reduce 
exposure to the sun, thus, reducing cutaneous vitamin D synthesis (Yates and Aruguete, 
2004; Pereira‐Santos et al., 2015). Findings from the current study show a statistically 
significant difference (p<0.001) in BMI among ethnicities; in particular, the prevalence of 
overweight was highest in the Arab group; a similar result has been found in the 
literature (Ahmed et al., 2013; Musaiger, 2011). Additionally, data from a Health Survey 
for England showed that it was likely for EAs and SAs to be in the range of normal weight 
(Leung and Stanner, 2011); similar findings have also been reported for SAs (Darling et 
al., 2013). The findings contradict the data from the Department of Health, which show 
a high prevalence of obesity was among AfroCs and SAs, particularly in women (Gilbert 
and Khokar, 2008). However, it has been suggested that the increased level of people 
overweight and obesity among EMGs may be due to lower levels of physical activity 
(Koshoedo et al., 2009). 
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Furthermore, current findings showed that the prevalence of obesity was higher among 
males and among older participants. This result may be explained by the impacts of 
quality of life and reduced physical activity (Chodzko-Zajko et al., 2009). It is in line with 
data from the Health Survey for England (2013), which found that the prevalence of 
obesity and overweight among adults was 62.1% and that men are more likely to be 
obese. In addition, ethnic differences have been clearly identified, with SAs and Arabs 
experiencing vitamin D deficiency more frequently than AfroCs and EAs.  
It has been separately suggested that smoking and alcohol intake affect vitamin D 
metabolism (Lamberg-Allardt et al., 2001; Lee, 2012; Shinkov et al., 2015). In the current 
study, there was a significant difference (p=0.04) between smoking status and gender, 
with more male smokers than females, while the highest proportion of smokers was in 
the Arab sample. This result is likely to be related to the fact that smoking by females is 
less socially acceptable (Islam and Johnson 2003; Thom, 2003). Alcohol intake was the 
highest amongst the middle-aged participants, which is consistent with previous studies 
(Lamberg-Allardt et al., 2001). It was also higher among AfroC than any other group, most 
of whom were Muslims, which is again in line with previous studies (Food Standards 
Agency, 2007; Michalak et al., 2007; Roy et al., 2007). Specifically, this can be explained 
by religious factors, as mentioned in Section 2.9.3.3.  
3.4.1 Sun exposure assessment 
Sun exposure is considered to be the richest source of vitamin D; indeed, about 90% of 
vitamin D can be synthesised cutaneously by exposing the skin to UVB radiation (Holick, 
2004a), which is more than can be obtained from the diet (O’Connor and Benelam, 2011). 
Therefore, it was important to assess the sun exposure behaviour of the participants to 
identify habits which might negatively affect vitamin D levels. As no typical or 
authenticated questionnaire was available (McCarty, 2008), the current study used 
questions designed according to the following requirements expressed in previous 
studies (Macdonald et al., 2008; McCarty, 2008; Gould et al., 2015): the questionnaire 
should include items on time outdoors, skin area exposed to sunlight, the use of 
sunscreen and sunbathing. The literature also indicates that the skin’s capacity to 
produce vitamin D is affected by the degree of pigmentation (Kift et al., 2013). Hence, 
identification of skin colour was important for the current study, which found that all 
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participants had dark skin, except the EAs and some Arabs, which suggests that the AfroC 
and SA groups might be at risk of inadequate vitamin D synthesis. According to reports 
in the literature, a high level of melanin in the skin blocks UVB rays from entering (Correia 
et al., 2014; Akhtar, 2016), to the extent that during winter, the level of vitamin D 
synthesis may fall to zero (Macdonald et al., 2011).  
Low UVB exposure may not be caused by deliberate avoidance of sunlight but could be 
the unintentional consequence of practices such as the wearing of particular clothing for 
cultural or religious reasons (Meltzer, 2007; Brough et al., 2010; Macdonald et al., 2011; 
De Roos et al., 2012; Darling et al., 2013; Webb et al., 2016) or of a person’s type of 
occupation; for example, office workers and students tend to receive relatively little 
exposure to sunlight (Hyppönen and Power, 2007; Sowah et al., 2017). Alternatively, 
however, avoidance of sunlight can be intentional: to avoid damaging solar radiation by 
staying in the shade or by using sunscreen to help maintain skin tone and beauty (Nesby-
O'Dell et al., 2002; Thieden et al., 2005; Kift et al., 2013). Although most Arabs 
participating in the current study had relatively light skin pigmentation, they were still at 
risk of developing vitamin D deficiency, as they used sunscreen and avoided sun exposure 
more than the other groups; this result is in line with previous findings (Ahmed et al., 
2013).  
The current study also showed that the area of uncovered skin differed significantly 
between ethnicities: a high proportion of Arabs, SAs and AfroCs exposed only their faces 
and hands to sunlight, thus limiting the benefit of exposure to UVB. This finding is 
consistent with previous studies in the UK (Pal et al., 2003; Ford et al., 2006; Maxwell et 
al., 2006; Macdonald et al., 2011; Patel et al., 2013), as well as those conducted in sunnier 
countries (Bassil et al., 2013; Al-Daghri, 2016). According to Farrar et al. (2011), the 
current recommendations are not suitable for darker-skinned groups to produce 
sufficient levels of vitamin D. In particular, the authors suggest that EMGs should expose 
35% of the skin surface area to the midday sunlight on a cloudless day for more than half 
an hour, three times a week (Farrar et al., 2011). Furthermore, time spent outdoors was 
low among all participants, regardless of ethnicity, which is in line with studies conducted 
on SAs (Kift et al., 2013), BAs (Nesby-O'Dell et al., 2002; Skull et al., 2003), Middle Eastern 
populations (Ahmed et al., 2013), a multi-ethnic sample (Van der Meer et al., 2008) and 
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EA women (Brock et al., 2013; Jang et al., 2013). However, the amount of vitamin D found 
by this study to be produced cutaneously differed slightly from the findings of other 
researchers, which can be attributed to differences in the techniques used to calculate 
sun exposure.  
3.4.2 Dietary intake of vitamin D 
The estimation of dietary intake of vitamin D was performed using an FFQ, a method 
which is commonly used in epidemiologic studies (Thompson et al., 1994) and has been 
employed in many studies of vitamin D status (Maxwell et al., 2006; Madar et al., 2008; 
Taylor et al., 2009). Other nutritional assessment tools employed in similar studies, 
depending on the aim of the study, include 7-day diaries (Farrar et al., 2011) and 24-hour 
recall (Moore et al., 2014); however, these methods do not reflect dietary habits, 
although they are useful to validate FFQ data (Willett, 2013). 
Data from the NDNS and LIDNS in the UK have shown a low average vitamin D intake, at 
2.8 µg/d (Mavroeidi et al., 2010; Whitton et al., 2011), while data from the third National 
Health and Nutrition Examination Survey showed that vitamin D intake was low among 
ethnic minority adults (Looker et al., 2002), as well as for African-American women in 
wintertime (Nesby-O'Dell et al., 2002). In the current study, all EMGs had vitamin D 
intake below the RNI recommendation, suggesting that all EMGs living in Manchester are 
at risk of vitamin D deficiency, which is consistent with a number of previous studies of 
ethnic adults in the UK (Wilkinson et al., 2000; Maxwell et al., 2006; Ahmed et al., 2013; 
Darling et al., 2013; Farrar et al., 2013; Kift et al., 2013; Patel et al., 2013). It should be 
noted that these other studies did not compare different EMGs; rather, each study 
focused on one or two groups only. To the researcher’s best knowledge, this is the first 
study to assess the ethnic differences in vitamin D intake and other risk factors in healthy 
adults from all of the main EMGs in the UK. 
Furthermore, the results are in accordance with those of studies among multi-ethnic 
groups living in other countries, which indicates that vitamin D is low globally (Holvik et 
al., 2005; Madar et al., 2008; Islam et al., 2012). However, the estimated vitamin D intake 
(although still below RNI) was somewhat higher for EMGs living in the USA (Moore et al., 
2005), Sweden (Andersson et al., 2013) and Canada (Gozdzik et al., 2008) compared to 
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the UK studies. This may be attributed to the abundance of fortified foods (Calvo et al., 
2004), which suggests that fortified products contribute approximately 60% towards 
dietary intake of vitamin D (Calvo and Whiting, 2013), while in the UK, strict legislation 
governs food fortification (Sinha et al., 2013), as mentioned in Section 2.1.1.  
Despite oily fish being the richest source of vitamin D available in the UK (Lanham-New 
et al., 2011), it makes only a relatively small contribution to the UK diet, due to its low 
consumption by the population. Results data the NDNS indicate that the contribution of 
fish is 21% and 30% of the dietary intake of vitamin D for male and female adults 
respectively (Weichselbaum et al., 2013). Bates et al. (2014) report the mean intake of 
oily fish by UK adults at only 54 g per week, which is below the recommended intake of 
at least one 140 g portion per week (Weichselbaum et al., 2013). Indeed, fish 
consumption was low among the participants in the current study, which is consistent 
with the literature (Maxwell et al., 2006; Ahmed et al., 2013; Andersson et al., 2013). 
Similarly, oily fish intake was low among the ethnic minority population living in Oslo, 
despite oily fish being popular in Norwegian cuisine (Holvik et al., 2005; Madar et al., 
2008). Andersson et al. (2013) consider it possible that these residents do not eat enough 
vitamin-D-rich food because they adhere to the traditional dietary customs of their 
ethnic groups; however, according to Cashman and Kiely, (2016), people cannot achieve 
the RNI of 10 µg/d even by following modern Western-style diets, which include few rich 
natural sources of vitamin D.  
The intake of egg was low in the present study, consistent with research findings that 
egg consumption is very infrequent among AfroCs (Maxwell et al., 2006) and Arabs 
(Ahmed et al., 2013). There is no doubt that frequent intake of eggs can be an effective 
source of vitamin D, as there are 1.8 µg in an egg yolk. 
It should be noted that there are many influences on dietary habits, including religion, 
lifestyle and environmental factors (Gilbert and Khokar, 2008; Ngo et al., 2014). For 
instance, although meat does not contain much vitamin D, it can be an effective dietary 
source if it is consumed frequently, but religion may forbid some people from consuming 
some types of meat (Higgins, 2008), as mentioned in Section 2.3.3.1. Data from the 
current study demonstrate that people of all ethnicities commonly consumed beef but 
that 31% of SAs never consumed it because they were Hindus. The majority of 
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participants never ate pork, probably because of their religious beliefs. These findings 
are comparable with those reported by Ahmed et al. (2013), Andersson et al. (2013), 
Nolan (2007) and Wandel et al. (2008). The highest intake of dairy products was among 
Arabs and SAs, which agrees with the findings of Nolan (2007) and Mellin-Olsen et al. 
(2005). 
Although it has been reported that dietary supplements are an excellent source of 
vitamin D whose use can provide normal vitamin D levels in the absence of other sources 
(Sinha et al., 2013), the consumption of vitamin D supplements was low among 
participants in this study. These results are in agreement with studies of SAs (Rees et al., 
2005), Black Africans and EAs (Holvik et al., 2005; Brock et al., 2013). However, 
supplement intake was low among EMGs living in Scandinavian countries including 
Norway, despite supplement intake being common among the population (Calvo et al., 
2005). Cost and lack of awareness are possible reasons for not taking supplements. 
The regression coefficient results in Table 3.17 indicate that ethnicity was a determinant 
of total intake of vitamin D and it was therefore not surprising that most EMGs had 
insufficient or deficient vitamin D intake, considering that consistent with previous 
research (Salamoun et al., 2005), both sun exposure and consumption of supplements 
and foods containing vitamin D were low. Therefore, members of EMGs need to obtain 
the maximum benefit from summer sunlight by regularly exposing at least a quarter of 
their bodies to sunlight, particularly around midday. Those who have type V or VI skin 
should use a sunbed once a month or follow the UK Department of Health 
recommendation by consuming one portion of oily fish a week. 
3.5 Conclusion  
The study has shown lifestyle differences between ethnic groups living in Manchester 
which may affect their ability to achieve the recommended intake of vitamin D. The main 
common cause of vitamin D deficiency amongst EMGs was found to be sun exposure 
behaviour, as sunlight is the main source of vitamin D. The study has shown that the 
highest sunlight exposure at peak time was among the EA group, while members of other 
groups were less exposed to sunlight. Regardless of environmental factors, the reasons 
for not benefiting adequately from sunlight are related to cultural and religious factors, 
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as most Arabs tend to avoid sunlight by using sunscreen. They also share with many SAs 
and AfroCs the wearing of clothing which limits sun exposure by following traditional 
Islamic dress styles. Type of occupation could be another a major factor limiting sunlight 
exposure by keeping people indoors at midday.  
Another common cause of vitamin D deficiency among EMGs is their dietary habits and 
infrequent use of supplementation. Generally, dietary intake was low among all groups, 
even the South Asians, who had the highest intakes of dietary vitamin D. However, this 
study provides evidence that the higher the education level of individuals, the higher 
their vitamin D intake. It is therefore recommended that healthcare policies and 
prevention campaigns focus on the at-risk population identified here and that preventive 
interventions be implemented to help them improve their health by increasing their 
vitamin D intake. 
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4. ASSOCIATION OF VITAMIN D INTAKE 
AND OTHER RISK FACTORS WITH 
25(OH)D CONCENTRATIONS
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4.1 Introduction  
The effects of vitamin D deficiency on bone health are well known (SACN, 2016; Shina et 
al., 2013). Epidemiological and experimental data indicate that hypovitaminosis D may 
increase the risk of several non-skeletal diseases, including some cancers and type 1 
diabetes (Holick, 2004b; SACN 2016). Serum 25(OH)D concentration is considered a 
reliable indicator of vitamin D status, but the deficiency cut-off level is still under debate, 
the highest cut-off in use being ≤30 nmol/L (Sinha et al., 2013). Hypovitaminosis D has 
been shown to be common in the general population in the UK due to reduced sun 
exposure and low dietary vitamin D intake (SACN, 2016). However, it is markedly more 
common among EMGs (Roy et al., 2006; Webb et al., 2016). Other factors which can 
affect cutaneous synthesis of vitamin D include the amount of melanin in the skin (Webb 
et al., 2018); the ability to synthesise vitamin D3, which decreases with rising age (Holick, 
2004b); BMI (low vitamin D has been associated with higher BMI) (Vanlint, 2013;  
Pourshahidi,  2015; Wortsman et al., 2000); sun avoidance for cultural or safety reasons 
(Holick, 2004a; Holick, 2007); health conditions such as kidney or liver failure; and the 
use of any medication which can interfere with vitamin D metabolism (Holick, 2007).  
Chapter 3 reported a study in which the dietary intake of vitamin D and length of time 
spent outdoors were assessed using a questionnaire and which compared the responses 
of four ethnic minority groups: Arabs, South Asians, Afro/Caribbeans and East Asians. 
Relevant factors including demographic characteristics, health factors and sun exposure 
behaviour were examined to assess their influence on vitamin D intake. The study 
reported in this chapter measured the vitamin D level in participants’ blood to investigate 
the associations of vitamin D intake and other risk factors with 25(OH) D concentrations 
in ethnic minority adults.  
4.1.1 Aim 
 Examine the association between dietary intake, lifestyle factors and 25(OH)D 
concentrations among ethnic minority adults. 
4.1.2 Objectives 
 Estimate vitamin D intake for Arab, South Asian and Black African from dietary 
sources, supplement use and sun exposure using a questionnaire. 
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 Measure serum 25(OH)D concentrations for ethnic minority participants. 
 Determine the diet and lifestyle factors that affect vitamin D status among 
ethnic minority adults. 
4.1.3 Research hypothesis 
There is an association between vitamin D status and vitamin D intake or 
lifestyle factors among members of ethnic minority groups. 
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4.2 Methodology 
4.2.1 Study population and recruitment 
Potential volunteers from EMGs were recruited in Manchester (Figure 4.1) between 
October and December 2016, using the same method as that detailed in Chapter 3 (see 
Section 3.2.3). Additional recruitment was done by using posters containing summary 
information about the research and the objectives of the study along with an email 
address for further information (Appendix 5). The posters were displayed in different 
places, such as universities, markets and places of worship, as well as being distributed 
via email and posted online at on the ethnic community pages of various social media 
platforms. The inclusion criteria were the same as those listed in Chapter 3, Section 3.2.2. 
4.2.2 Confidentiality 
All information provided by the participants was kept confidential and used for the 
purposes of this study only. The data were collected and stored in accordance with the 
Data Protection Act, 1998. 
4.2.3 Study protocol  
A flowchart of the recruitment and study protocol is presented in Figure 4.1 
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Figure 4.1: Recruitment and study protocol flowchart 
4.2.3.1 Questionnaire design 
Participants completed a food frequency questionnaire (FFQ), a sun exposure 
assessment and a questionnaire on lifestyle and health factors (see Section 3.2.4).  
4.2.3.2  Blood collection 
The dried blood spot technique was used to measure 25(OH)D, this having been shown 
by Shea and Berg, (2017) to be a valid and reliable method. The results of their test of 
the correlation between blood and plasma values are shown graphically in Figure 4.2. 
Each participant’s finger was pricked with a lancet and four blood drops placed on the 
test card provided as part of the vitamin D test kit supplied by Sandwell and Birmingham 
Hospitals NHS trust. Total 25(OH)D concentrations were subsequently determined by 
LC/MS/MS. A 3 mm punched section was taken from each dried blood spot and the 
25(OH)D was extracted with 4-phenyl-1,2,4-triazole-3,5-dione (PTAD) and then the 
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sample was injected into LC/MS analyser (Waters i-Class UPLC and Waters Xevo TQ-S 
Triple Quad Mass Spectrometer. Multiple reaction monitoring (MRM) was used to 
analyse the samples for 25-(OH)D2 and 25-(OH)D3 and then the total 25-(OH)D was 
reported. 
 
Figure 4.2: Relationship between paired plasma and blood spot samples for 
measurement of 25-hydroxyvitamin D (Source: Shea and Berg, 2017) 
The cut-off values used, shown in Table 4.1, were in line with the reference range of the 
laboratory providing the tests, the Institute of Medicine and the National Osteoporosis 
Society (Ross et al., 2011; Francis et al., 2013). 
Table 4.1: References of vitamin D 
Total vitamin D reference (nmol/L) Vitamin D status 
<15 Severe deficiency 
15–30 Deficiency 
30.1–50 Insufficiency 
>50 Adequate 
Source: SWBH NHS Trust. 
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4.2.3.3 Anthropometric measurements 
Participants’ height and weight were measured without shoes or heavy clothing. Height 
in centimetres was measured using a calibrated stadiometer (Model 2251821009, Seca, 
Hamburg, Germany) while an electronic standing calibrated scale (DP2400 BMI Indicator, 
Marsden, UK) was used to measure participants’ weight in kilograms. Body fat was 
estimated using the BMI equation as detailed in Chapter 3, Section 3.2.4.5. 
4.2.4 Statistical analysis 
Data analysis was performed using SPSS software, version 21 (SPSS Inc., Chicago, IL, USA). 
Vitamin D status was stratified into the four categories listed in Table 4.1. Descriptive 
analysis was used to analyse the socio-demographic, diet and health factors relating to 
vitamin D. The distribution of data was checked using a histogram and Q–Q plot. The 
differences and association between ethnicity and the selected factors (continuous 
variables) were examined by one-way ANOVA if the data were normally distributed. In 
cases where the data were skewed, the Kruskal-Wallis H test was used to analyse them. 
The chi-square test was performed to detect the differences and associations between 
ethnicity and selected factors (categorical variables). Two-way ANOVA was performed to 
measure the effect of two categorical variables on a dependent variable (McDonald, 
2009). 
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4.3 Results  
4.3.1 Recruitment of participants 
A total of 213 participants were approached, of whom 87 were recruited from the first 
stage. Of the 213, 63 did not respond, 26 others did not complete the questionnaire and 
22 participants withdrew. A total of 102 participants met the inclusion criteria (section 
3.2.2) and were recruited, but 28 of these were excluded from the study because they 
refused to a give blood sample. Therefore, 74 participants had their vitamin D levels 
tested and completed the study.  
Figure 4.3 is a flow diagram of recruitment and selection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recruited participants 
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Participants invited 
(n=213) 
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Analysis  
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Figure 4.3: Flow diagram of recruitment and selection of study participants 
4.3.2 Participants’ demographic characteristics  
Table 4.2 illustrates the main demographic characteristics of the sample. Among the 74 
who completed the study, there were more males than females. The study sample 
comprised 37.8% Arab, 35.1% South Asian and 27.0% Black African participants, with a 
mean age of 29.8 years. The majority defined themselves as Muslim. More than half of 
participants had lived in Manchester for more than five years and only 12.2% had been 
resident in the city for less than a year. 
Table 4.2: Demographic characteristics of sample (n = 74) 
Variables n (%) 
Agea 29.9± 8.3 
Sex   
Male  39 (52.7) 
Female  35 (47.3) 
Country of Birth  
Gulf countries$ 20 (27.0) 
Syria 3 (4.1) 
South Asia^ 15 (20.3) 
Africa 19 (25.7) 
Other& 17 (23.0) 
Ethnicity  
Arab* 28 (37.8) 
South Asian 26 (35.1) 
Black African 20 (27.0) 
Religion  
Muslim 57 (77.0) 
Christian 11 (14.9) 
Hindu 6 (8.1) 
Length of residence in UK  
<1 year 9 (12.2) 
1–5 years 22 (29.7) 
>5 years 43 (58.1) 
a Mean± Standard Deviation.  
$ Saudi Arabia, Kuwait, United Emirates. ^India, Pakistan and Sir Lanka. 
&France, England and Poland. *Saudi Arabia, Kuwait, United Emirates, Syrian, Algeria and Egypt. 
 
 
4.3.3 Socioeconomic factors according to ethnicity 
Table 4.3 shows that the median age of the total sample was 28.5 years and that the 
median age of the Arabs was slightly higher than the other groups. As to education level, 
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a higher percentage of the Arabs held postgraduate-level qualifications compared with 
other ethnicities, while the BA group had a higher percentage of members who were 
educated to college/diploma level. The Arabs reported the highest income, while the 
ethnicity with the highest percentage of members reporting an income of less than 
£5,200 was the BA group. More than half of all participants were students and more than 
a third were in employment. The highest percentage of employed participants was seen 
among the Arabs, while 15% of BAs were unemployed. The majority of participants 
reported that they typically spent much of their time indoors during the day; this may be 
related to their majority status as students. A quarter of the Arab group reported working 
half indoors and half outdoors, while only 15% of SAs were mainly based outdoors. Table 
4.3 shows that there was no association between ethnicity and the socioeconomic 
factors studied (p>0.05), except for religion (p=0.009). 
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Table 4.3: Socioeconomic factors according to ethnicity (n=74) 
Variable 
Arab (n = 28) South Asian (n = 26) Black African (n = 20) 
Total sample  
(n = 74)  p value$ 
n (%) 
Age& 30.0 (10.7) 28.0 (6.25) 27.5 (16.2) 28.5 (10.7) 0.64^ 
Religion   
Muslim 27 (96.4) 19 (73.1) 11 (55.0) 57 (77.0)  
Christian  1 (3.6) 1 (3.8) 9 (45.0) 11 (14.9) <0.001 
Hindu 0 (0) 6 (23.1) 0 (0) 6 (8.1)  
Education level  
College/diploma 0 (0.0) 3 (11.5) 5 (25.0) 8 (10.8)  
Bachelor  13 (46.4) 11 (42.3) 9 (45.0) 33 (44.6) 0.07 
Postgraduate 15 (53.6) 12 (46.2) 6 (30.0) 33 (44.6)  
Income status (£)   
<5,200 6 (21.4) 11 (42.3) 9 (45.0) 26 (35.1)  
5,200–10,399 10 (35.7) 10 (38.5) 8 (40.0) 28 (37.8) 0.15 
10,400–20,000 12 (42.9) 5 (19.2) 3 (15.0) 20 (27.0)  
Occupation  
Employed 12 (42.9) 9 (34.6) 6 (30.0) 27 (36.5)  
Unemployed  0 (0.0) 3 (11.5) 3 (15.0) 6 (8.1) 0.31 
Student  16 (57.1) 14 (53.8) 11 (55.0) 41 (55.4)  
Occupation location  
Mainly indoors 26 (71.4) 17 (65.4) 16 (58.5) 53 (71.6)  
Half indoor/outdoor 7 (25.0) 5 (19.2) 4 (20.0) 16 (21.6) 0.39 
Mainly outdoors 1 (3.6) 4 (15.4) 0 (0.0) 5 (6.8)  
&Median interquartile range (IQR). $Chi square test was used to examine the association between ethnicity and socioeconomic factors. 
^Kruskal–Wallis H test was used to find the difference between ethnicity and age. 
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4.3.4 Distribution of health and lifestyle factors according to ethnicity  
The median BMI by ethnicity is shown in Figure 4.4. The highest median weight was 79.5 
kg among the Arabs, with the median weight of SAs and BAs being similar. The median 
BMI of the Arabs was 26.4 kg/m2, which is defined as overweight, while the other groups 
were in the normal range. However, all three median values were close to the cut-off 
value of 25 kg/m2 and the Kruskal-Wallis test revealed no significant differences in BMI 
associated with ethnicity (p>0.05).  
 
 
 
Figure 4.4: Distribution of BMI (median) by ethnicity. Error bars represent 95% 
confident interval 
The incidence of smoking, alcohol intake, and history of vitamin D deficiency according 
to ethnicity are presented in Table 4.4. Only 17.6% of participants were smokers and 
20.3% alcohol drinkers. The highest percentage of alcohol drinkers was among the BA 
population, while only a few Arabs reported any alcohol intake. Looking at history of 
vitamin D deficiency, only 31% of the whole sample had experienced of this. The highest 
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percentage was among the SA at 42.3%. Significant ethnic differences were not found 
between the factors shown in Table 4.4, except in alcohol intake, which was significantly 
different across ethnicities (p=0.002). Table 4.4 shows that approximately the same 
number of participants consumed fortified food in each ethnicity. 
 
Table 4.4: Health and lifestyle factors according to ethnicity 
Variable 
Arab n = 
28 
South 
Asian n = 
26 
Black 
African n 
= 20 
Total 
sample 
n = 74 
p value^ 
n (%) 
Smoking status  
Yes  5 (17.9)  4 (15.4) 4 (20.0)  13 (17.6) 0.93 
No 23 (82.1) 22 (84.6) 16 (80.0) 61 (82.4)  
Alcohol intake  
No 27 (71.6) 21 (80.8) 11 (55.0) 59 (79.7)  
Yes  1 (3.6) 5 (19.2) 9 (45.0) 15 (20.3) 0.002 
History of vitamin D 
deficiency 
 
Yes  6 (21.4) 11 (42.3) 6 (30.0) 23 (31.1) 0.25 
No  22 (78.6) 15 (57.7) 14 (70.0) 51 (68.9)  
Consumption of 
fortified food 
 
Yes  4 (14.3) 4 (15.4) 5 (25.0) 13 (17.6)  
No  5 (17.9) 11 (42.3) 8 (33.3) 24 (32.4) 0.32 
Sometimes  12 (42.9) 6 (23.1) 4 (18.2) 22 (29.7) 
 
Don’t know 7 (25.0) 5 (19.2) 3 (15.0) 15 (20.3)  
^Chi-square test was used to examine the association between ethnicity and health factors. 
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4.3.5 Ethnic differences in sun exposure behaviour  
The incidence of self-reported skin colour by ethnicity are shown in Figure 4.5. More than 
half of the Arabs said that they had medium skin colour and a third had olive skin, whilst, 
half of SA participants had brown skin. 
 
 
Figure 4.5: Percentage of participants by self-reported skin colours and ethnicity 
(n=74) 
The average time spent outdoors for all participants was 102 min/d, ranging from 15 to 
232.5 minutes per day for the month before completing the questionnaire.  
CHAPTER 4 
109 
 
 
Figure 4.6: Distribution of median time spent outdoors by ethnicity. 
Error bars represent 95% confident interval 
The median time spent outdoors for each ethnic group is shown in Figure 4.6. The daily 
time outdoors for the SA group was 97 minutes, while for both Arabs and BAs it was 90 
minutes. Application of the Kruskal-Wallis H test showed that there was no significant 
difference between the ethnicities in time spent outdoors (p=0.88).  
Table 4.5 shows that no statistically significant ethnic differences were detected in sun 
index or sunscreen use. In terms of exposed body area, the results of the chi-squared 
test reveal a significant difference between ethnic groups in body area exposed to 
sunlight (p=0.002). The highest percentage of people who exposed only face and hands 
to the sun was among the Arabs (46.4%), whereas the highest percentage of those who 
exposed their face, full arms and full legs was in the BA group (30.3%).  
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Table 4.5: Sun exposure behaviour and protection according to ethnicity 
Variable 
Arab 
n = 28 
South 
Asian 
n = 26 
Black 
African 
n = 20 
Total 
sample 
 n = 74 
p value& 
The total sun index 
(hours/week)$ 
 
Median (IQR) 0.27 (0.31) 0.30 (0.35) 0.33 (0.57) 0.28(0.34) 0.49* 
Sunscreen use n (%)  
Yes  5 (17.9) 5 (19.2) 5 (25.0) 15 (20.3) 0.87 
SPF 15 2 (40.0) 2 (40.0) 2 (40.0) 6 (8.1) 
 
SPF 45 2 (40.0) 1 (20.0) 1 (20.0) 4 (5.4) 
 
SPF 50 1 (20.0) 2 (40.0) 2 (40.0) 5 (6.8) 
 
Exposed area to the sun n (%)  
Face and hands 13 (46.4) 9 (34.6) 2 (10.0) 24 (32.4)  
Face and half arms 15 (53.6) 16 (61.5) 12 (60.0) 43 (58.1) 0.002 
Face, full arms and full legs 0 (0.0) 1 (3.8) 6 (30.3) 7 (9.5)  
$Sun index = hours of sun exposure per week × fraction of BSA exposed to sun light. 
&Chi-square test was used to examine the association between ethnicity and sun behaviour exposer. 
*Kruskal–Wallis H test. 
BSA: body surface area; IQR: interquartile range; SPF: sun protection factor. 
4.3.6 Ethnic differences in vitamin D intake and vitamin D status  
4.3.6.1 Dietary intake of vitamin D  
Table 4.6 illustrates the findings that the majority of the participants in each group never 
consumed fresh mackerel and that only a few Arabs consumed it at least once a week. A 
similar percentage in each ethnic group ate no fresh tuna, while three quarters of Arabs 
consumed canned tuna at least once a month, as did more than half of SAs and BAs. Very 
few participants of any ethnic background ate sardines, either canned or fresh. 
Approximately half of Arabs consumed fresh salmon at least once a month, followed by 
BAs, while no more than 15% of any ethnic group reported eating canned salmon. 
Herring had low consumption rates, with only one member of each group consuming it 
weekly. Overall, ethnicity was not found to be significant in the consumption of fish 
(p>0.05). 
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Table 4.6: Frequency of consumption of fish group according to ethnicity 
Food 
Arab n = 28 
South Asian 
 n = 26 
Black African  
n = 20 p value$ 
n (%) 
Fresh mackerel  
Never 24 (85.7) 24 (92.3) 17 (85.0)  
1–3 times a month 3 (10.7) 2 (7.7) 3 (15.0) 0.92 
Once or more a week$ 1 (3.6) 0 (0.0) 9 (0.0)  
Fresh tuna  
Never 17 (60.7) 18 (62.2) 12 (60.0)  
1–3 times a month 7 (25.0) 6 (23.1) 5 (25.0) 0.93 
Once or more a week$ 4 (14.3) 2 (7.7) 3 (15.0)  
Canned tuna  
Never 7 (25.0) 11 (42.3) 9 (45.0)  
1–3 times a month 13 (46.4) 11 (42.3) 7 (35.0) 0.54 
Once or more a week$ 8(28.6) 4 (15.4) 4 (20.0)  
Fresh sardine  
Never 22 (78.6) 21 (80.8) 18 (90.0)  
1–3 times a month 3 (10.7) 1 (3.8) 1 (5.0) 0.72 
Once or more a week$ 2 (10.7) 4 (15.4) 1 (5.0)  
Canned sardine  
Never 24 (85.7) 22 (84.6) 17 (85.0)  
1–3 times a month 4 (14.3) 1 (3.8) 2 (10.0) 0.31 
Once or more a week$ (0.0) 3 (11.5) 1 (5.0)  
Fresh salmon  
Never 10 (35.7) 14 (53.8) 9 (45.0)  
1–3 times a month 13 (46.4) 9 (34.6) 8 (40.0) 0.78 
Once or more a week$ 5 (17.9) 3 (11.5) 3 (15.0)  
Canned salmon  
Never 24 (85.7) 22 (84.6) 17 (85.0)  
1–3 times a month 4 (14.3) 2 (7.7) 3 (15.0) 0.50 
Once or more a week$ 0(0.0) 2 (7.7) 0 (0.0)  
Herring  
Never 25 (89.3) 13 (88.5) 19 (95.0)  
1–3 times a month 2 (7.1) 2 (7.7) 0 (0.0) 0.87 
Once or more a week$ 1 (3.6) 1 (3.8) 1 (5.0)  
$ Some categories which had very few responses were collapsed into once or more a week. 
Table 4.7 shows the frequency of the consumption of meat among by the ethnic groups. 
Beef was the most popular meat in each ethnic group, the majority of whom ate it more 
than once a week. The majority of participants never ate pork, but a fifth of SAs and of 
BAs did so daily. None of the Arabs and only two members of each of the other groups 
consumed any pork liver at all, while a quarter of participants of SA and BA origin had 
lamb’s liver once or more a week. Overall, ethnic differences in the meat consumption 
of the groups studied were found to be statistically non-significant (p>0.05). 
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Table 4.7: Frequency of consumption of meat groups according to ethnicity 
Food 
Arab n = 28 
South Asian  
n = 26 
Black African  
n = 20 p value^ 
n (%) 
Beef   
Never 8 (28.6) 7 (26.4) 6 (30.0)  
1–3 times a month 7 (25.0) 8 (30.8) 6 (30.0) 0.98 
Once or more a week$ 13 (46.4) 11 (42.3) 8 (40.0)  
Pork  
Never 27 (96.4) 21 (80.8) 15 (75.0)  
1–3 times a month (0.0) 0 (0.0) 1 (5.0) 0.09 
Once or more a week$ 1 (3.6) 5 (19.2) 4 (20.0)  
Lamb/beef liver  
Never 12 (42.9) 10 (38.5) 7 (35.0)  
1–3 times a month 11 (39.3) 9 (34.6) 8 (40.0) 0.94 
Once or more a week$ 5 (17.9) 7 (26.9) 5 (25.0)  
Pork liver  
Never 28 (100.0) 24 (92.3) 18 (90.0)  
1–3 times a month 0 (0.0) 1 (3.8) 1 (5.0) 0.51 
Once or more a week$ 0 (0.0) 1(3.8) 1 (5.0)  
$Some categories having very few responses were collapsed into once or more a week. ^Chi-square test and 
Fisher’s exact test. 
Table 4.8 shows that a quarter of SAs consumed eggs daily, more than any other group, 
while more than half of participants in all ethnicities reported eating eggs at least once a 
week. Ethnicity was not found to be a significant factor in egg consumption (p>0.05). 
Table 4.8: Frequency of consumption of eggs according to ethnicity 
Food 
Arab n = 28 
South Asian  
n = 26 
Black African  
n = 20 p value^ 
n (%) 
Egg   
Never 0 (28.6) 2 (7.7) 2 (30.0)  
1–3 times a month 8 (25.0) 2 (7.7) 3 (30.0) 0.18 
Once or more a week$ 16 (46.4) 16 (61.5) 14 (70.0)  
Once a day 4 (14.3) 6 (23.1) 1 (5.0)  
$ Some categories were collapsed into once or more a week; because of that, they contained a few number of 
responses. ^Chi-square test. 
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Figure 4.7: Frequency of consumption of cheese according to ethnicity
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Similarly Figure 4.7 indicates no significant difference (p>0.05) between ethnic groups in 
their consumption of either cream cheese or hard cheese. More than half of Arabs 
consumed both types once and more a week, while 15% of BAs consumed them daily 
and around 40% of SAs consumed none of each type of cheese. 
Table 4.9 lists results for the dairy group. The highest percentage of participants who 
reported never consuming yogurt was among the SAs, followed by the Arabs (50.0%), 
while 65% of BAs consumed it at least once a week and a few participants from each 
ethnicity reported daily consumption. More than half of Arabs and of SAs drank whole 
milk more than once a week, while consumption was slightly lower among BAs and the 
semi-skimmed alternative was avoided by at least half of every group. 
Table 4.9: Frequency of consumption of dairy products according to ethnicity 
Food 
Arab n = 28 
South Asian 
n = 26 
Black African  
n = 20 p value$ 
n (%) 
Yogurt   
Never 14 (50.0) 16 (61.5) 7 (35.0)  
Once a week 5 (17.9) 6 (23.1) 6 (30.0) 0.41 
2–3 times a week 6 (21.4) 2 (7.7) 6 (30.0) 
 
Once a day 3 (10.7) 2 (7.7) 1 (5.0) 
 
Whole milk  
Never 7 (25.0) 9 (34.6) 9 (45.0) 
 
Once week 2 (7.1) 4 (15.4) 3 (15.0) 0.55 
2–3 times a week 8 (28.6) 6 (23.1) 2 (10.0) 
 
Once a day 11 (39.3) 7 (26.9) 6 (30.0) 
 
Semi-skimmed milk  
Never 14 (50.0) 17 (65.4) 10 (50.0)  
1–3 times a week 8 (28.6) 7 (26.9) 6 (30.0) 0.61 
Once a day 6 (21.4) 2 (7.7) 4 (20.0)  
$ Fisher’s exact test. 
Figure 4.8 shows that the majority of participants from each ethnic group consumed 
butter one or more times a month, while 39% of Arabs and 27% of SAs consumed it at 
least once a week. On the other hand, margarine was not favoured, as more than half of 
participants did not eat it at all (p>0.05).  
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Figure 4.8: Frequency of consumption of fat products according to ethnicity
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Figure 4.9: Frequency of consumption of mushrooms according to ethnicity 
The consumption of mushrooms is shown in Figure 4.9. The largest percentage 
consuming them daily was 40% among BAs, followed by 34% of SAs (p=0.41). 
As to breakfast cereals, Figure 4.10 shows that daily consumption was low in all groups, 
although two thirds of BAs, half of Arabs and around 40% of SAs ate cereals at least twice 
weekly. There was, however, no significant difference (p=0.67) in the consumption of 
breakfast cereal among the ethnic groups studied. 
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Figure 4.10: Frequency of consumption of breakfast cereal according to ethnicity 
4.3.6.2 Estimates of vitamin D intake by ethnicity 
Vitamin D intake from different sources including diet, sun and the use of supplements 
is presented in Table 4.10. The estimated mean value of dietary intake of vitamin D for 
all of the participants was 1.35 μg/day, considerably lower than the recommended value 
of 5 μg/day (WHO and FAO, 2004). The intake of vitamin D supplements was reported by 
less than a fifth of the total sample and by only 15% of BAs. Conversely, the highest 
dietary intake of vitamin D was among the BAs, at 2.31 μg/day, followed by SAs (1.75 
μg/day). To examine the total intake of vitamin D (dietary, supplemental and sun), 
Equation 3 (Chapter 3, Section 3.2.5.2) was used. The highest total intake, which was 
among the BAs, at 2.76 µg/d is considerably below the RNI for vitamin D intake (10 µg/d) 
(SACN, 2015). None of these factors differed significantly by ethnicity (p>0.05). 
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Table 4.10: Estimates of vitamin D intake by ethnicity 
Food  Arab n=28 
South 
Asian 
n=26 
Black 
African 
n=20 
Total n=74  P value& 
Vitamin D supplement (%) 
 
Yes 6 (21.4) 5 (19.2) 3 (15.0) 14 (18.9) 
0.93^ 
No  22 (78.6) 21 (80.8) 17 (85.0) 60 (81.1) 
Average dietary intake of 
vitamin D (g/day)a 
1.56 (1.2) 1.75 (0.93) 2.31 (1.4) 1.26 (1.3) 0.20 
Total oral vitamin D intake 
(g/day)*a 
2.31 (1.5) 1.98 (0.9) 2.49 (1.3) 2.20 (1.6) 0.43 
Total vitamin D intake 
(g/day)**a 
2.39 (1.8) 2.24 (0.9) 2.76 (1.6) 2.38 (1.37) 
0.19 
 
a Data presented as median (IQR). 
*Sum of vitamin D intake and supplement intake. 
**Sum of vitamin D from diet, supplement and sunlight. 
& Kruskal-Wallis H test was used to determine ethnic difference in vitamin D intake. 
^Chi-square test. 
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4.3.6.3 Vitamin D status  
The median level of vitamin D for all participants was 29.9 nmol/L, with a range of 11.8 
to 112 nmol/L. The classification of vitamin D levels was based on the laboratory cut-off 
values as presented in Table 4.1. Figure 4.11 shows that the median level of serum 
25(OH)D was approximately the same for the Arabs (29.7, range 19 to 80 nmol/L) and 
BAs (29.95, range 11.8 to 91 nmol/L) and lowest in the SAs (28.70, range 15.6 to 78.6 
nmol). The Kruskal-Wallis H test showed that there was no statistical significance 
between ethnic groups in vitamin D status (p=0.43). 
 
Figure 4.11: Median 25(OH)D levels (nmol/L) according to ethnicity. 
The classification of vitamin D status for the whole population studied is shown in Figure 
4.12. Little more than a quarter of the total sample had above the 50 nmol/L level which 
is deemed to be adequate, while more than half had a vitamin D deficiency and 4% had 
a severe deficiency. 
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Figure 4.12: Percentage of participants by the classification of vitamin D levels (n=74) 
The classification of vitamin D levels by ethnicity is presented in Figure 4.13. A few BAs 
and SAs had a severe deficiency, while an approximately equal percentage of SAs and 
Arabs had a deficient level of vitamin D. There was no significant variation according to 
ethnicity (p=0.58). 
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Figure 4.13 Percentage of participants by classification of vitamin D levels and 
ethnicity (n=74) 
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Figure 4.14: Percentage of participants by classification of vitamin D level, sex and 
ethnicity 
 
Figure 4.14 shows that among the SAs and Arabs, the prevalence of low 25(OH)D 
concentration was higher in men than women, while among the BAs, more women than 
men had an adequate level of 25(OH)D concentration. A two-way ANOVA conducted to 
examine the effects of ethnicity and sex on 25(OH)D level found no statistically significant 
associations (p=0.31). 
Figure 4.15 shows 25(OH)D level against education level ethnic grouping. Again, a two-
way ANOVA was used and found no statistically significant effect of ethnicity and 
education on 25(OH)D  level (p=0.52). 
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Figure 4.15: Distribution of mean 25(OH)D concentration by education and ethnicity 
Figure 4.16 shows that a high level of vitamin D was associated with taking vitamin D 
supplements and that this association was approximately equally strong among all ethnic 
groups. When a two-way ANOVA was conducted to examine the effect of ethnicity and 
supplement intake on serum 25(OH)D level, it found a significant difference at for all 
supplement intake (p<0.001) but no significant main effect for ethnicity (p=0.52). There 
was no significant interaction between the effects of ethnicity and supplement intake on 
serum 25(OH)D level (p=0.77). 
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Figure 4.16: Distribution of mean 25(OH)D concentration by supplement intake and 
ethnicity 
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Figure 4.17: Distribution of mean 25(OH)D concentration by income and ethnicity 
Figure 4.17 indicates that the mean level of vitamin D was greater in BAs who had a high 
income (over £10,400), while the Arab and SA participants with low income had a mean 
level of vitamin at 31 nmol/L and 35 nmol/L respectively. There was a significant main 
effect for income only (p=0.03). However, there was no statistically significant 
interaction between the effects of ethnicity and income on 25(OH)D concentrations 
(p=0.64).  
4.3.6.4 Effects of different characteristics on 25(OH)D concentration 
Multiple linear regression analyses were conducted to examine the relationships of 
predictors with 25(OH)D concentration and the results are tabulated in Table 4.11. After 
adjustment for sex, age, BMI, ethnicity, occupation and educational level, income status 
was seen to have a statistically significance association with 25(OH)D concentration. 
Participants who had an annual income of £5.200–£10.399 had higher levels of 25(OH)D 
than those receiving <£2,500 (B=0.135, 95% CI: 0.017, 0.252, p<0.001). Additionally, time 
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spent outdoors (B=0.002, 95% CI: 0.00, 0.00, p<0.03), supplement intake (B=0.855, 95% 
CI: 0.107, 0.636, p<0.001) and dietary intake of vitamin D (B=0.238, 95% CI: 0.115, 0.361, 
p<0.001) showed significant associations with 25(OH)D concentration. 
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Table 4.11: Effects of different characteristics on 25(OH)D concentration using 
multiple linear regression model  
Variables Coefficient (B) 95% CI p value 
Sex  
Female  Reference    
Male  0.04 0.05, 0.15 0.35 
Age 0.00 0.00, 0.00 0.99 
BMI(kg/m2) 0.00 0.01, 0.01 0.69 
Time spent outdoors 0.002 0.00, 0.00 0.03 
Ethnicity  
Arab Reference   
South Asian 0.081 0.20, 0.03 0.18 
Black African 0.016 0.14, 0.11 0.80 
Occupation  
Unemployed  Reference   
Student  0.087 0.282, 0.10 0.38 
Employed  0.002 0.112, 0.10 0.97 
Education level  
College/diploma  Reference   
Bachelor  0.04 0.22, 0.13 0.60 
Postgraduate  0.00 0.18, 0.17 0.96 
Exposed area to the sun   
Face and hands Reference   
Face and half arms 0.014 0.04, 0.07 0.61 
Face, full arms and full legs 0.046 0.02, 0.11 0.17 
Smoking (yes)  0.06 0.04, 0.17 0.24 
Alcohol consumption (yes) 0.09 0.03, 0.22 0.14 
Income status  
<5,200 Reference   
5,200–10,399 0.13 0.01, 0.25 0.02 
10,400–20,000 0.12 0.00, 0.25 0.05 
Supplement intake (yes) 0.85 0.107, 0.63 <0.001 
Vitamin D intake (µg) 0.23 0.115, 0.361 <0.001 
 
B: beta; CI: confidence interval; BMI: body mass index.  
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4.4 Discussion 
The aim of the work reported in this chapter was to determine whether there was an 
association between lifestyle factors and levels of 25(OH)D among healthy ethnic 
minority adults living in Manchester. Seventy-four participants were categorised into 
three ethnic groups: Arab, South Asian and Black African.  
4.4.1 Socioeconomic status and lifestyle factors  
It is indicated in the literature that socioeconomic status has a significant impact on a 
person’s vitamin D status (Dealberto, 2006). Lack of awareness and knowledge of vitamin 
D can lead to increased vitamin D deficiency, as can the inability to afford enough vitamin 
D fortified food or supplements to maintain a sufficient level of 25(OH)D (Brough et al., 
2010). Therefore, it was important for this study to detect ethnic differences in 
socioeconomic status and examine the association between these factors and vitamin D 
level. 
It has been reported that low socioeconomic status was related to the incidence of 
severe vitamin D deficiency among EMGs and obese adults (Webster, 2013; Léger‐
Guist’hau et al., 2017), whereas a large epidemiologic study showed an association 
between higher socioeconomic status and improved diet and health status (Darmon and 
Drewnowski, 2008). This was attributed to greater awareness and adoption of healthy 
dietary choices among the better-educated populations (Attorp et al., 2014) and to the 
ability to afford the higher cost of low-energy diets with higher nutritional quality 
(Maillot et al., 2007), as well as taking vitamin D-enriched food and supplements (Léger‐
Guist’hau et al., 2017). 
Results of the current study identified no significant difference (p>0.05) in socioeconomic 
status variables, including income, education status and occupation, between the EMGs 
sampled. This result may be explained by the fact that merging ethnic categories in one 
group does not reflect actual socioeconomic status gradients between ethnicities. In 
spite of this, it was found that Arabs tended to report higher incomes than the other 
groups and have higher levels of education, with more than half of Arabs in the study 
having a postgraduate degree. It should be noted that this finding may not reflect rates 
in the UK population at large, as most Arab participants recruited had come to the UK to 
study. 
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The present findings point to the possibility that higher educational levels and 
socioeconomic status could, to some extent, account for Arab participants having the 
lowest percentage of vitamin D deficiency; these findings are in agreement with a 
previous study carried out by Ahmed et al. (2013). It would be interesting to study this 
aspect further on a larger cohort to see whether such a correlation exists among the 
minorities studied in Manchester. 
It has been reported in the literature that a higher BMI, having been associated with 
lower vitamin D levels due to the deposition of vitamin D in body fat compartments, 
results in decreased bioavailability of vitamin D3 (Vanlint, 2013; Wakayo et al., 2016). 
Thus, it was important to consider differences in BMI between ethnicities, but the 
current study found none of these to be significant, although the median BMI of Arab 
participants (26.3 kg/m2) is defined as overweight, while the median BMIs of other 
ethnicities were within normal range. This indicates, interestingly, that the diet of Arab 
participants, despite their higher socioeconomic status, may not be any healthier than 
that of the other two groups in this study. The correlation between 25(OH)D levels and 
BMI was not statistically significant in this study, as the measured BMI levels showed 
insufficient variation; however, this subject warrants further examination. 
Among lifestyle factors studied, alcohol intake varied significantly (p=0.002) based on 
ethnicity, but smoking status did not; the prevalence of drinking behaviour was higher in 
BAs (45%) than in the other two ethnic groups. These results are in line with a previous 
study carried out by Bayley and Hurcombe (2011), which suggested that this could be 
due to religious considerations, since alcohol intake is prohibited among Muslims  
(Michalak et al., 2007). Although smoking reportedly affects vitamin D metabolism 
(Lamberg-Allardt et al., 2001; Cheng et al., 2014; Kassi et al., 2015), this study found no 
significant correlation, which is in line with previous research (Rapuri et al., 2000; 
Arunabh et al., 2003; Lee, 2012). The role of alcohol in vitamin D levels is still not clear 
(Touvier, et al., 2015), but it has been hypothesised that alcohol intake results in the 
suppression of PTH secretion; PTH is responsible for decreasing the conversion of 
25(OH)D to 1,25(OH)D2, so high levels of unconverted serum 25(OH)D would be expected 
with moderate alcohol intake (Tardelli et al., 2017). Unlike previous studies (Grimes et 
al., 2011; Léger‐Guist’hau et al., 2017), this study did not show socioeconomic status and 
health to be predictive of 25(OH)D concentration, which is likely to be because of the 
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relatively small size of the cohort studied. However, income was found to be a significant 
predictor of 25(OH)D concentration, which is consistent with a previous study (Webster, 
2013). 
4.4.2 Sun exposure behaviour and protection 
Cutaneous production is a rich source of vitamin D, but is markedly reduced in the UK, 
which is situated at a high latitude where a large amount of solar radiation is lost in the 
atmosphere (Webb and Engelsen, 2008; Webb, 2006). In fact, it has been suggested that 
sufficient vitamin D levels may not be achieved even in the summertime at UK latitudes 
(Rhodes et al., 2010), particularly among people with highly pigmented skin (Farrar et al., 
2011; Martin et al., 2016). Although the capacity to produce vitamin D cutaneously is 
similar across ethnicities (Holick, 2004a; Roy et al., 2007), longer exposure time may be 
needed for EMGs than for Caucasians because of their darker skin pigmentation (Farrar 
et al., 2013; Holick, 2004a). 
Self-reported sun exposure behaviours was used to determine potential risk factors 
affecting vitamin D synthesis. The study found that time spent outdoors was ~90 
minutes/d amongst EMGs, showing no significant difference (p = 0.88), which is in line 
with a study conducted on a multi-ethnic population (Van der Meer et al., 2008). Time 
spent outdoors was higher in the current study than that reported by SAs in previous 
studies (Hamson et al., 2003; Kift et al., 2013). As this study found that over half of the 
participants in all EMGs were students, it is not surprising that the majority, irrespective 
of ethnicity, reported spending most of their time indoors, particularly at midday, when 
the outdoor UV radiation levels are highest and more vitamin D is synthesised (Farrar et 
al., 2011). Therefore, it is reasonable to question whether the results concerning time 
spent outdoors can be generalised to the whole population in the UK. It has been shown 
in previous studies that lack of sun exposure also existed among outdoor workers from 
EMGs (Nesby-O’Dell et al., 2002; Skull et al., 2003; Kift et al., 2013). This suggests that 
the avoidance of sun exposure may be a problem that exists more widely among EMGs. 
It is worth noting, however, that the average amount of time spent outdoors has been 
found to be lower among Cauc: A study by Kift et al. (2013) found that Caucs spent 63 
minutes per day outdoors on average, while SAs spent 69 minutes. A similar result is 
reported by Webb et al. (2010), who found that Caucs spent an average of 70 minutes 
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per day outdoors. Regardless of shorter sun exposure times, 25(OH)D levels are expected 
to be higher in Caucs than in EMGs, because the former need less exposure time to attain 
a sufficient level (Holick, 2004a). This suggests that time spent outdoors does not 
necessary reflect the actual effective exposure due to the effect of clothing.  
Nevertheless, Caucs require exposure of only a quarter of the body to sunlight for 10 
minutes at midday without applying sunscreen (Rhodes et al., 2010). Time spent 
outdoors was significantly associated (p=0.03) with vitamin D status in the present study, 
as has been reported previously by some researchers (Kim et al., 2012; Darling et al., 
2013), but not by others (Madar et al., 2008; Van der Meer et al., 2008). There could be 
several explanations, including the differences in calculation and the effects of clothing 
and skin pigmentation. 
Furthermore, it has been indicated that the amount of vitamin D produced by the skin is 
dependent on how much of the body surface area is exposed to sunlight (Macdonald 
2013); therefore, covering the skin with clothing can reduce vitamin D synthesis (Rhodes 
et al., 2014; Webb et al., 2014). In the current study, the exposed body area differed 
significantly (p=0.002) between ethnicities, since skin exposure was markedly higher 
among BAs than any of the other groups studied, which is in line with previous studies 
(Patel et al., 2013; Van der Meer et al., 2008). This result may be explained by the fact 
that a majority of Arab and SA participants were Muslim and thus followed Islamic dress 
codes. 
Although BAs tend toward greater body exposure, they have been shown to require 
longer exposure times to achieve adequate 25(OH)D levels (Farrar et al., 2013); this is 
consistent with the findings of earlier studies (Brough et al., 2010; De Roos et al., 2012). 
This study found no significant difference between Arabs and SAs in extent of body 
exposure, but the latter group was predominantly darker in skin colour; the Arab group 
had the lowest incidence of vitamin D deficiency, which may be partly attributable to this 
group being lightest in skin colour. 
It is possible that a combination of environmental factors and lifestyle behaviours, 
including dress style and the use of sun-blocking cosmetics, contributes to decreased 
vitamin D production among EMGs and particularly SAs, who have a history of 
disproportionate vitamin D deficiency; although not statistically shown in this study, it 
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has been indicated that the use of sunscreen and the wearing of clothing that covers 
large areas of the body are predictors of vitamin D deficiency (Gillie, 2010; Holick, 2004b).  
Latitude is well known as the major determinant of vitamin D status. Previous studies 
have been conducted on EMGs and Caucs in the UK and Europe to observe how high 
latitude affects vitamin D synthesis (Hyppönen and Power, 2007), with results suggesting 
that lifestyle must be adjusted to take advantage of sunlight during summer in order to 
achieve sufficient vitamin D levels. Kift et al. (2013) suggest that EMGs can maintain 
sufficient 25(OH)D levels through the winter by attaining 25(OH)D levels of at least 89 
nmol/L by late summer. 
4.4.3 Dietary intake of vitamin D  
As mentioned earlier, few foods are naturally rich in vitamin D (Sinha et al., 2013). It was 
not unexpected that the dietary intake of vitamin D reported in this study was below the 
recommended level of 5µg/d (WHO and FAO, 2004) for all ethnicities, as it would be 
difficult to achieve sufficient vitamin D levels from food alone. This finding is consistent 
with British studies of SA (Darling et al., 2013; Kift et al., 2013; Webb et al., 2010), BA 
(Maxwell et al., 2006; Patel et al., 2013), and Middle Eastern (Ahmed et al., 2013) 
populations. Ethnic differences were not found to be significant in this study, which is 
consistent with two previous studies (Hall et al., 2010; Goodman et al., 2016). 
Fish consumption was low among all participants, regardless of ethnicity. Although it has 
been recommended by Public Health England (2014) that one portion of oily fish be 
consumed per week, British studies have found fish consumption to be low among Caucs 
(Bates et al., 2012; Weichselbaum et al., 2013) as well as EMGs (Ahmed et al., 2013; 
Andersson et al., 2013; Lanham-New et al., 2011; Maxwell et al., 2006). Despite fish 
consumption being high in northern European countries such as Norway, EMGs there are 
reported to have the lowest intake of fish (Holvik et al., 2005; Madar et al., 2008). This 
suggests that immigrants often do not adopt the consumption of traditional foods of the 
host country. 
Consumption of other dietary sources of vitamin D was relatively low among all group of 
participants, as reported in Chapter 3, Section 3.3.7 and discussed Section 3.4.3. The 
British Nutrition Foundation (2014) has recommended that an individual consume two 
to three 200 ml portions of milk, 150 g of yoghurt and 30 g of cheese per day. As dairy 
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products contain only small quantities of vitamin D, many countries tend to fortify them 
with vitamin D.  
In this study, fewer than 20% of participants reported consuming fortified foods, while 
half of participants reported ‘sometimes’ doing so or stated their consumption as 
‘unknown’, perhaps because the availability of foods fortified with vitamin D is limited in 
the UK market (NHS, 2011; O’Connor and Benelam, 2011). However, it is also possible 
that these participants were not aware of the types of vitamin D-fortified foods available, 
such as breakfast cereal and margarine, and thus had never sought them, or that they 
had indeed consumed such foods but were unaware that they were fortified. Data from 
the 2008–2009 National Diet and Nutrition Survey (NDNS) indicates that the dietary 
intake of vitamin D whether from natural or fortified foods, is low across the UK 
population (Whitton et al., 2011). Participants in the present study reported low 
consumption of vitamin D supplements, with fewer than 20% saying that they consumed 
them. Similar intakes have been reported in previous studies of SAs (Rees et al., 2005; 
Darling et al., 2013; Kift et al., 2013) and BAs (Holvik et al., 2005), as well as a studies 
involving Arab, BA and SA groups (Van der Meer et al., 2008). This study showed that the 
total daily intake of dietary vitamin D and vitamin D supplements, which did not differ 
significantly across ethnic groups, was a strong determinant of 25(OH)D concentration, 
agreeing with earlier published studies (Holvik et al., 2005; Nesby-O’Dell et al., 2002). In 
the absence of sun and natural food, taking vitamin D supplements is considered an 
effective way to maintain sufficient vitamin D level, especially during winter (Macdonald, 
2013). 
4.4.4 Assessment of vitamin D status  
Levels of 25(OH)D were measured to determine vitamin D status and to identify vitamin 
D-related factors among EMGs. Assessment of 25(OH)D levels was performed by 
subjecting dry blood spot samples to LC-MS/MS analysis. The DBS method has been 
employed in some recent vitamin D studies and has been reported to be a reliable and 
valid alternative method for measuring plasma/serum vitamin D (Heath et al., 2014; Shea 
and Berg, 2017). 
There has been considerable debate over the cut-off level of 25(OH)D to define 
hypovitaminosis D. Symptoms of skeletal disease (rickets and musculoskeletal pain) 
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typically occur in adults and children with levels of serum 25(OH)D below 30 nmol/L 
(Sinha et al., 2013), but some research has placed the threshold at below 25 nmol/L 
(Heaney, 2004). It has been suggested that every individual should have a vitamin D level 
of at least 75 nmol/L to ensure the beneficial effects of vitamin D on bone and muscle 
metabolism (Cashman, 2016), while 75–100 nmol/L is ideal when considering other 
health issues (Binkley et al., 2010; Holick and Chen, 2008; Sinha et al., 2013). In this study, 
the prevalence of vitamin D deficiency was generally high among all EMGs (≤30 nmol/L), 
and could relate to adverse clinical effects (IOM, 2011; Sinha et al., 2013). Skeletal 
disease has been reported among a number of EMGs (Hamson et al., 2003; Roy et al., 
2007; Solanki et al., 1995), while Patel et al. (2013) estimate the risk of cardiovascular 
disease in BAs and SAs with low 25(OH)D to be 40% higher than in  Caucs. 
This study’s finding of low 25(OH)D among SAs (28.7nmol/L) is in accordance with other 
British studies. Darling et al. (2013) found that 25(OH)D levels in SA participants averaged 
20 nmol/L, lower than those in Caucasians (59.9 nmol/L). Farrar et al. (2011) report SAs 
as having an average 25(OH)D level of 16.2 nmol/L, while a study by Kift et al.(2013) 
found that 25(OH)D levels among SAs was 24.9 nmol/L. Levels of 25(OH)D reported by 
previous studies were lower than those in this study. There are multiple possible 
explanations for this inconsistency. For example, Darling’s study focused on females 
only, and dress style may have affected the result; Farrar’s study was conducted in the 
winter, when exposure to the sun is less frequent. This study’s findings are in accordance 
with studies conducted on BAs (Bunn et al., 2004; Maxwell et al., 2006) and Arabs 
(Ahmed et al., 2013). Furthermore, this study accords with research showing vitamin D 
deficiency to be prevalent among minorities in other parts of Europe (Meyer et al., 2004; 
Madar et al., 2008; Eggemoen et al., 2013; Holvik et al., 2005; Cashman et al., 2016; 
Demeke et al., 2015; Van der Meer et al., 2006). 
Although no significant ethnic differences in 25(OH)D concentrations were found in this 
study, it is worth noting that SAs had the lowest median 25(OH)D levels. This is consistent 
with the findings of Ford et al. (2006), Lowe et al. (2010) and Patel et al. (2013), who 
found SAs to have the lowest median 25(OH)D levels of the groups studied, and is 
possibly due to the effect of genetic variation in VDBP.  
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It has been found that vitamin D levels differ between sexes (Holvik et al., 2005; Zadshir 
et al., 2005; Webb et al., 2010); in particular, males have been shown to have higher 
serum 25(OH)D levels than females. A possible explanation for this is that many women 
habitually wear clothing that covers most of the body, increasing the risk of vitamin D 
deficiency. Other studies found no significant difference (Hagenau et al., 2009; Van der 
Meer et al., 2008) and, interestingly, neither did this study. Within ethnicities, severe 
deficiency was higher among SA females than males, in line with an earlier study by Ford 
et al. (2006) this is likely to be due to the dress style of SAs (Roy et al., 2007). It has been 
found that more BA females than males have adequate vitamin D levels (Patel et al., 
2013). In contrast, Pal et al. (2003) found no statistical differences in EMGs’ vitamin D 
levels based on sex, which is in agreement with the results of the present study. This may 
be due to a lack of adequate sunlight in Manchester, where even a high degree of body 
surface area exposure may not allow for enough vitamin D. The observation that vitamin 
D deficiency occurs more frequently in SA and BA males than in SA and BA females 
warrants further study. 
While latitude and season have also previously been found to be predictors of vitamin D 
status (Tsiaras and Weinstock, 2011), participants were recruited for the current study 
in autumn between October and December, hence, the only significant predictors were 
income status, dietary intake of vitamin D and supplement intake. According to Webb et 
al. (2016), Vitamin D cannot be produced between October and March, so it has been 
suggested that individuals can meet winter requirements of 25(OH)D through vitamin D 
stores in the body acquired during the previous summer (Macdonald et al., 2008). Kift et 
al. (2013) report that EMGs could maintain sufficient 25(OH)D levels during the winter 
months by having 25(OH)D levels of at least 89 nmol/L at the end of summer. It would 
appear from the current result that the Manchester EMGs did not derive enough benefit 
from the summer sun to maintain sufficient 25(OH)D levels during winter, meaning that 
vitamin D supplementation was required. These findings are in line with previous multi-
ethnic studies (Holvik et al., 2005; Nesby-O’Dell et al., 2002); it would be likely that 
people in Manchester, especially members of ethnic minority groups, have insufficient 
levels of vitamin D, due to their low consumption of dietary vitamin D and to not taking 
supplements (Holick, 2006). 
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4.5 Conclusion  
The link between the lack of sun exposure due to skin colour and cultural factors has 
been shown previously among minorities not originating from the northern hemisphere 
(Mishal 2001; Madar et al., 2008; Reed et al., 2007). While the association is important, 
it is appreciated that challenging such behaviours as mode of dress would be difficult, if 
not impossible, in the majority of those communities (Reed et al., 2007). The low intake 
of fortified foods and supplements, coupled with low income, could account for the low 
intake reported in this study. Thus, low levels of education and income influenced 
vitamin D intake, which would affect vitamin D status (Chowbey and Harrop, 2016). It is 
recommended that preventative and health education programmes be introduced, 
targeting the population identified as at risk. Farrar et al. (2011) rightly assert that the 
sunlight exposure and vitamin D intake recommendations need to be reviewed in light 
of evidence that a higher level of melanin reduces the skin’s ability to synthesise this 
vitamin. Kim et al. (2012) propose the introduction of ‘specific vitamin D educational 
programmes that can target certain groups according to beliefs about vitamin D and 
demographic characteristics’. 
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5. THE EFFICACY OF CALCIFEDIOL 
SUPPLEMENTATION IN INCREASING 
25(OH)D CONCENTRATIONS 
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5.1 Introduction  
The prevalence of vitamin D deficiency among EMGs has been demonstrated in the work 
reported Chapter 4 and in previous studies cited in this thesis (Roy et al., 2006; Farrar et 
al., 2011; Webb et al., 2016). Vitamin D supplementation has been suggested to be an 
effective option for maintaining vitamin D at an optimal level (Dawson-Hughes et al., 
2005; Wicherts et al., 2011; Sinha et al., 2013).  
There is a consensus among researchers that the level of 25(OH)D should be at least 75 
nmol/L (Dawson-Hughes et al., 2005; Holick et al., 2011) and that maintaining this 
optimum level is important not only for bone health but also to prevent non-skeletal 
disease (Holick et al., 2011). However, many people, especially those who have high skin 
pigmentation, do not reach this level (Farrar et al., 2011; Buttriss, 2015; NICE, 2016). 
Recently, a new recommended intake (RNI) of 10 µg/d has been set for adults (SACN, 
2015). However, it has been reported that a dose of 10 or 20 µg/d may result in a level 
of only 50 nmol/L and that a daily dose of 40 to 100 µg may be needed to reach the target 
of 75 nmol/L (Bischoff-Ferrari et al., 2010). There is much evidence that a daily intake of 
20 µg of D3 taken over 2-3 months could help to achieve a 25(OH)D level of 75 nmol/L 
(Harris et al., 2002; Nelson et al., 2009; Gallagher et al., 2012). 
Alternatively, the optimal level of vitamin D could be achieved in a short duration by 
taking a single dose of 2500 µg vitamin D3 (Bischoff-Ferrari et al., 2012) or 175–250 
µg/day (Pludowski et al., 2013b), but concerns have been raised that the use of these 
mega doses of vitamin D to correct hypovitaminosis D may lead to toxicity (Brandi and 
Minisola, 2013). Given these concerns and the difficulty of attaining an optimal 25(OH)D 
level and eliminating the symptoms of hypovitaminosis D with a small dose over a short 
period (Bischoff-Ferrari et al., 2006; Wicherts et al., 2011; Cashman et al., 2016), an 
alternative strategy of using calcifediol would be beneficial. 
Researchers have recently examined the effect of using calcifediol to correct vitamin D 
deficiency among older adults (Russo et al., 2011; Bischoff-Ferrari et al., 2012; Cashman 
et al., 2012; Jetter et al., 2014), although published research is still limited on multi-ethnic 
young adults. Therefore, the present efficacy trial was performed to investigate the 
effect of calcifediol in enhancing 25(OH)D levels and treating vitamin D deficiency among 
EMGs (since deficiency is more common among this population) living in Manchester 
CHAPTER 5 
139 
 
over a short period. This study is the first of its kind to be conducted in the UK, as 
calcifediol is not readily available here, so that it could be considered as another option 
for treatment of hypovitaminosis D in the UK. 
This chapter presents the method, results and analysis of the calcifediol efficacy study, 
whose aims and objectives were as follows.  
5.1.1 Aim 
 Investigate the efficacy of calcifediol supplementation, and its effects on 
improving vitamin D levels in deficient adults from ethnic minority groups. 
5.1.2 Objectives 
 Investigate the effect of 140 µg/week calcifediol supplementation on vitamin D 
levels among deficient ethnic minority participants. 
 Measure serum 25(OH)D concentrations for ethnic minority participants after 
five weeks of supplementation. 
 Examine the persistence effects of calcifediol after five weeks of termination of 
supplementation. 
 Analysis of serum 25(OH)D concentrations at baseline (pre-intervention), mid-
intervention and post-intervention. 
5.1.3 Research hypothesis 
Supplementation with 140 µg calcifediol, per week, will result in a rapid improvement in 
the vitamin D status of deficient ethnic minority adults. 
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5.2 Methodology 
5.2.1 Sample size considerations 
Sample size was determined using Minitab software, version 16 (Minitab Inc., State 
College, PA, USA). The calculation of the optimal sample size for the efficacy study are 
based on three major principles: sample number, based on earlier approved published 
work; the availability of participants for recruitment, including ethical considerations; 
and the statistical boundaries. The sample size was estimated using the power size 
method with an alpha of 0.05, a power of 80% and predicted standard deviations (SDs) 
used in previous studies (Barger-Lux et al., 1998; Jetter et al., 2014). The predicted SDs 
in these studies were 13.2 ng/ml and 19.9 ng/ml, respectively. According to the 
calculation using the predicted data, the minimal sample size is between five and nine 
participants for each group; however, a higher sample size than the calculated values 
would help to achieve more precise results and cover any participant withdrawals or 
exclusions during the study. A minimum sample size of 45 participants, anticipating a 
25% dropout rate, is a number typically used in the literature (Jetter et al., 2014; 
Cashman et al., 2012; Cavalli et al., 2009). 
5.2.2 Study population 
Potential volunteers were recruited in Manchester between July 2016 and September 
2016 by using the questionnaire and posters described in Chapter 3, Section 3.2.3, and 
chapter 4, Section 4.2.1. The inclusion criteria for participation are outlined in Chapter 3, 
Section 3.2.2. Participants who had chronic disease were pregnant or lactating, were 
vegan or vegetarian, or were using medication that could interfere with vitamin D 
metabolism (e.g. phenobarbital and phenytoin) were excluded from the study. 
Additionally, participants were excluded if they were taking a vitamin D supplement or 
experienced significant sun exposure (via a trip to sunny countries/visits to a tanning 
salon) during the study, or were unable/unwilling to return for follow-up. 
5.2.3  Study protocol  
An outline of the study protocol is shown in Figure 5.1. In the initial phase, interested 
individuals attended a first meeting with the researcher to learn more about the study, 
to read the information sheet, and to have their eligibility assessed using a brief self-
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administered questionnaire, covering health, lifestyle and vitamin D intake prior to study 
enrolment (Appendix 4). Other participants received the information sheet via email and 
agreed to participate in the study by completing the questionnaire. 
The efficacy trial was conducted from October 2016 for 10 weeks.  
 
Figure 5.1: Flow diagram of efficacy study protocol 
 
As shown in Figure 5.1, eligible participants attended three times over the 10-week study 
period: at baseline (week 0), then at week 5 and at week 10. Study visits took place at a 
physiology lab based at Manchester Metropolitan University. At week 0, the 
anthropometric measurements of participants were taken (Section 5.2.3.4) and blood 
samples were collected (see section 5.2.3.3) to confirm vitamin D levels ≤30 nmol/L (10 
ng/ml). In addition, the participants met with the researcher for supplement allocation 
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and to be trained to measure the exact dose (Section 5.2.3.2). They were advised to 
follow their usual diet intake, to avoid any food-containing vitamin D or fortified food 
during the study and to contact the researcher with any queries. A blood sample was 
collected during the second visit, at the midpoint of the trial period (week 5) to detect 
any improvement in vitamin D levels and to ensure safety. Participants were instructed 
to stop the calcifediol and not to take any other supplement or vitamin D-fortified food 
for a minimum period of five weeks. Once the trial was nearing completion, they received 
an email or text message for a follow-up examination appointment. At this follow-up visit 
(week 10), the final blood samples were taken from participants to detect supplement 
persistence (Appendix 7). 
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5.2.3.1 Calcifediol supplementation  
As shown in Figure 5.2, each participant received a kit containing the supplement, an 
instruction leaflet and an oral syringe. The supplement was given as a liquid in a bottle 
of 10 ml of calcifediol (Bruno Farmaceutici S.p.A., Rome, Italy), each drop containing 5 
µg of 25(OH)D3 as indicated by the supplier. Participants were asked to take 28 drops 
(140 µg) per week for five weeks. To avoid counting errors that might occur while taking 
the drops, participants were instructed to administer it using a 1 ml oral syringe (28 drops 
= 0.93 ml) (Figure 5.3) (Sobhani et al., 2008; Elliott et al., 2014).  According to Jetter et al. 
(2014) and Bischoff-Ferrari et al. (2012), serum 25(OH)D concentrations did not 
significantly differ according to administration frequency (weekly or daily). To minimize 
error, the instruction sheet provided information on dose frequency, length of 
treatment, storage and instructions for dose measurement and consumption (Appendix 
6). Furthermore, participants took the first dose in front of the researcher, 
demonstrating that they were clear as to how they should measure the exact dose. In 
the period between weeks 5 and 10, participants were asked to stop taking the 
supplement and to avoid taking any supplement containing vitamin D or vitamin D-
fortified food. 
 
Figure 5.2: The supplementation kit 
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Figure 5.3: The oral syringe used for taking the supplement 
 
5.2.3.2 Adherence monitoring 
In order to maximize adherence (their commitment to taking the supplement), 
participants were given a table in the leaflet to record the dose taken and were asked to 
bring it at follow-up stage (Appendix 6). Apart from recording dose times, participants 
were asked to bring the supplement bottle on follow-up visits in order that the 
researcher could assess their adherence (Williams et al., 2013) by measuring the bottle’s 
pre- and post-trial weight using an analytical balance (AS X2 Analytical Balance, Radwag, 
Radom, Poland). During the trial, participants received reminders to take the supplement 
via text messages and phone calls from the researcher; this method has been shown to 
improve medication adherence by 17.8% (Strandbygaard et al., 2010). 
5.2.3.3 Safety  
 A weekly dose of 140 µg of calcifediol is based on published findings on its efficacy and 
safety among elderly populations (Bischoff-Ferrari et al., 2012; Cashman et al., 2012; 
Jetter et al., 2014) and adults (Barger-Lux et al., 1998; Russo et al., 2011). Participants 
were asked to contact the researcher if they encountered any problems during the study 
such as weakness, fatigue, anorexia, nausea, vomiting, or constipation. 
5.2.3.4 Blood collection 
Blood samples were collected three times, at baseline, mid-study and at the end of the 
study using a Vitamin D blood spot test (Chapter 4, Section 4.2.3.2). Vitamin D deficiency 
was defined as having a vitamin D concentration at 30 nmol/L or below. 
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5.2.3.5 Anthropometric measurements 
Height and weight were measured without shoes or heavy clothing on the date of the 
first visit using the methods described in Chapter 4, Section 4.2.2.3. 
5.2.4 Statistical analysis 
The data were analysed using the SPSS software package, version 21 (SPSS Inc., Chicago, 
IL, USA). Descriptive analysis was used to examine the socio-demographic data for 
different ethnicities and biochemical measurements. The results were given as a median 
and interquartile range (IQR) for skewed data, and mean and SD for normally distributed 
data. The data were first checked for normality and were found to be skewed, so could 
not be normalised using a transformation; hence a non-parametric test was used to 
analyse the result. The Wilcoxon signed-rank test was used to assess the change in serum 
25(OH)D concentrations (pre–post supplement) within all samples and for subgroups. 
The Kruskal-Wallis H test was used to assess the differences between EMGs. Additionally, 
the Friedman test was performed to analyse the changes in serum 25(OH)D between 
baseline, week 5 and week 10 within all participants (pre–mid–post). It is worth noting 
that not all participants were included in the inferential statistics, because two had 
dropped out at the mid-point and another at the final test stage. 
Correlation tests were run to determine the relationship of some variables such as BMI 
and age with serum 25(OH)D level at mid-point. Multiple linear regression analysis, using 
as dependent variables 25(OH)D concentration at week 5 and week 10, was performed 
to determine the significance of several explanatory variables including age, sex, BMI, 
baseline 25(OH)D, smoking, dietary intake of vitamin D and sun index.  
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5.3 Results  
5.3.1 Recruitment of participants  
A total of 102 participants were recruited for the study. Twenty-eight of these were 
excluded from the study due to pregnancy, having chronic disease or for taking vitamin 
D supplement. Only 74 participants met the primary inclusion criteria and were 
subsequently tested to determine their vitamin D status. Forty-two participants who had 
vitamin D level ≤ 30 nmol/L were deemed eligible, subsequently started on the trial in 
October 2016 and were given the calcifediol supplement. Two participants were 
excluded from the study after the baseline test because they were unwilling to comply 
and one other participant failed to respond to follow-up for the final test. Thus, as. Figure 
5.4 shows, a total of 39 sets of data were subjected to analysis. 
 
Figure 5.4: Flow diagram of study participants 
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5.3.2 Participants’ demographic, health and vitamin D intake characteristics 
The socio-demographic, anthropometric and dietary data are summarised in Table 5.1. 
The participants were divided into three groups according to their ethnicity: Arab, South 
Asian and Black African. Sixty-two percent of participants were male and the mean age 
of the sample was 30.4 years (range 18 to 48 years). Looking at socioeconomic status in 
Table 5.1, more than half of participants were students and almost a third were 
employed. The highest percentage of employed participants was found in the Arab group 
(60%). A little less than half of respondents received an average income of £5,200 to 
£10,399, while only a fifth received in excess of £21,000. None of the demographic 
characteristics differed significantly between the ethnicities (p>0.05). 
Table 5.1: Baseline characteristics of the total sample according to ethnicity (n=42) 
Variable 
Arab n=15 
South Asian 
n=15 
Black 
African 
n=12 
Total 
sample 
n=42 P-value
$ 
n (%) 
Age (years)* 32.2 ± 7.4 29.3 ± 5.4 29.2 ± 9.7 30.3 ± 7.5 0.68 
BMI(kg/m2)*        28.0 ± 3.3 24.2 ± 5.2 26.1 ± 4.0 26.4 ± 4.4 0.68 
Sex      
Male 10 (66.7) 8 (53.3) 8 (66.7) 26 (61.9) 0.92 
Female 5 (33.3) 7 (46.7) 4 (33.3) 16 (38.1) 
Education level      
College/diploma 4 (26.7) 4 (26.7) 5 (41.7) 13 (31.0)  
Bachelor  3 (20.0) 6 (40.0) 4 (33.3) 13 (31.0) 0.59 
Postgraduate 8 (53.3) 5 (33.3) 3 (25.0) 33 (38.1)  
Annual income (£)   
<5,200       4 (26.7) 7 (46.7) 8 (66.7) 19 (45.2)  
5,200–10,399       6 (40.0) 5 (33.3) 3 (25.0) 14 (33.3) 0.36 
10,400–20,000       5 (33.3) 3 (20.0) 1 (8.3) 9 (21.4)  
Occupation  
Employed 6 (40.0) 4 (26.7) 3 (25.0) 13 (31.0)  
Unemployed  0 (0) 2 (13.3) 2 (16.7) 4 (9.5) 0.71 
Student  9 (60.0) 9 (60.0) 7 (58.3) 25 (59.5)  
History of vitamin 
D deficiency 
 
Yes   2 (13.3) 5 (33.3) 3 (25.0) 10 (23.8) 0.44 
No  13 (86.7) 10 (66.7) 9 (75.0) 32 (76.2)  
Smoking       
Yes 3 (20.0) 3 (20.0) 3 (25.0) 9 (21.9) 1.00 
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Variable 
Arab n=15 
South Asian 
n=15 
Black 
African 
n=12 
Total 
sample 
n=42 P-value
$ 
n (%) 
No 12 (80.0) 12 (80.0) 9 (75.0) 33 (78.6.3) 
Alcohol intake      
Yes       0 (0.0) 1 (6.7) 3 (25.0) 4 (9.5) 0.19 
No       15 (100.0) 14 (93.3.0) 9 (75.0) 38 (90.5) 
Dietary intake of 
vitamin D 
(µg/d)** 
     
Total intake 1.41 (1.01) 1.36 (1.01) 1.42 (1.26) 1.41 (1.03) 0.87 
Oily fish intake 0.95 (0.57) 0.95 (1.56) 0.77 (0.46) 0.95 (0.59) 0.83 
Meat intake 0.03 (0.02) 0.7 (0.11) 0.05 (0.12) 0.04 (0.05) 0.21 
Egg intake 0.26 (0.17) 0.18 (0.17) 0.09 (0.46) 0.15 (0.19) 0.81 
Dairy intake 0.16 (0.20) 0.15 (0.19) 0.10 (0.24) 0.15 (0.21) 0.83 
Time spent 
outdoors 
(minutes)** 
86.2 (116.25) 101.2 (91.8) 101.2 (86.2) 97.5 (93.7) 0.89 
Sun index 
(hours/week)** 
0.24 (0.05) 0.31 (0.31) 0.32 (0.52) 0.27 (0.35) 0.77 
*Mean  SD. **Median interquartile range (IQR). $Chi-square test was used to examine the association between 
ethnicity and socioeconomic factors. 
 $Kruskal–Wallis H test was used to find the difference between ethnicity and age, BMI, dietary intake and sun 
exposure. 
Health information is also summarised in Table 5.1. All participants stated that they had 
no health problems. Three-quarters had not experienced deficiency and the remaining 
24% had all had a diagnosis of vitamin D deficiency at some time. The mean BMI was 
26.4 kg/m2, which was classified as overweight, with most of these being from the Arab 
and BA groups. The dietary intake of vitamin D was not significantly different across 
ethnicities (p=0.87). Oily fish was the highest contributing dietary source of vitamin D 
among all ethnicities, followed by egg products, while meat intake was the lowest 
contributing food group, with a mean of just 0.08 µg/d. The median time spent outdoors 
for all participants was 94 minutes and the shortest time spent outdoors was reported 
by the Arab group, with a median value of 86.2 minutes. 
5.3.3 The effect of using calcifediol supplement to increase vitamin D level  
The changes in 25(OH)D concentration between pre- and post-supplementation for all 
participants are shown in  Figure 5.5. The median level of 25(OH)D increased from 26.6 
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nmol/L to 151.4 nmol/L, with no adverse effect reported by the participants. The 
Wilcoxon signed-rank test was performed and the results reveal a steep and highly 
significant (p<0.001) increase in vitamin D level after supplementation. Changes in 
median 25(OH)D concentrations (week 5 minus pre-test) according to ethnicity are 
compared in Table 5.2.  
  
 
Figure 5.5: Changes in 25(OH)D levels for all participants from week 0 to week 5. Error 
bars represent 95% confidence interval (n=40)
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Table 5.2:  Difference 25(OH)D concentration before and after 5 weeks of receiving 
140 µg calcifediol by ethnicity (n=40) 
Ethnicity 
Baseline week 
0 (nmol/L) 
Week 5 
(nmol/L) 
Change** 
p value* 
Median (IQR) 
Arab(n=14) 27.7 (4.9) 135.3 (65.1) 108.7 (62.7) <0.001 
South Asian (n=14) 19.8 (13.1) 171.4 (35.4) 140.1 (45.2) <0.001 
Black African (n=12) 26.6 (11.7) 140.1 (37.0) 110.0 (31.4) <0.001 
*Wilcoxon signed rank test. 
**Week 5 minus pre-test. 
IQR: interquartile range. 
 
From Table 5.2, the key facts seem to be that all ethnicities showed a marked increase 
after supplementation and that this effect was most prominent in the SA group. 
 
Figure 5.6: Correlation between BMI and 25(OH)D levels at week 5 
Pearson correlation was used to determine the strength of the relationship of some 
variables such as BMI and age with 25(OH)D levels at mid-point. Figure 5.6 shows that 
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there was a strong inverse correlation between BMI and 25(OH)D level, which was 
statistically significant (r=0.63, p<0.0001). Conversely, neither age nor sex was found to 
have a significant correlation with 25(OH)D level at mid-point (p>0.05). 
5.3.4 Factors that may affect 25(OH)D levels at week 5 
BMI, age, sex, dietary intake of vitamin D, smoking and baseline 25(OH)D level are all 
considered factors that may affect a participant’s 25(OH)D levels at week 5. Multiple 
linear regression was performed and only BMI showed a statistically significant 
association with 25(OH)D level at week 5. Each 1 kg/m2 increases in BMI, it was 
associated with 3.89 nmol/L decrease in 25(OH)D level at week 5 (B=-3.89, 95% CI: -4.80, 
1.97, p=0.00). ( 
Table 5.3). 
Table 5.3: Multiple regression model of 25(OH)D level at week 5 
Variable Coefficient (B) 95% CI^ p-value 
Sex   
Male  Reference   
Female  8.88 –8.76, 26.53 0.31 
Age 0.73 -0.29, 1.76 0.15 
Sun index 19.4 -23.78, 62.7 0.36 
BMI(kg/m2) - 3.89 -5.80, -1.97 <0.001 
Dietary intake -1.44 -11.4, 8.59 0.36 
Baseline 
25(OH)D(nmol/L) 
.23 -1.37, 1.85 0.67 
Ethnicity  
Arab Reference   
South Asian 16.40 -3.23, 36.04 0.09 
Black African - 5.32 -24.16, 13.51 0.56 
Smoking  
Yes  Reference   
No  16.01 –0.15, 0.14 0.15 
^CI: confidence interval. 
5.3.5 Persistence of vitamin D insufficiency after calcifediol supplement 
As shown in Figure 5.7, median 25(OH)D concentrations decreased from 151.4 nmol/L at 
week 5 to 55.9 nmol/L at week 10 (p<0.001). 
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Figure 5.7: Persistence of vitamin D insufficiency after termination of calcifediol 
supplement. Error bars represent 95% confidence interval (n=40) 
The changes in median 25(OH)D concentration (week 5 minus persistence-test) in the 
Arabs, SA and BA groups are compared in  
Table 5.4, the level of 25(OH)D decreased over 5 weeks for all ethnic groups, but the 
median reduction was higher in the SA group than in either of other groups.  
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Table 5.4: Difference in 25(OH)D concentrations between weeks 5 and 10 by ethnicity 
Ethnicity 
Week 
5(nmol/L) 
 Week 10 
(nmol/L) 
Change** 
p value* 
Median (IQR) 
Arab (n=14) 135.3 (65.1) 58.8 (22.3) 83.1 (54.5) <0.001 
South Asian(14) 171.4 (35.4) 57.1 (15.9) 108.0 (32.7) <0.001 
Black African (n=11) 140.1 (37.0) 51.3 (10.6) 82.9 (22.0) <0.001 
*Wilcoxon signed-rank test.**Week 5 minus week 6. IQR: interquartile range. 
 
Multiple linear regression was applied to determine which factors predicted the post-5-
weeks change in 25(OH)D level and the results are presented in Table 5.5. The level of 
25(OH)D at week 5 showed the following significant association: For every 1 nmol/L 
increment in 25(OH)D level at week 5, the persistence of vitamin D rose by .18 nmol/L (B 
= 0.18, 95% CI: 0.01, 0.35, p = 0.03). 
Table 5.5: Multiple linear regression model of persistence of vitamin D 
Variable Coefficient(B) 95% CI^ p-value 
Sex   
Male  Reference   
Female  -5.02 –12.82, 1.87 0.14 
Age(year) - 0.10 -0.58, 0.38 0.67 
BMI(kg/m2) -0 .02 -1.13, 1.07 0.96 
Dietary intake 2.40 -1.85, 6.80 0.25 
25(OH)D at week 5 0.18 0.01, 0.35 0.03 
Ethnicity  
Arab Reference   
South Asian - 5.13 -14.02, 3.75 0.24 
Black African - 5.38 -13.74, 2.98 0.19 
Smoking  
Yes  Reference   
No  1.48 –7.43, 10.41 0.34 
^CI: confidence interval. 
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5.3.6 Differences in 25(OH)D concentrations over three time points 
Figure 5.8, shows that the median 25(OH)D value for all participants at baseline was 25.1 
nmol/L (range 11.8–30.0 nmol/L). This increased to 151.4 nmol/L (range 93.9 to 195.0 
nmol/L) after supplementation for five weeks, then dropped once supplementation was 
stopped to 55.9 nmol/L (range 27.7 to 96.1 nmol/L). The Friedman test showed that 
there was a significant difference (p<0.01) in vitamin D level over the three time points. 
 
 
Figure 5.8: Difference in 25(OH)D concentrations over three time points for 
participants receiving 140 µg calcifediol. The error bars are the 95% confidence 
interval 
5.3.7 25(OH)D levels over different times by ethnicity 
From Table 5.6 it can be seen that there was no statistical difference in baseline 25(OH)D 
level between the different ethnicities (p>0.05), while there was a significant difference 
(p=0.01) in serum 25(OH)D level at mid-point. A post hoc comparison showed that the 
median 25(OH)D was higher in SAs than the other groups, whereas there was no 
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significant difference between Arabs and BAs (p>0.05). No significant differences were 
observed in the median serum 25(OH)D level at the final test. 
Furthermore, looking at the changes, which were detected between different time 
points in Table 5.6, the median change in 25(OH)D level between baseline and mid-point 
was higher among SAs than in the other groups (p=0.02). The changes from mid-point to 
the final week also differed significantly (p=0.01), the largest changes again being in the 
SA group. 
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Table 5.6: Comparison between 25(OH)D concentration at different time points by ethnicity 
Variable (nmol/L) 
Arab South Asian 
Black African 
 
Total sample p-value* 
Post hoca p value**** 
Median (IQR) 
Baseline vitamin D test* 27.7(4.9) 19.8(13.1) 26.6 (11.7) 26.6(10.2) 0.42 Arab–SA 0.10 
      BA–SA 0.67 
      Arab–BA 0.94 
Mid-point vitamin D test** 135.3 (65.1) 171.4(35.4) 140.1 (37.0) 151.4 (50.6) 0.01 Arab–SA 0.01 
      BA–SA <0.001 
      Arab–BA 1.00 
Final vitamin D test*** 58.8 (22.3) 57.1(15.9) 51.3 (10.6) 55.9(17.3) 0.50 Arab–SA 0.47 
      BA–SA 0.19 
      Arab–BA 0.47 
Changes (baseline–mid-point) 108.7 (62.7) 140.1 (45.2) 110.0 (31.4) 127.0(40.4) 0.02 Arab–SA 0.02 
      BA–SA 0.01 
      Arab–BA > 0.05 
Changes (mid-point–final) 83.1 (54.5) 108.0 (32.7) 82.9 (22.0) 88.9(33.3) 0.01 Arab–SA 0.02 
      BA–SA <0.001 
      Arab–BA 1.00 
*N= 42. **N= 40. ***N= 39. ^The Friedman test was used to determine the difference over repeated measures (p<0.01).  
****The Kruskal–Wallis test was used to determine if the observed difference were statistically significant between ethnicity and time points.  
aDunn’s nonparametric comparison 25(OH)D. IQR: interquartile range. 
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5.3.8 Adherence  
According to then information that they gave via the recording table (Appendix 6), all 
participants achieved 100% compliance in consuming the stated doses. Therefore, there 
was no significant difference in adherence across the ethnicities (p>0.05). 
CHAPTER 5 
158 
 
5.4 Discussion  
5.4.1 Participants’ demographic, health and vitamin D intake characteristics 
There were forty-two participants from the Arab, SA and BA ethnic groups, with a mean 
age of ~30 years. Ethnic differences in the socioeconomic status, health and vitamin D 
intake were not statistically significant (p>0.05) in the present study. By contrast, as 
discussed in Chapter 4, a number of studies have found significant differences in these 
factors among different ethnicities (Meyer et al., 2004; Holvik et al., 2005; Moore et al., 
2005; Madar et al., 2008; Patel et al., 2013). The current study also found no statistically 
significant ethnic differences in baseline 25(OH)D levels (p=0.42), which is consistent 
with previous studies (Ford et al., 2006; Lowe et al., 2010; Patel et al., 2013) as well as 
with data from the study reported in Chapter 4. Nevertheless, the median baseline 
25(OH)D level was lower in the SA group (19 nmol/L) than among the Arab (27.7 nmol/L) 
and BA (26.6 nmol/L) participants. These results are likely to be related to the variants of 
the VDBP gene (Gozdzik et al., 2011). 
5.4.2 The effect of using calcifediol supplement to increase vitamin D level  
The aim of this study was to investigate the efficacy of calcifediol supplementation, in 
order to improve vitamin D levels in deficient adults from ethnic minority groups. This 
study found that weekly supplementation with calcifediol was associated with 
significantly (p<0.001) higher 25(OH)D levels by week 5 in all EMGs, reaching a level of 
≥75 nmol/L. The supplementation of 140 µg calcifediol for five weeks was thus effective 
and was also safe, as no adverse effects were reported.  
To the researcher’s knowledge, this is the first study to examine the efficacy of calcifediol 
in enhancing 25(OH)D levels among EMGs living in the UK. A study in the USA by Shieh 
et al. (2017), which was published when the present study was close to completion, had 
only 19 participants (half as many as this study), in four ethnic groups: Caucasian, African 
American, Asian American and Hispanic/Latino. Other studies of Caucasian participants 
in Europe and the USA have also had relatively small samples (Barger-Lux et al., 1998; 
Cashman et al., 2012; Bischoff-Ferrari Et al., 2012; Jetter et al., 2014). The current study 
can thus be considered the largest to examine the efficacy of calcifediol to increase the 
level of vitamin D. 
CHAPTER 5 
159 
 
Given the existence of differences in various aspects of study design such as demographic 
characteristics and inter-laboratory techniques, including the type of assays used and the 
cut-off values used to define 25(OH)D deficiency (Binkley et al., 2004; Jones et al., 2012; 
Phinney et al., 2011), any comparison of the results of the current study with those of 
previous studies needs to be undertaken cautiously. 
Comparing this study’s findings with those of the abovementioned research examining 
healthy multi-ethnic adults (Shieh et al., 2017), the two studies used the same dose of 
20 µg/d (140 µg/week) of calcifediol and both found that 25(OH)D levels increased 
rapidly as a result. However, in the Shieh et al. study, participants’ mean serum 25(OH)D 
level rose to a mean of 86.2 nmol/L at week 4, which was lower than the 125.3 nmol/L 
level recorded in the present study. Barger-Lux et al. (1998), who assessed the changes 
in serum 25(OH)D levels of healthy men after consuming 20 µg/d calcifediol for four 
weeks, reported that the mean change in serum 25(OH)D levels was approximately 76 
nmol/L, whereas the change in 25(OH)D level in the current study was 101 nmol/L at 
week 4.  
Despite the difference between these studies in the sex distribution of the samples, there 
is no indication in the results of earlier studies that sex affects circulating 25(OH) levels 
in response to supplementation (Trang et al., 1998; Cashman et al., 2012; Shieh et al., 
2017) and the current study also found this (p=0.31). Therefore, the differences in the 
results could be attributed to the baseline 25(OH)D level, which was lower (26 nmol/L) 
in the current study than in the Shieh et al. study (40.4 nmol/L), as well as in the Barger-
Lux et al. study (67 nmol/L). As demonstrated by Mazahery and Hurst (2015), the 
response to supplementation is stronger when baseline 25(OH)D levels are low than 
when they are high, suggesting that ‘hepatic 25-hydroxylation is a saturable process’ 
(Barger-Lux et al., 1998). Both studies also concluded that calcifediol was more effective 
than vitamin D3 in enhancing 25(OH)D levels, although they used a larger dose than in 
calcifediol (Barger-Lux et al., 1998; Shieh et al., 2017). 
As reported in earlier studies, no significant difference in the extent of the increase in 
25(OH)D level was observed when the regimen of administration was varied between 
daily and weekly (Bischoff-Ferrari et al., 2012; Jetter et al., 2014). Jetter et al. (2014) 
found that supplementation by a daily 20 µg dose or 140 µg weekly resulted in a rapidly 
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increased plasma 25(OH)D level to at least 154.7 nmol/L at week 5. Another clinical trial 
reported that mean plasma 25(OH)D level increased from 30.6 nmol/L to 112.3 nmol/L 
at week 5 and continued to increase until it reached 175 nmol/L after 16 weeks (Bischoff-
Ferrari et al., 2012).These results are consistent with those of the current study, 
regardless of ethnicity and age, which show that a weekly dose of 140 µg calcifediol was 
quickly effective in shifting 25(OH)D levels into an optimal level of vitamin D. 
Additionally, beside the benefit of calcifediol for treating vitamin D deficiency, Bischoff-
Ferrari et al. showed that there was a significant therapeutic benefit of calcifediol on 
blood pressure and lower extremity function, compared to vitamin D3. This result 
supports the advantages of using calcifediol over vitamin D3. In addition, both studies 
found that in groups supplemented with the same dose of vitamin D3, serum 25(OH)D 
levels reached 75 nmol/L after nine weeks (Jetter et al., 2014) and that only half of 
participants remained below this cut-off. This confirms that calcifediol is more potent in 
enhancing 25(OH)D level than vitamin D3. 
A study conducted by Cashman et al. (2012), similar in design and sample to that of 
Bischoff-Ferrari et al., found that mean serum 25(OH)D levels increased rapidly from 38.2 
to 98.1 nmol/L at week 5, rising further to 134.6 nmol/L at week 10. Despite the levels 
of 25(OH)D reaching over 75 nmol/L in the studies both of Cashman et al. (2012) and of 
Bischoff-Ferrari et al. (2012), the increase was less than in the current study, which may 
be due to differences in methodology. In a more recent study by Navarro-Valverde et al. 
(2016), it was shown that the serum 25(OH)D level of 40 women (baseline 25(OH)D level 
of 37nmol/L) who received a supplement of 20 μg/day reached a mean value of 
161 nmol/L over six months. 
It should be noted that most previous studies were conducted in the summertime, 
meaning that sunlight could have affected their results (Bischoff-Ferrari et al., 2012; 
Navarro-Valverde et al., 2016; Jetter et al., 2014). An exception is the study by Cashman 
et al. (2012), which was carried out in wintertime to avoid the influence of vitamin D 
synthesis; they also gave one group a placebo and found that there was no change in 
serum 25(OH)D level. Similarly, the current study was conducted in wintertime, so 
summer sunlight did not affect the 25(OH)D level, and participants were instructed to 
avoid consuming any vitamin D-fortified food. 
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In addition, a study conducted by Russo et al. (2011) on 18 females showed that three 
days of oral administration of 500 µg/month of calcifediol raised plasma 25(OH)D levels 
from a base level of 45 nmol/L to 124.8 nmol/L, after which it declined slowly for the rest 
of the month. Some concern has been expressed that monthly administration of a large 
dose of calcifediol this could lead to an absorption problem by increasing the level of 
1,25(OH)2D3, as reported by Brandi and Minisola (2013:5), who refer to ‘high calcitriol 
levels with consequent increase in osteoclast activity and activation of the bone 24,25-
hydroxylase that would reduce the local calcidiol pool’. However, Russo et al. (2011) 
reported no adverse effect being detected during course of four months. 
The present study found ethnic differences in post-supplementation 25(OH)D levels, 
which were higher in South Asians compared to the other groups, which is inconsistent 
with the study of Shieh et al. (2017). A possible explanation for this is that there were 
ethnic differences in baseline 25(OH)D, with the lowest value being found among South 
Asians, resulting in a higher subsequent increase in 25(OH)D level.  
In spite of significant increases in level of 25(OH)D in the previous trials, none of these 
reported the incidence of hypercalcemia; urinary and serum calcium levels were stable 
during the studies (Bischoff-Ferrari et al., 2012; Cashman et al., 2012; Jetter et al., 2014; 
Russo et al., 2011; Shieh et al., 2017). This suggests that calcifediol is safe and that the 
risk of toxicity is low. 
5.4.3  Factors affecting levels of 25(OH)D at week 5 
It has been indicated that the 25(OH)D level at week 5 is affected by several factors such 
as BMI, baseline 25(OH)D level, age and ethnicity (Aloia et al., 2008; Mazahery and von 
Hurst, 2015). In the current study, sex and age were not found to have any significant 
effect on 25(OH)D, these results being consistent with those of previous studies (Harris 
and Dawson-Hughes, 2002; Aloia et al., 2008; Talwar et al., 2007; Fu et al., 2009; 
Cashman et al., 2012; Shieh et al., 2017). However, Zittermann et al. (2014) report that 
there was a 3.7% variation in 25(OH)D levels which can be explained by age. 
The current study found that the levels of 25(OH)D at week 5 were inversely associated 
with BMI, which is in line with the literature (Barger-Lux et al., 1998; Gallagher et al., 
2012; Nelson et al., 2009). This association is attributed to the biological pathway by 
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which vitamin D is stored in adipose tissue for later use (Mazahery and von Hurst, 2015); 
Wortsman et al. (2000) report that the greater the amount of adipose tissue, the more 
vitamin D is likely to be trapped. It has also been reported that response to 
supplementation is about 30% lower in obese subjects (Heaney et al., 2003a; Zittermann 
et al., 2014). In common with the other studies (Holvik et al., 2007; Aloia et al., 2008; 
Shieh et al., 2017), ethnicity was not a significant factor affecting 25(OH)D levels. 
5.4.4 Persistence of vitamin D insufficiency among ethnicities 
It has been reported that once vitamin D is ingested, some is converted to 25(OH)D, while 
the remainder is stored in fat and released into the circulation over time (Heaney et al., 
2008). Therefore, a vitamin D supplement could sustain levels in the blood circulation for 
an extended period. Calcifediol is easily absorbed by the gut and is cleared speedily from 
the blood, having a high affinity to VDBP and high polarity. These properties make it a 
highly bioavailable compound; with a decreased risk of toxicity, so it is less likely less to 
be stored in the fatty tissue. However, there is no evidence to support this (Brandi and 
Minisola, 2013). 
Supplementation trials using vitamin D3 have found that the levels of 25(OH)D reached 
a plateau after 6-8 weeks (Harris and Dawson-Hughes, 2002) with no further increases 
after week 5 (Cashman et al., 2012). In the calcifediol study by Bischoff-Ferrari et al. 
(2012), it seems that 25(OH)D levels reached equilibrium by week 11, remained stable 
for a few weeks and then started to increase. 
In studies using vitamin D3, 25(OH)D levels fell on cessation of supplementation by week 
5–6 to below 75 nmol/L for a high dose of 1250 µg (Armas et al., 2004; Heany et al., 2011) 
and for a dose of 100 µg (Tjellesen et al., 1986). Gupta et al. (2017) showed that an oral 
dose of 1500 µg of D3 for 6 weeks resulted in a decline in serum levels to 40 nmol/L at 
week 12. The findings of the current study show that after supplementation ceased at 
week 5, the level of 25(OH)D declined over the next 5 weeks, while nevertheless 
remaining above the baseline value. This result is in agreement with those obtained by 
Russo et al. (2011), who found that 25(OH)D levels increased rapidly and reached a peak 
at day 3 of consuming a monthly dose of 500 µg, then declined during the rest of the 
month but remained higher than the basal value. In addition, Cashman et al. (2012) 
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report that in participants receiving 20 µg/d of D3, 25(OH)D level reached a plateau at 
week 5, while in the group on 20 µg/d of calcifediol, levels increased further until week 
10. This suggests that calcifediol is more effective not only raising 25(OH)D levels but also 
at sustaining a sufficient level. 
After addressing their vitamin D deficiency, people can maintain sufficient 25(OH)D 
levels by changing their lifestyle and their dietary intake of D3 and by increasing their 
sunlight exposure time without any barriers that may block vitamin D synthesis. They 
should increase their dietary intake of vitamin D, especially by consuming a weekly 
portion of oily fish as per the UK recommendation, but this recommendation may not be 
sufficient for EMGs (Farrar et al., 2011; Webb et al., 2018). Therefore, low doses of 
supplement would be another option. According to Kennel et al. (2010), a 15-20 µg dose 
may be required after addressing the initial deficiency for an extended period. However, 
Balvers et al. (2015) have argued that due to the 3–4-week half-life of 25(OH)D (Holick 
2004a; Sinha et al., 2013), a single high annual dose of vitamin D3 will not be enough to 
sustain sufficient levels throughout the year. DeLuca et al. (2014) support this conclusion 
and recommend frequent dosing. 
5.5 Conclusion  
The results of the current study demonstrate the therapeutic advantage of using oral 
calcifediol in raising 25(OH)D level to ≥ 75 nmol/L in ethnic minority adults living in 
Manchester. The results also show the effectiveness of calcifediol to enhance 25(OH)D 
levels without any obvious detrimental effects, such as symptoms of hypercalcaemia. As 
reported in the literature, calcifediol is more potent than vitamin D3 in significantly 
raising serum 25(OH)D levels, which provides evidence that it could be employed as a 
satisfactory option for treating and preventing vitamin D deficiency. It is recommended 
that the calcifediol supplement be made available on the UK market.  
  CHAPTER 6 
164 
 
6. GENERAL DISCUSSION 
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6.1 Introduction 
This final chapter of the thesis summarises the findings of the study and its three 
component trials, considers its original contribution, reviews its strengths and 
limitations, then details its practical implications. 
6.2 Summary of findings  
The literature review highlighted the issue of the prevalence of vitamin D deficiency in 
the UK and showed how specific environmental and lifestyle factors increase the risk of 
developing vitamin D deficiency among the population, with particular reference to 
ethnic minority groups. In spite of intensive research into vitamin D, there is still debate 
as to the optimal 25(OH)D level that the body needs to ensure related health benefits, 
as there is regarding the optimal behaviour to benefit from sun exposure, given that the 
current recommendations are not sufficient for people with highly pigmented skin. 
Although a dose of 10 μg/d vitamin D has been recommended for adult (SACN, 2015), it 
would be difficult to achieve this through dietary sources alone. In the UK, few foods 
contain sufficient levels of vitamin D; and food fortification, which could provide an 
effective means of correcting vitamin D deficiency, is restricted by the government.  
Additionally, most of the previous trials conducted on elderly Caucasians and a few in 
among young adults have shown that calcifediol is more effective in raising serum 
25(OH)D levels than vitamin D3. However, no supplementation trials have been 
conducted in the UK using calcifediol. Therefore, this research was conducted to identify 
ethnic differences in lifestyle factors, vitamin D intake and sun exposure behaviours 
among ethnic minority adults living in Manchester to determine the group(s) who may 
be most prone to developing vitamin D deficiency. Further, an efficacy trial was then 
performed to examine the effect of calcifediol in enhancing serum 25(OH)D levels among 
multi-ethnic adults in the UK. 
6.2.1 Study 1: Risk factors influencing vitamin D status of ethnic minority adults 
living in Manchester 
The first aim was addressed by using a questionnaire comprising of three sections on sun 
exposure assessment, health factors and vitamin D intake. A total of 253 respondents, 
consisting of Arabs, South Asians, Afro/Caribbeans and East Asians completed the 
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questionnaire. The findings revealed that there were significant differences between 
these EMGs in some of the demographic and lifestyle factors. Notably, religion was 
identified as a fundamental factor that could affect vitamin D intake by restricting dietary 
choices and encouraging dress styles that can block UVB radiation. All of the Arab 
participants and half of SAs identified as Muslims. Multiple regression analysis revealed 
that education level and economic status were significant predictors of vitamin D intake, 
with higher levels of education and income associated with increased vitamin D intake. 
However, the only ethnic difference in these factors detected in this study was in 
education level: the AfroC group had the largest percentage of member who had 
obtained only a diploma or college education, followed by the EA group. Notably, the 
sample size was relatively small in the latter group. 
Statistically significant differences were also found in smoking and alcohol intake by 
ethnic group, with the highest percentage of smokers in the Arab group and the highest 
percentage of alcohol intake in the AfroC group. More SAs had a history of vitamin D 
deficiency compared to the other groups studied. However, the reason could be a lack 
of vitamin D screening among the other groups, as it has been reported that symptoms 
of vitamin D deficiency can be unclear (Holick et al., 2011; Pearce and Cheetham, 2010). 
The current study has also shown that a lack of sun exposure among Arabs could be a 
cause of vitamin D deficiency, as this ethnic group spent the longest time indoors during 
the day, used sunscreen the most and limited most the body area exposed to sunlight. 
This finding is consistent with a previous study (Ahmed et al., 2013). Thus, the EA group 
may be at a lower risk than other EMGs due to their sun exposure behaviour. 
6.2.2 Study 2: Association of vitamin D intake and other risk factors with 
25(OH)D concentrations  in ethnic minority adults living in Manchester 
In the second study, the associations of various risk factors with 25(OH)D levels were 
examined in order to identify potential explanations of low vitamin D status among 
ethnic minority groups. Ethnicity made no significant difference to lifestyle, health 
factors or sun exposure in the study sample, except in relation to religion, alcohol intake 
and sun-exposed skin area, as shown in Study 1. However, these factors were found to 
differ between ethnic groups in previous studies, as discussed in chapter 4. In agreement 
with previous studies, the dietary intake of vitamin D reported here was low among all 
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participants, as were the levels of 25(OH)D with a median of 29.9 nmol/L. This evidence 
suggests that research should cover all EMGs rather than focusing solely on SAs as a 
group at risk of vitamin D deficiency/insufficiency. Severe deficiency of vitamin D was 
found in BA and SA women, while vitamin D deficiency was higher in men than women 
in the Arab and SA groups. Multiple regression analysis revealed that time spent 
outdoors, income status, dietary intake of vitamin D and supplement intake were reliable 
predictors of vitamin D status. 
This research indicates that the current recommendations are not sufficient to achieve 
optimal vitamin D levels among EMGs. In addition, there is unfamiliarity with the current 
vitamin D recommendations and the use of fortified food, exacerbating the prevalence 
of vitamin D deficiency/insufficiency. This study has revealed significant trends in vitamin 
D intake among EMGs that could potentially help people to improve their vitamin D 
status. It is recommended that members of EMGs in the UK modify their sun exposure 
behaviour during the summer months as much as possible to increase their capacity for 
cutaneous synthesis of vitamin D. In general, Webb et al. (2018) found that dark-skinned 
people could sustain a sufficient level of vitamin D throughout the winter months by daily 
exposure of 35% of their skin area to the summer midday sun for at least 40 minutes.  
6.2.3 Study 3: The efficacy of calcifediol supplementation in increasing 25-
hydroxyvitamin D concentration 
Chapter 5 reported an investigation of the effect of five weeks of supplementation with 
calcifediol, a type of vitamin D unused in the UK, to increase 25(OH)D level among ethnic 
minority adults living in Manchester. The results of this investigation show that 
regardless of ethnicity, a weekly dose of 140 µg of calcifediol rapidly increased the 
25(OH)D concentration of participants to more than 75 nmol/L in only five weeks. This is 
the first trial to examine the efficacy of calcifediol in enhancing 25(OH)D levels among 
EMGs living in the UK and provides incisive proof that calcifediol supplementation is 
effective in correcting vitamin D deficiency over a short period. Multiple regression 
analysis revealed that of the variables measured, only BMI showed a statistically 
significant association with 25(OH) D level at week 5. 
Although a daily dose of 10 μg vitamin D should theoretically increase 25(OH)D 
concentrations to the optimal level, several studies carried out on ethnic groups have 
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reported that supplementation with 15-20 μg/d vitamin D was not sufficient to increase 
or maintain an adequate concentration in the absence of sun exposure and with limited 
natural dietary sources (Osmancevic et al., 2016; Shieh et al., 2017; Talwar et al., 2007). 
Therefore, it is apparent that relying on the RNI recommendation is insufficient to reach 
a desirable level of vitamin D and to avoid negative health outcomes related to vitamin 
D insufficiency; instead, it should be considered as a daily recommendation for sustaining 
25(OH)D level throughout the year. In addition, 25(OH)D concentration decreased 
slightly in five weeks and reached a sufficient level of vitamin D with a median 55 nmol/L, 
while a multiple regression test showed that only the level of vitamin D at week 5 had an 
impact on the persistence of vitamin D. 
At present, calcifediol is not licensed as a source of vitamin D in the UK; however, this 
study has shown that it is effective in increasing the 25(OH)D level and indicates that it 
is more effective than the existing D3/D2 supplements, as it results in increased 25(OH)D 
once an oral dose is consumed. Although no incidence of hypercalcemia was reported in 
the previous studies, it is worth mentioning that caution should be exercised when 
considering the dose and duration of supplementation, as calcifediol was found to 
produce a significant enhancement in 25(OH)D level. 
6.3  Research contribution  
This research determined differences in the influencing factors that could lead to vitamin 
D deficiency between the main EMGs and based on the findings an appropriate 
recommendations have been developed to improve the vitamin D status among those 
groups.  
Most research to date has tended to focus on community-dwelling South Asians in 
Manchester, rather than other ethnic minority groups, whose numbers have increased 
markedly in recent years and who could be at high risk of vitamin D deficiency. The 
current research contributes to the existing literature and adds to vitamin D research by 
concentrating on the differences in vitamin D-influencing factors between EMGs, 
including time of the day, age, skin colour, BMI, clothing, sunscreen, health condition and 
socioeconomic factors. Current findings would help to set an official and proper 
recommendation for those communities as the current recommendations are not 
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sufficient to assure an adequate level of vitamin D. Factors that were not studied in this 
research such as physical activity, seasonal and genetic variance should be taken into 
consideration when setting recommendations. 
Different habits and behaviour were reported between EMGs in the current research. 
Although Arabs have light skin they may not benefit from this because they tended to 
avoid sunlight by spending less time outdoors and used sunscreen. Whilst, BAs tend 
toward greater body exposure, they have been shown to require longer exposure times 
due to the high skin pigmentation. In addition, one of the most significant findings to 
emerge from this study was that the dietary intake of vitamin D from supplementation 
was lower than the recommended intake among all groups, as well as the level of vitamin 
D among participants regardless of ethnicity. Although the current study did not detect 
significant differences in some factors, which is most likely due to the small sample size, 
it showed that all EMGs could be susceptible to vitamin D deficiency, that there is, 
therefore, a need for attention and effective intervention. 
This research also examined the efficacy of calcifediol on vitamin D status among EMGs. 
There is no doubt, however, that vitamin D3 lead to an increase in serum 25OHD 
concentration. But according to this research, calcifediol resulted in a greater increase in 
25(OH)D over a short period, where the results showed that regardless of ethnicity, a 
weekly dose of 140 µg of calcifediol rapidly increased the 25(OH)D concentration of 
participants to more than 75 nmol/L in only five weeks, with no adverse effects reported. 
This study provides evidence that it could be employed as a satisfactory option for 
treating and preventing vitamin D deficiency. However, a large, controlled randomised 
trial is needed to control for confounding variables in order to determine the true factors 
affecting response to calcifediol including genetic variants.  
6.4 Strengths of the study 
A major strength of the present study is that it is to the best of the researcher’s 
knowledge the first to compare the lifestyle factors, vitamin D intake and sun exposure 
behaviour of ethnic minority adults living in Manchester. Not only were sun exposure 
habits assessed, but the sun index was also calculated, to estimate the amount of vitamin 
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D produced by cutaneous synthesis. This is also the first trial of the use of a calcifediol 
supplement to correct vitamin D deficiency among multi-ethnic groups living in the UK. 
6.5 Limitations and suggestions for future studies 
Although the researcher has done a great effort to attain its aims. However, this study 
has several limitations, which could potentially be addressed in future studies by 
considering some ideas developed by the researcher. 
For study 1 and 2, the most important of these limitations was the small sample size, a 
consequence of the restricted time and budget available to the researcher, which may 
have preclude the detection of differences between EMGs in the operation of risk 
factors. Although the researcher explored all possible ways to increase the number of 
participants through a considerable connection with their communities and places of 
assembly and worship, such as mosques and churches, the rate of response was low 
amongst the target sample. The requirement to use English language was a barrier to 
many potential participants who did not read or write the language and were therefore 
unable to complete the questionnaire. Future studies conducted on multi-ethnic or 
immigrant populations should use data-gathering tools (e.g. questionnaires or food 
diaries) translated into the different languages spoken by the target groups or should 
employ the services of interpreters to maximise the rate of participation. 
Another limitation in this study was that the researcher used existing valid 
questionnaires from other studies rather than to create new questionnaires. If time were 
not a limiting factor, it would have been useful to create questionnaires especially for 
the current sample and determine reliability and validity. In addition, data from self-
reported questionnaire may have been affected by social desirability bias such as self-
reported BMI, whereby participants would have failed to respond truthfully. The type of 
BMI measurement is often costly, particularly in population research that requires large 
samples. Future research that would use self-reported BMI, it could be minimise the bias 
by developing correction methods and compare it to population-based datasets, which 
contain both measured and self-reported values of BMI for the same individuals..  
There are also some limitations in the efficacy trial (study 3) primarily reflecting limited 
budget and time constraints: 
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 Although the researcher did her best to recruit a large number of participants, 
the recruitment was difficult among EMGs because many of their member did 
not speak English or were unaware of consent forms and the nature of the study 
(three visits for blood tests). This was reflected in the sample size of the group 
that contributed to this study. Having interpreters would have been beneficial in 
increasing the number of participants. 
 The fact that this study did not use a control group may have compromised its 
ability to detect actual changes after supplementation. Double-blind randomised 
control trials should be conducted to control for confounding variables in order 
to determine the true factors, particularly genetic ones, affecting the response to 
calcifediol supplementation. In addition, as this study shows that 140 μg/week 
(20 μg/d) of calcifediol increased 25(OH) levels to ≥75 nmol/l, it would be 
interesting to see whether the RNI of 10 μg/d (SACN, 2015) calcifediol is sufficient 
to achieve a desirable level of vitamin D among different ethnic groups. 
 The researcher faced a problem in finding a supplier for calcifediol as it is not 
available on the market in the UK with only a few companies providing calcifediol 
in liquid form. Therefore, the researcher was restricted to using the liquid form 
instead of tablets, making it more problematic for participants to administer and 
for the researcher to assess compliance. The researcher put into place strategies 
to minimise any error that could occur by using a liquid supplement, i.e., using a 
syringe to help to measure the dose more precisely than by using a more 
inaccurate dropper, which might have resulted in some of the dose being lost. 
Participants were trained to measure the required dose and they took the first 
dose in front of the researcher. The use of a weekly regimen was chosen to help 
maximise compliance. Finally, to monitor overall compliance the supplement 
bottle was accurately weighted pre-trial and post-trial. 
 Calcium levels were not measured during the trial to check for hypercalcaemia, 
therefore, participants were asked to contact the researcher if they were having 
any problems during the study. It would be beneficial to measure calcium levels 
as well as 25(OH)D concentration, thus obtaining an accurate indication of 
vitamin D status while monitoring toxicity (Kennel et al., 2010). 
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6.6 Implication of findings 
This section considers the implications of the study and its findings for the research 
community, for health professionals, for policymakers, for public health and for 
individuals. 
6.6.1 Research community 
There has been a research focus on the vitamin D status of members of the South Asian 
community in the UK, as it has been considered the EMG at particular risk of vitamin D 
insufficiency/deficiency, especially in Manchester. The findings of the current study show 
that other EMGs are just as vulnerable to vitamin D deficiency. This study needs to be 
replicated using a large sample with equal group sizes to increase statistical power, as 
well as exploring seasonal differences in dietary intake of vitamin D and sun exposure 
behaviour by repeating the assessment throughout the year. Further studies are also 
needed to focus on the social and cultural barriers to seeking health among this at-risk 
population, in order to develop effective policy interventions and awareness campaigns. 
Further research into the perceptions of EMGs in the UK of the importance and benefits 
of vitamin D should be conducted in order to address their concerns and the barriers to 
increasing their vitamin D intake. 
Most supplementation trials have used vitamin D3, treating it as the only form of vitamin 
D that can be used to address vitamin D deficiency, which may have led to the potential 
value of other forms of supplementation being ignored. As the present study has 
highlighted the efficacy in human use of calcifediol, a form which is not available 
everywhere, research interest should now be focused on using it, with the potential to 
enhance its availability.  
6.6.2 Health professionals  
Although a daily intake of 10 μg of vitamin D is recommended for adults, this study raises 
serious concern about the execution of this guideline, as it appears to leave a large 
number of ethnic minority adults deficient in vitamin D. It is unclear whether this is due 
to inadequate screening for deficiencies by health workers, or to the existence of barriers 
to vitamin D intake within the communities in question. In 2012, the UK government’s 
Chief Medical Officer wrote that the duty of practitioners and health workers was to raise 
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awareness of vitamin D among ethnic minority groups and to highlight the 
recommended vitamin D intake (Davies et al., 2012).  
This first efficacy trial conducted to date in the UK has shown conclusively that calcifediol 
is effective in improving vitamin D status, raising 25(OH)D levels to an optimal level and 
maintaining them. In the clinical setting, cholecalciferol may be preferential in treating 
vitamin D deficiency. It is, however, important to note that the small dose of calcifediol 
did increase 25(OH)D levels, but to a greater extent than vitamin D3 and within a shorter 
time frame (according to the literature). When addressing hypovitaminosis D, a high dose 
of vitamin D3 would be required if the goal were to achieve ≥25 nmol/L within a short 
time, while smaller doses of calcifediol are required to achieve a similar effect and then 
for maintenance, which may result in better adherence to the supplement. 
6.6.3 Policy makers 
This study has provided evidence that there are few foods containing vitamin D which 
members of EMGs in Manchester tend to consume and that their sun exposure is 
restricted by environmental and lifestyle factors. These findings suggest that strong 
action is needed to establish dietary compensation for these limitations, to produce 
sufficient vitamin D and to prevent hypovitaminosis D, by fortification of foods 
commonly consumed within multi-ethnic groups, in order to help them reach at least the 
recommended value of 10 µg/d and to sustain adequate 25(OH)D levels. 
Calcifediol should be approved for use as a nutritional supplement to correct vitamin D 
deficiency, particularly given that a small dose of calcifediol increases the level of vitamin 
D to the optimal level at lower cost than vitamin D3, as a bottle of calcifediol costs £4.37, 
while a 12-week course of vitamin D3 costs £50 (NICE 2014). 
6.6.4 Public health 
The diseases resulting from vitamin D deficiency have worsened among ethnic minorities 
and the high cost of treatment has become an escalating problem in public health. This 
could be avoided by the following steps: 
 Advantage should be taken of modern technologies, in two ways in particular. 
First, social media should be used to reach a large number of people with 
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awareness messages about the beneficial effects of exposure to the summer sun. 
Current mobile applications should also be used to track and calculate the 
amount of vitamin D from food and sun exposure. 
 Comprehensive education and awareness campaigns should be launched to 
challenge false assumptions among ethnic groups and educate them about the 
benefits of normal vitamin D levels, as well as providing information on the 
symptoms of vitamin D deficiency and its prevention. In addition, sources of false 
information about the risk of exposure to sunlight should be blocked. 
 Dietitians or health practitioners should make regular visits to places typically 
frequented by EMGs to educate people about the importance of vitamin D and 
the risks associated with its deficiency.  
 A vitamin D screening programme should be established, involving in particular 
the periodic testing of the level of vitamin D among at-risk groups and people 
who have a history of vitamin D deficiency. 
6.6.5 Individuals 
Individuals should spend a daily minimum of 25 minutes outdoors while exposing 35% of 
the body area in the case of men and wearing non-restrictive dress in the case of women, 
particularly at midday, without sunscreen or facial products that may have a high SPF 
rating (Farrar et al., 2011; Webb et al., 2018). Muslim women who are restricted in their 
dress style may achieve a sufficient vitamin D level from sunlight by exposing their face 
and hands for 25 minutes daily during summertime (i.e. between June and August) 
without sunscreen. However, those with skin types V and VI will need to expose their 
face and hands for more than 25 minutes daily in the same conditions. 
Although foods containing vitamin D are limited, members of EMGs should make some 
changes to their diet by increasing the intake of food rich in vitamin D, such as fatty fish. 
According to Nakamura et al. (2000), frequent consumption of fish can be an effective 
means of preventing vitamin D deficiency. However, it is probable that fish is not a 
preferred food for many people, among whom vitamin D supplementation may be a 
more effective way of addressing this issue. 
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6.7 Conclusion 
In conclusion, the present study has shown that members of EMGs living in Manchester 
are at high risk of developing vitamin D deficiency. Effective interventions and strategies 
need to be established to address this problem, which may augment the risk of 
developing other diseases (Solanki et al., 1995; Hamson et al., 2003; Roy et al., 2007).   
The study also found that 25(OH)D levels increased significantly following five weeks of 
supplementation with calcifediol, regardless of ethnicity. It thus adds to the growing 
body of evidence supporting the use of calcifediol not only to correct vitamin D status 
over a short period of supplementation, but to achieve this with a relatively small dose. 
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Appendix 2: Participants information sheet 
Participant Information Sheet     
Study title: Risk factors influencing vitamin D status of ethnic minority adults 
living in the UK and the efficacy of calcifediol supplementation on 25-
hydroxyvitamin D concentrations. 
Background: 
Vitamin D is essential for bone health and plays a role in maintaining the level 
of calcium and phosphorus for mineralisation. Therefore, a lack of vitamin D 
causes rickets in children and osteoporosis in adults. It is also associated with 
an increased risk of non-musculoskeletal conditions such as cancers, 
autoimmune and infectious diseases. Vitamin D precursors are found in a few 
foods, including fatty fish, fish liver oil, and egg yolks. The level of vitamin D 
produced in the body by the skin is much higher (90%) than that obtained from 
the diet. Vitamin D deficiency is a pervasive problem in the world, It is 
estimated that a billion people in the world suffering from vitamin D 
deficiency or insufficiency. The UK statistics note that an approximately half 
of the UK’s population who are of white Caucasians and a substantial 
proportion (90%) of its ethnic minority populations are also likely to be 
affected by hypovitaminosis. For instance, the percentage of ethnic minorities 
who are living in Manchester are approximately 33.3% of the total population 
(Manchester city council, 2015). Reduced sunshine exposure and few sources 
of vitamin D in Manchester could increase hypovitaminosis D especially 
among those groups due to their eating habits and high skin pigmentation. 
I would like to invite you to take part in a research study. Before you decide, 
you need to read and understand why the research is being done and what it 
would involve for you. Please take time to read the following information 
carefully: 
What is the purpose of this study? 
The purpose of this study is to determine which ethnic minorities who are 
living in Manchester are at a higher risk of vitamin D deficiency by detecting 
the main risk factors that effect on their vitamin status, and to determine the 
efficacy of vitamin D supplement to increase vitamin D level. 
Who has approved this project? 
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The Research Ethics Committee of Manchester Metropolitan University has 
reviewed the project and given its ethical approval. 
Why have I been invited? 
We have invited healthy volunteers from different ethnic minority groups who 
wish to measure their vitamin D level and to treat the deficiency if it is 
detected by following an intervention with calcifediol supplement for 10 
weeks. 
Do I have to take part? 
Your participation is voluntary. If you agree to take apart in this study, we will 
ask you to sign a consent sheet. In addition, you can withdraw at any time 
without having to give an explanation. 
What will happen to me if I take part? 
You will be asked to complete a short questionnaire to assess lifestyle, health 
factors and vitamin D intake. Blood spot will be taken on two separate 
occasions, one at the beginning to check the vitamin level, and one at the end 
of study by a trained phlebotomist. You will have to come to our Physiology 
Laboratory in order for us to be able to take a blood sample at MMU. 
Will taking part be of any benefit to me? 
By taking a part in this study, you will be told about your current vitamin D 
status and whether you need to increase vitamin D level by following an 
intervention, which is taking drops of calcifediol supplements once a week for 
10 weeks. Supplementation of calcifediol is safe and simple. It used to treat 
vitamin D deficiency. After this period you well be told if you increased your 
vitamin D level. After completion of study, you will be given a compensation 
for your participation. In addition, the information you provide can contribute 
to the future development of the treatment for hypovitaminosis D and to know 
the efficacy of the supplement that used. 
Are there disadvantages to taking part? 
We do not expect anyone to suffer any harm or injury as a result of 
participating in this project. We recognise that taking part will take up some of 
your time. We will do our best to minimise any inconvenience by ensuring that 
we meet at time and place convenient for you. 
* The study will be carried out in accordance with: 
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1. Human Tissue Act (2004), that covers the use of tissue for a number of 
which include research, clinical diagnosis and teaching. 
2. Declaration of Helsinki guidelines, which is a statement of ethical principles 
to provide guidance to participants in medical research involving human 
subjects. 
What if I have any concerns? 
If you have any complaint or think of questions about the study please feel free 
to contact the research team using the contact details below. 
Will my data be confidential? 
All the information you give us will be confidential and used for the purposes 
of this study only. The data will be collected and stored in accordance with the 
Data Protection Act 1998 and will be disposed of in accordance of Human 
Tissue Act (2004). 
What will happen to the results of the research study? 
If information from this research is published or presented at scientific 
meetings, your name and other identifiers will not be used. 
* If you have any further question please do not hesitate to contact the 
research student of the project. 
• Researcher: Mona Sulaiman 
• Email: 13161463@stu.mmu.ac.uk 
• Direct of studies: Dr Andrew Plunkett.
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Appendix 3: Consent forms to participate in research 
project 
 
Consent form to participate in research project 
  
 
Study title: Risk factors influencing vitamin D status of ethnic adults living in the UK 
and the efficacy of calcifediol supplementation on 25-hydroxyvitamin D concentrations. 
Name of Researcher: Mona Almujaydil 
          Please initial 
box 
1. I confirm that I have read and understood the information sheet dated  
  
 …. for the above project and have had the opportunity to ask questions about 
 the research procedure. 
 
2. I understand that my participation in this research project is to provide 
blood sample on three separate occasions.   
 
3. I have been informed that the blood sample will be drawn by putting a lancet 
 into a finger.          
  
 
4. I have been informed that my blood sample will be kept and used for testing 
 until study activities are completed.  At that time, it will be disposed of.   
                                                         
5. I understand that I can withdraw my consent for use of my blood in this research 
 at any time.    
 
 
I have read the above information and have been given an opportunity to ask questions.  I agree 
to provide blood for this study, and I have been given a copy of this signed consent form for my 
own records. 
________________________ ________________         ____________________ 
Name of Participant Date Signature 
_________________________ ________________         ____________________ 
Researcher Date Signature 
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Consent form to participate in research project 
  
 
Title of Project:  Risk factors influencing vitamin D status of ethnic adults living in the 
UK and the efficacy of calcifediol supplementation on 25-hydroxyvitamin D 
concentrations 
 
Name of Researcher: Mona Almujaydil 
 
Please initial 
all boxes 
1. I confirm that I have read and understood the information sheet dated .........for the above study 
and have had the opportunity to ask questions   about the research procedure. 
    
2. I confirm that I am eligible (no chronic disease or using vitamin D supplements               
 (3 months prior to or during the trail), not pregnant or breast feeding and not using of     
medication that could interfere with vitamin D metabolism such as Phenobarbital and  Dilantin 
(phenytoin).          
           
3. I understand that my participation is voluntary and that I am free to withdraw   
at any time without giving any reason to the named researcher. 
 
 
4. I understand that my responses will be used for analysis for this research project.  
 
5. I understand that my responses will remain anonymous. 
 
            
6. I agree to take part in the above research project.      
            
 
________________________ ________________         ____________________ 
Name of Participant Date Signature 
 
_________________________ ________________         ____________________ 
Researcher Date Signature 
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Appendix 4: Questionnaire 
 
QUESTIONNAIRE 
Name: ……………. 
Contact number: …………… 
Email: …………………….. 
 
PART 1: PERSONAL INFORMATION 
 
1) What is your gender? 
 ☐ Male              ☐ Female 
2)  Your Age: 
 ☐ Under 18  
 ☐18 to 29 years 
 ☐ 30-39 years 
 ☐ 40-49 years 
 ☐ > 50 
3) Your weight: ……………….kg 
4) Your height: ………………..cm 
5) Country of Birth: ………….………  
6) How long have you been in the UK? 
☐ Less than one year 
☐ 1- 5 years 
☐ More than 5 years 
7) What is your race/ethnicity? 
☐White/ Caucasian  ☐ Black African  ☐ Caribbean 
☐ Arab   ☐ South Asian (Indian, Pakistan and Bangladesh)  
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☐ Chinese   ☐Other Asian Background 
8) What is your religion? 
 ☐ Muslim    ☐ Christian  
 ☐ Jewish   ☐ Other  
9) Socioeconomic Status: 
    9.1 Income position: (per year) 
☐ Less than £5,200 ☐ £26,000 to £36,399 
☐ £5,200 to £10,399 ☐ £36,400 to £49,399 
☐ £10.500 to £20.000 ☐£62,400 to £77,999 
    9.2 Education level: 
☐ Did not complete primary school 
☐ Primary school 
☐ Secondary school 
☐  Diploma 
☐ Bachelor’s degree 
☐ Postgraduate degree 
    9.3 Occupation: 
☐ Employed  
☐ Unemployed 
☐ Student 
    9.4 Which best describes your occupation? 
☐ Mainly indoors 
☐ Half indoor and half outdoor 
☐ Mainly outdoors 
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PART 2: SUN EXPOSURE  
The following questions ask about your skin and how it reacts to the sun 
10)  How would you describe your skin colour? 
    ☐ Pale white; blond or red hair; blue eyes; freckles (Always burns, never tans) 
    ☐ White; fair; blond or red hair; blue or green eyes (Burns easily) 
    ☐ Cream white; fair with any hair or eye colour (Mild burn, tans average) 
 ☐ Moderate brown; typical Mediterranean skin (Rarely burns, tans easily) 
    ☐ Dark brown, Arab and Asian skin types (Very rarely burns) 
    ☐ Dark-skinned black (No burn) 
11) What areas of your body are often exposed to sunlight? (Tick more than one) 
☐Face  ☐ Hands 
☐Full arms  ☐ Half arms 
☐Full legs  ☐ Half legs 
☐Other ……………. 
12) Have you been sunbathing or used a sunbed in the last month? 
☐Yes  ☐No (go to question 15) 
13) How many times did you do that per month? 
 …………………….. 
14) How long did it take for each session? 
 …………………… 
15) Do you use sunscreen? 
☐Yes   ☐No (go to question 17) 
16) What is the sun protection factor (SPF) number of the sunscreen that you 
use must often? 
☐ 8   ☐ 45 
☐15   ☐ Other ………. 
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17) How often are you exposed directly to the sun (not through glass or window) in 
typical weekdays? (Monday- Friday)  
Please tick only one per line 
The 
time 
< 15 minutes 15 
minutes 
15-30 
minutes 
30-45 
minutes 
45-60 
minutes 
7-8 am ☐ ☐ ☐ ☐ ☐ 
8-9 am ☐ ☐ ☐ ☐ ☐ 
9-10 am ☐ ☐ ☐ ☐ ☐ 
10-11 
am 
☐ ☐ ☐ ☐ ☐ 
11-12 
am 
☐ ☐ ☐ ☐ ☐ 
12-1 pm ☐ ☐ ☐ ☐ ☐ 
1-2 pm ☐ ☐ ☐ ☐ ☐ 
2-3 pm ☐ ☐ ☐ ☐ ☐ 
3-4 pm ☐ ☐ ☐ ☐ ☐ 
4-5 pm ☐ ☐ ☐ ☐ ☐ 
   
18) How often are you exposed directly to the sun (not through glass or window) in 
typical weekends? (Saturday-Sunday) 
Please tick only one per line 
The 
time 
< 15 minutes 15 
minutes 
15-30 
minutes 
30-45 
minutes 
45-60 
minutes 
7-8 am ☐ ☐ ☐ ☐ ☐ 
8-9 am ☐ ☐ ☐ ☐ ☐ 
9-10 am ☐ ☐ ☐ ☐ ☐ 
10-11 
am 
☐ ☐ ☐ ☐ ☐ 
11-12 
am 
☐ ☐ ☐ ☐ ☐ 
12-1 pm ☐ ☐ ☐ ☐ ☐ 
1-2 pm ☐ ☐ ☐ ☐ ☐ 
2-3 pm ☐ ☐ ☐ ☐ ☐ 
3-4 pm ☐ ☐ ☐ ☐ ☐ 
4-5 pm ☐ ☐ ☐ ☐ ☐ 
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PART 3: HEALTH INFORMATION 
19) Do you suffer from any disease? 
☐ Yes   ☐ No  
If yes, do you suffer from any of the following? 
☐ Osteoporosis   ☐ Parathyroid 
☐ Liver disease   ☐ Kidney disease 
☐ Heart disease   ☐ High blood pressure 
☐ Diabetes   ☐ Cancer 
☐ Other …………………  
 If you are a female: please answer questions number 20 and 21, otherwise move to 
question number 22 
20) Are you currently pregnant? 
       ☐ Yes 
       ☐ No 
21) Are you currently breastfeeding? 
        ☐ Yes     ☐ No 
 
 22) Do you have a history of vitamin D deficiency?  
☐ Yes  ☐ No 
 23) Smoking status?    
☐ Current  
☐ Former  
☐ Never (go to question 25)  
24) How would you describe yourself? 
☐ I smoke every day  ☐ I smoke occasionally, but not every day 
 
25)  Do you drink alcohol? 
☐ Yes 
☐ No (go to question 28) 
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26) On how many days during a typical week did you usually drink alcohol, on 
average? 
Number of days…………… 
 
27) On the days that you drank alcohol, how many drinks did you have on 
average? 
  ☐ Half pint/glass of beer, lager, stout or cider 
 ☐ Single measure of spirits (e.g. whiskey, rum, vodka, gin) 
 ☐ Single glass of wine, sherry, port 
 ☐ Premixed drinks (e.g. Twodogs, Bacardi Breezer, Hooch) 
Number of drinks ………. 
PART 4: FOOD AND DIETARY ASSESSMENT 
Food frequency questionnaire 
28) Please put a tick (√ ) in the box to indicate how often ,on average ,you have eaten these 
food  
FOOD AVERUGE USE   
Once 
a day 
Twice 
a day 
Once 
a 
week 
2-3 
times a 
week 
1-3 
times a 
month 
Less than 
once a 
month 
Never 
Fresh mackerel  cooked ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
Fresh tuna cooked    ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
Fresh sardines cooked  ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
Fresh salmon  cooked ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
Canned tuna   ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
Canned sardine  ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
Canned salmon  ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
Herring  ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
Beef   ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
Pork and Ham   ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
Beef liver   ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
Pork liver ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
Egg (Whole)  ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
Yogurt    ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
Cream cheese  ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
Hard cheese (e.g 
cheddar, Swiss)  
☐ ☐ ☐ ☐ ☐ ☐ ☐ 
Butter    ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
Milk (Whole) ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
Semi-skim Milk   ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
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Margarine  ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
Sun dried mushroom ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
 
 
29) Would you describe yourself as a vegetarian or vegan? 
☐ Yes  ☐No 
 
30) How much milk do you drink each day, including with tea, coffee and 
cereal etc.? 
☐ None    ☐ 1 pint (568ml or 2 cups) 
☐ 250 ml (1 cup or mug) ☐ More than 1 pint 
 
31) Do you usually eat breakfast cereal? 
 ☐ Yes   ☐No (go to question 32) 
 
 If yes, which brand and types of breakfast cereal, did you usually eat? 
 
Brand e.g.  Kellogg’s Type  e.g. cornflakes 
  
  
 
32) Do you use any products fortified with vitamin D such as margarine, 
orange juice and breakfast cereal? 
 
     ☐ Yes   ☐ Sometimes 
 
     ☐ No    ☐ Don’t know 
 
 
33) Do you take any vitamins, minerals, fish oils or other food supplement? 
☐ Yes   ☐ No 
If yes, please complete the table below: 
Name and brand Dose please state 
number of pills or 
capsules or teaspoons 
consumed  
How often do you take 
these? 
Daily  Weekly  Monthly  
     
     
     
 
Thank you very much for completing this questionnaire.
 217 
 
 
Appendix 5: Poster 
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Appendix 7: Checklist for the procedures 
 
 Visit 1 Visit 2 Visit 3 Visit 4 
ID code Date  Consent forms 
for research 
trial & provide 
blood sample 
Anthropometric 
measurements 
Blood 
sample 
(week0) 
Intervention  
Blood 
sample 
(week 5) 
Blood 
sample 
(week 10) Height (cm) Weight (kg) allocation pre post 
           
           
           
           
           
           
           
           
 
